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ABSTRACT 
Epilepsy is associated with marked alterations in the structure and function of GABAA receptors 
in the hippocampus, a key structure for the genesis of epilepsy. Two types of inhibition are 
mediated via distinct GABAA receptors. Phasic inhibition results from the synaptic γ2-containing 
receptors, whereas tonic inhibition is primarily mediated by the continuous activation of δ-
containing, extrasynaptic receptors by ambient GABA present in the extracellular fluid. The δ-
subunit receptors exhibit greater sensitivity to neurosteroid potentiation through positive 
allosteric modulation. The abundance of δ-subunit and the extent of tonic inhibition are altered 
by physiological and pathological neuroendocrine conditions. However, the precise functional 
impact of δ-subunit on inhibition in the hippocampus and epileptogenesis remain poorly 
understood. 
The main objective of this dissertation research was to understand the role of δ-subunit-
containing GABAA receptors in the hippocampus dentate gyrus in mediation of tonic inhibition 
and epileptogenesis using a combination of electrophysiological, behavioral, and 
pharamcological techniques. We sought to understand the contribution of δ subunit to 
GABAergic inhibition and network excitability. We  incorporated a perimenstrual model of 
catamenial epilepsy in which female mice experience acute neurosteroid withdrawal. The 
correlates of receptor plasticity and function were then examined. Furthermore, the structure-
activity relationship of neurosteroids at extrasynaptic GABAA receptors was investigated in 
conducting the tonic inhibition. Alterations to hippocampus epileptogenesis of the δ-subunit 
knockout mouse as a model for hyperexcitability and susceptibility to seizures was also 
explored. Overall, these studies reveal a unique and novel role for δ-subunit-containing GABAA 
receptors as key modulators of tonic inhibition and excitability in the brain. These extrasynaptic 
receptors may represent new therapeutic targets for the control of epileptic conditions. 
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CHAPTER I 
BACKGROUND AND INTRODUCTION
*
 
I.1 GABAA Receptor Subunit Composition and Structure 
GABAA (γ-aminobutyric acid type A) receptors are composed of a pentamer of subunits, and 
each of subunit has four transmembrane domains (M1-M4) (Figure 1). The pentamer within the 
neuronal plasma membrane forms a selective channel for chloride ions when gated and opened 
by GABA. The second transmembrane domain lines the internal wall of the channel pore. There 
are at least 19 variants of GABAA receptor subunits (α1-6,β1-3,γ1-3,δ,ε,θ,π,ρ1-3). GABAA 
receptors are typically composed of two α subunits, 2 β subunits, and one γ subunit, which 
accounts for approximately 90% of GABAA receptors (Sieghart, 2006). The δ subunit can be 
assembled as the fifth subunit instead of γ, and there is high incidence of its occurrence within 
the cerebellum, thalamus, and hippocampus (Pirker et al., 2000). The functional stoichiometry 
forming the synaptic channel pore is 2α:2β:1γ (Baumann et al., 2002; Ernst et al., 2003). 
Receptors of extrasynaptic α4βδ isoform assemble functional channels with a stoichiometry of 
2α:2β:1δ (Shu et al., 2012). Due to the large degree of heterogeneity in pentamer isoforms, the 
classification of underlying GABAA receptor physiology and pharmacology has become an 
expansive field of study. 
Synaptic GABAA receptors are primarily γ2-containing channels. The α-subunit expression 
within synaptic receptors varies, but they are typically benzodiazepine sensitive (Hajos et al., 
2000). Synaptic receptors respond to vesicular release of GABA across the synapse, resulting in 
transient, phasic events. Extrasynaptic receptors are most often characterized by the inclusion of 
δ subunit rather than γ2 together with α and β2/3. Extrasynaptic receptors respond to low levels 
of ambient GABA in continuous opening of channels known as tonic inhibition. This inhibition 
results in prolonged hyperpolarization and shunting of excitatory activity. Tonic inhibition plays 
a unique role in controlling hippocampal seizures by setting the baseline excitability (Brickley 
and Mody, 2012). The α-subunit isoforms contribute to phasic or tonic inhibition differentially in 
hippocampal neurons (Prenosil et al., 2006).  The α4βδ-containing receptors are found within 
*
 Reprinted with kind permission from Springer Science and Business Media, “Neurosteroid interactions 
with synaptic and extrasynaptic GABAA receptors” by Carver CM and Reddy DS, 2013. 
Psychopharmacology, 230, 151-188, Figures 1-5, Copyright [2013] by Springer-Verlag Berlin Heidelberg. 
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dentate gyrus granule cells (DGGC) and thalamic relay neurons, whereas the expression of α6βδ 
is pervasive within and exclusive to cerebellar granule cells.  
 
 
 
 
 
 
 
Figure 1. GABAA receptor structure and subunit arrangement. GABAA receptors are heteropentamers 
made up from 19 known subunits (α1-6, β1-3, γ1-3, δ, ε, θ, π, and ρ1-3) with an integral channel that is 
permeable to Cl
-
 ion. A, A cross section of the intramembrane structure shows the Cl
-
 channel pore formed 
by M2 helical elements. Each subunit has four transmembrane segments, with both the amino and carboxy 
terminals located extracellularly. B, A top view of GABAA receptor channel, illustrated as five cylinders 
arranged to form the Cl
-
 pore by the M2 domains. The receptor is pentameric, being composed of two α, 
two β, and one γ subunit stoichiometry. The δ subunit may be assembled in the place of γ. Binding of 
GABA in the two sites at the interface between α and β subunits opens the receptor-associated Cl- channel.  
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Interneurons of the hippocampus may contain α1βδ receptors rather than containing α4 like the 
principal neurons within the dentate gyrus. In addition, α5βγ2 extrasynaptic receptors have been 
typified in CA1-3 neurons of the hippocampus (Persohn et al., 1992; Benke et al., 1997; Pirker et 
al., 2000; Wei et al., 2003; Sun et al., 2004; Mangan et al., 2005; Zheleznova et al., 2009). These 
profiles are common expression patterns, however much crossover exists in the variety of 
subunit assembly within brain regions and neuronal cell-type specificity. 
 
In the hippocampal DGGCs, α4βδ receptors are expressed primarily extrasynaptically, whereas 
α1βγ2 and α2βγ2 receptors are located at synpatic sites. However, α1, α4, γ2, and δ subunits are 
all present in the extrasynaptic or perisynaptic location of neurons (Sun et al., 2004). According 
to immunostaining studies, a population of interneurons in the molecular layer of the dentate 
gyrus also express the δ subunit, but the α4 subunit is not present (Sun et al., 2004). These 
receptors have been found to coexpress and colocalize α1 and δ subunits extrasynaptically  with 
different kinetics and pharmacology than α4/α6βδ receptors (Glykys et al., 2007). In addition, 
parvalbumin-positive interneurons in the subgranular zone of the granule layer have been shown 
to co-express α1 and δ (Milenkovic et al., 2013). Therefore, principal cells and interneurons in 
the hippocampus may have quite distinct extrasynaptic receptor composition and properties. 
Further investigations into β subunit-containing receptors have identified that β2 is a component 
of benzodiazepine-insensitive receptors contributing to extrasynaptic GABAA receptor currents 
in DGGCs, whereas β3-containing receptors are predominantly assembled in synaptic receptors 
associated with phasic current (Herd et al., 2008). 
 
I.2 Neurosteroid Background 
Neurosteroids are steroids synthesized within the brain with rapid effects on neuronal 
excitability. The term neurosteroid was coined in 1981 by the French endocrinologist Etienne-
Emile Baulieu to refer to steroids that are synthesized de novo in the nervous system, 
independent of the peripheral steroidogenic endocrine glands (Baulieu, 1981). Subsequently, the 
term neuroactive steroid has been widely used to describe natural or synthetic steroids that 
rapidly alter the excitability of neurons by binding to membrane-bound receptors (Paul and 
Purdy, 1992; Kulkarni and Reddy, 1995; Reddy 2003a). From the pioneering work of Hans 
Selye, it has been known that naturally occurring steroids such as the ovarian steroid 
progesterone and the adrenal steroid deoxycorticosterone can exert anesthetic and anticonvuslant 
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actions (Selye, 1941). Recognizing that some steroids could produce acute central nervous 
system effects, researchers at the pharmaceutical company Glaxo identified the synthetic steroid 
alfaxolone as having anesthetic properties. Alfaxolone was found to enhance synaptic inhibition 
via binding to GABAA receptors in the brain (Scholfield, 1980; Harrison and Simmonds, 1984). 
 
A major advance occurred when 5α-reduced metabolites of progesterone and 
deoxycorticosterone were found to enchance GABAA receptor function (Majewska et al., 1986; 
Kulkarni and Reddy, 1995). The anesthetic and anticonvulsant properties of progesterone and 
deoxycorticosterone, known since the time of Selye, are due to their conversion to 
allopregnanolone (3α-hydroxy-5α-pregnane-20-one, AP) and allotetrahydrodeoxycorticosterone 
(3α,21-dihydroxy-5α-pregnane-20-one, THDOC), respectively (Reddy, 2003b) (Figure 2). The 
androgenic neurosteroid androstanediol (5α-androstan-3α,17β-diol, AD) is synthesized from 
testosterone. There is compelling evidence that all the enzymes required for the conversion of 
the steroid hormone precursors to their active 5α-reduced metabolites are present in the brain, 
and therefore their synthesis from cholesterol can occur locally (Kulkarni and Reddy, 1995; Do 
Rego et al., 2009). Therefore, AP, THDOC, and androstanediol can be considered endogenous 
neurosteroids (Reddy, 2011). Since neurosteroids are highly lipophilic and can readily cross the 
blood-brain barrier, neurosteroids synthesized in peripheral tissues accumulate in the brain. 
Pregnenolone, its sulfate ester pregnenolone sulfate (PS), dehydroepiandrosterone (DHEA), and 
its sulfate ester, DHEAS, are also present in the brain and could elicit rapid effects in enhancing 
neuronal excitability as negative modulators of GABAA receptors. 
 
GABAA receptors are responsible for the majority of inhibitory activity within the brain. 
Increasing evidence points to the vast array of potent effects that endogenous neurosteroids have 
on GABAA receptors in modulating brain inhibition (Reddy 2013a, b). GABAA receptors are 
membrane-bound, ligandgated ion channels which, when activated by GABA, hyperpolarize 
neurons through influx of negatively charged chloride ions in the adult brain. At birth, the 
chloride driving force is positive such that GABA transmission causes depolarization. As the 
brain matures, a negative shift in the chloride ion reversal potential alters the electrochemical 
gradient to allow for inward current flow upon GABAA receptor channel opening (Rivera et al., 
1999). The hyperpolarizing current serves to reduce neuronal excitability and short-circuit action 
potential firing. Inhibitory GABAA receptors are heterogenic, possessing a high degree of 
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variation in their subunit composition and pharmacodynamics. GABAA receptor agonist and 
antagonist ligands each have distinct affinity and efficacy for receptor isoforms (Mitchell et al, 
2008; Uusi-Oukari and Korpi, 2010). Inhibitory network control by GABAA receptors is 
essential to maintain proper neuronal function for motor actions, cognition, autonomic activity, 
and nearly every other function of the brain. For the purposes of this dissertation, discussion will 
be centered on neurosteroid and GABAA receptor interaction as it pertains to limbic structures, 
specifically the hippocampus. 
 
The human brain contains approximately 100 billion neurons. An estimated 20-30% of the 
neurons within the central nervous system are GABAergic. Activation of neuronal GABAA 
receptors typically results in hyperpolarization, and thus, GABA is the major inhibitory 
neurotransmitter in the brain. In the general scheme of feed-forward and feed-back interactions 
between principal neurons and interneurons, inhibitory circuits play a critical role in regulating 
network excitability. By controlling spike timing and sculpting neuronal rhythms, inhibitory 
GABAergic interneurons play a key role in regulating neuronal circuits. 
 
I.3 Neurosteroid Biosynthesis and Regulation in the Brain 
Neurosteroids are synthesized de novo in the brain or derived in peripheral endocrine tissues 
from metabolism of classical steroids such as progesterone, deoxycorticosterone, and 
testosterone. Reduction reactions are catalyzed by 5α-reductase and subsequently 3α-
hydroxysteroid oxidoreductase (3α-HSOR) (Figure 2). AP and THDOC are classified as 
pregnane steroids, and they are the most commonly studied endogenous neurosteroids (Belelli 
and Lambert, 2005). AP is synthesized from progesterone, and THDOC is synthesized from 
deoxycorticosterone. Pregnenolone, progesterone, and deoxycorticosterone are pregnane steroid 
precursors and also exhibit neuroactive effects. The androstane class of neurosteroids, including 
androstanediol (AD), androsterone (AN), and etiocholanolone (ETIO) are derived from 
testosterone (Reddy, 2004b; Kaminski et al., 2006; Reddy, 2008). Estradiol has neuroactive 
effects in modulating GABAergic substrates and regulation of neuronal plasticity to promote 
excitability, especially within the hippocampus (Herzog, 2009). Synthesis of estradiol can occur 
through the aromatase-driven modification of testosterone, which could serve as an endogenous 
regulator of neuronal excitability in men, as well as women (Herzog, 1999). 
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Figure 2. Biosynthetic pathways of prototypical endogenous neurosteroids. Enzymatic pathways for 
the production of three protoype neurosteroids allopregnanolone, THDOC, and androstanediol are 
illustrated from cholesterol and intermediate steroid precursors. Cholesterol is converted to pregnenolone 
by P450cc in the inner mitochondrial membrane. Pregnenolone is the precursor for progesterone and other 
neurosteroids. Progesterone, deoxycorticosterone, and testosterone undergo two sequential A-ring 
reduction steps catalyzed by 5α-reductase and (3α-HSOR) to form the 5α,3α-reduced neuroactive steroids. 
The conversion of progesteron, deoxycorticosterone, or testosterone into neurosteroids occurs in several 
regions within the brain. The 5α-reductase, 3α-HSOR, and other enzymes are present within the brain. 
P450scc: cholesterol side-chain cleavage enzyme, 3β-HSD: 3β-hydroxysteroid dehydrogenase, 3α-HSOR: 
3α-hydroxysteroid oxidoreductase, 17β-HSD: 17β-hydroxysteroid dehydrogenase, P450c21: cytochrome 
P450 21-hydroxylase  
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Neurosteroids reach neuronal GABAA receptors from the periphery or local brain tissue. 
Precursor steroids may enter the brain from the blood circulation and can be converted to 
neurosteroids (Agis-Balboa et al., 2006). Subcutaneous injection of progesterone rapidly elevates 
plasma and brain levels of AP in rodents, even in the case of animals in which the progesterone 
receptor gene is removed (Reddy and Mohan, 2011). The drug finasteride is used as a tool to 
inhibit endogenous neurosteroid biosynthesis, as it has strong specificity in blocking the activity 
of type II 5α-reductase conversion to their 5α-dihydro-reduced form (Reddy, 2010; Reddy and 
Ramanathan, 2012). 
 
In addition to peripheral production and humoral delivery, it is clear that neurosteroids can be 
formed locally in the brain from steroid hormone precursors. 5α-Reductase activity has been 
identified in both neurons and glia in rodent and sheep brain within regions such as the neocortex 
and hippocampus (Melcangi et al., 1998; Petratos et al., 2000). 3α-HSOR is also widely 
expressed in the brain (Khanna et al., 1995). In humans, both enzymes have been found in 
neocortex and hippocampus (Stoffel-Wagner et al., 2000, 2003; Stoffel-Wagner, 2001). Taken 
together, all of the necessary enzymes required for steroid synthesis are region specific, cell 
specific, and available within the neural tissue, both in neurons and glia (Compagnone and 
Mellon, 2000; Porcu et al., 2009). 
 
I.4 Neurosteroid Modulation of GABAA Receptors 
The endogenous neurosteroids AP, THDOC, and androstanediol are positive allosteric 
modulators of GABAA receptors, which modify the natural affiinity and/or efficacy of GABA 
and thereby exert control over neuronal excitability. At concentrations in the range 10-500 nM, 
AP and THDOC enhance the activation of GABAA receptors by GABA (Harrison et al., 1987; 
Kokate et al., 1994; Reddy and Rogawski, 2002). At higher concentrations, these neurosteroids 
directly activate the receptor without the requirement of GABA agonist activity. The exact 
binding sites are not well understood; the location and maximal number of neurosteroid binding 
sites are not clearly established. Therefore, there is no validated assay for measuring the direct 
binding of neurosteroids to GABAA receptors. Alternative or allosteric binding assays are 
commonly used to study neurosteroid-GABAA receptor interactions. Unlike benzodiazepines 
(which enhance the channel open frequency) or barbiturates (which increase the channel open 
duration), neurosteroid positive allosteric modulation of GABAA receptors occurs in a hybrid 
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fashion, increasing both the frequency and duration of channel opening (Twyman and 
Macdonald, 1992; Hosie et al., 2007, 2009; Lambert et al., 2009; Ramakrishnan and Hess, 2010). 
Moreover, neurosteroids operate on a wider array of receptor isoforms than classical 
benzodiazepines. Thus, neurosteroids greatly enhance the probability of GABAA receptor 
chloride channel opening, thereby enhancing GABAA receptor-mediated inhibition. 
 
Consistent with potentiation effects at the cellular level, endogenous neurosteroids like AP and 
THDOC are capable of sedative, anxiolytic, and anticonvulsant behavioral effects on the central 
nervous system (Reddy and Kulkarni, 1997; Reddy, 2003a, 2011; Reddy and Zeng, 2007). It is 
important to understand the systemic pharmacological effects of neuromodulatory agents. 
Structure-activity studies of neurosteroid potentiation of GABA-gated currents revealed unique 
structural features of neurosteroids (Harrison et al., 1987; Gee et al., 1988). A range of steroid 
structures have activity as positive modulators of GABAA receptors in agreement with the 
hydrophobic surface binding site model. Nevertheless, there are certain strict structural 
requirements for neruosteroid positive modulation. A hydrogen bond-donating 3α-hydroxy 
group on the steroid A-ring and a hydrogen bond-accepting group (typically a keto moiety) on 
the D-ring at either C20 of the pregnane steroid side chain or C17 of the androstane ring system 
are critical for positive modulatory activty at GABAA receptors (Purdy et al., 1990; Lambert et 
al., 2003). Structural configurations of α and β neurosteroid epimers have highly differential 
effects on GABAA receptor function, owing to the stereoselectivity of binding. The orientation of 
the C5 hydrogen group only modestly influences potency, such that 5β-epimers are less potent 
than the corresponding 5α-epimers (Kokate et al., 1994). Behavioral, electrophysiological, and 
pharmacological data substantiate that 5α-reduced steroids, but not 5β-reduced steroids possess a 
high level of enantiospecificity and selectivity in function of GABAA receptor modulation and 
anesthetic efficacy (Covey et al., 2000). However, these data have yet to be substantiated in 
functional studies of neurosteroid activity on extrasynaptic receptor currents.  
 
Neurosteroids can act as autocrine factors in principal neurons or interneurons. Although 
neurosteroids are viewed as high potency modulators of GABAA receptors since they are 
effective at concentrations in the nanomolar range in aqueous solution, recent studies indicate 
that neurosteroid binding to the GABAA receptor is actually of low affinity (true membrane 
EC50, ~1 mM) (Chisari et al., 2010). The high effective potency of neurosteroids results from 
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partitioning of the lipophilic steroids within the plasma membrane, such that the concentrations 
accessible to the receptor are orders of magnitude greater. Neurosteroids access the GABAA 
receptor from the lipohilic plasma membrane. The nonspecific accumulation and removal of the 
neurosteroids from the membrane are the major factors determining the rates of neurosteroid 
action when applied to cells via aqueous solution; rates of binding and unbinding are only 
secondary factors (Chisari et al., 2009). It is noteworthy that intracellular delivery through the 
plasma membrane is compatible with the autocrine mechanism discussed above, in which the 
neurosteroids act on GABAA receptors in the same neurons in which they are produced 
(Saalmann et al., 2007). 
 
Endogenous neurosteroids often have low availability due to the rapid inactivation or conversion 
into other steroidal products. To overcome these limitations, synthetic neurosteroid analogs have 
been developed for therapeutic use (Reddy and Kulkarni, 2000; Figure 3). Analogs also serve as 
pharmacological tools to better understand specific ligand binding characteristics of 
neurosteroids based on their conserved lipophilic properties. Ganaxolone (3α-hydroxy-3β-
methyl-5α-pregnan-20-one, GNX) is an analog of AP, which is altered to include a β-methyl 
group at the C3 position (Carter et al., 1997; Reddy and Woodward, 2004). GNX posesses 
sedative and anticonvulsant effects and positively modulates GABAA receptors allosterically, 
similar to AP (Reddy and Rogawski, 2010). It is the only neurosteroid analog thus far to be 
considered in human clinical trials for the treatment of epilepsy (Nohria et al., 2010). Alfaxalone 
is a general anesthetic that has been well classified in GABAA receptor binding characteristics. 
The synthetic derivative minaxolone has been shown to induce an extrasynaptic, GABAergic 
conductance, similar to AP at 1 µM concentrations (Mitchell et al., 2007). These analogs have 
the ability to potentiate GABAA receptors and induce sedative, anticonvulsant, anesthetic, or 
anxiolytic actions, very similar to the endogenous neurosteroids. Their positive interaction with 
receptors verifies that neurosteroid structural selectivity is reliant on conserved sites to bind and 
enhance GABAergic function. 
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Figure 3. Chemical structures of synthetic neurosteroids. Alphaxolone (alfaxolone, ALFX) is an 
analog of AP in the addition of the C11 position ketone with a conserved C17 group. Alphadolone is an 
analog of THDOC in the addition of the C11 position ketone with a conserved C17 group. Ganaxolone is 
an analog of AP in the addition of the C3β-position methyl group, but retaining the 3α-hydroxyl structural 
feature. Minaxolone contains a C2 position ethoxyl group and the C11 position dimethylamino group. 
Ganaxolone is the only synthetic neurosteroid to that is currently undergoing testing in clinical trials for 
the modulation of seizures.  
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While neurosteroids are able to modulate both synaptic and extrasynaptic receptors (Figure 4), 
there are clear differencies in efficacy between γ-containing and δ-containing receptors (Pillai et 
al., 2004) as well as differences between the composition of α subunits (Belelli et al., 2002; see 
Table 1). While much has been determined concerning the subunit isoform influences on 
GABAA receptor properties, most comparative information has been uncovered using 
heterologous expression systems rather than native neurons. The δ-containing receptors produce 
a much higher maximal response to neurosteroids (Brown et al., 2002), and they possess unique 
functional actions at extrasynaptic and dendritic sites, where they respond to low levels of 
ambient GABA (Wei et al., 2003; Semyanov et al., 2004). δ-containing receptors participate in a 
distinctive role to control the excitability of the hippocampus and other neuronal regions by 
setting a baseline level of inhibitory current. Therefore, receptors that are attuned to 
extrasynaptic concentrations of GABA (low-efficacy) can be modulated by endogenous agents 
like neurosteroids that can finely adjust and potentiate tonic inhibition (Stell et al., 2003; Farrant 
and Nusser, 2005). Knockout studies reveal that α4βδ and α5βγ2 subunit-containing receptors 
mediate the majority of tonic inhibition in DGGC and CA1 hippocampal neurons, respectively 
(Caraiscos et al., 2004; Glykys et al., 2008). Similarly, neurosteroids have high affinity for the 
α6βδ-containing GABAA receptors, which are responsible for tonic inhibition within cerebellar 
granule cells (Hadley and Amin, 2007; Meera et al., 2011). 
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Figure 4. Neurosteroid modulation of synaptic and extrasynaptic GABAA receptors. Postsynaptic 
GABAA receptors are pentameric chloride channels composed of 2α:2β:1γ subunits and mediate the phasic 
GABAergic inhibition. Extrasynaptic GABAA receptors are pentamers composed of 2α:2β:δ subunits and 
primarily contribute to tonic inhibition in the dentate gyrus, thalamus, and cerebellum. Neurosteroids 
activate both synaptic and extrasynaptic receptors and enhance the phasic and tonic inhibition, thereby 
promoting maximal net inhibtion. The trace illustrating phasic inhibition depicts an IPSC produced by 
endogenous GABA vesicle release (black) and in the presence of 300 nM allopregnanolone (blue). 
Neurosteroids enhance IPSCs by prolonging the deactivation/decay kinetics, resulting in a longer mean 
channel open time. The trace illustrating tonic inhibition shows continuous, non-desensitizing chloride 
conductance activated by GABA (black bar) that was further potentiated by application of AP (blue bar). 
Bicuculline (BIC, red bar) blocks both phasic and tonic portions of GABAergic current. 
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Table 1. GABAA receptor pharmacological efficacy and potency 
Drug 
Interaction 
Efficacy Potency References* 
AP and αxβ1γ2 α4 > α1 > α6 > α5 > α3 > 
α2 
α3 > α1 > α2 > α6 > α5 > α4 Belelli et al., 2002; 
Mortensen et al., 2012 
AP and αxβ2/3δ α6 > α4 α4 > α6 Brown et al., 2002; 
Pillai et al., 2004; 
Mortensen et al., 2012 
THIP α6β3γ2 > α1β2/3γ2 > α4β3γ2 
> α4β3δ > α6β3δ 
α6β3δ  > α4β3δ > α6β3γ2 > 
α4β3γ2  > α1β2/3γ2   
Saarelainen et al., 2008; 
Mortensen et al., 2012; 
Meera et al., 2011 
DS1 (δ-selective 
compound 1) 
α4β3δ > α4β3γ2 > α1β3γ2 α4β3δ > α4β3γ2 > α1β3γ2 Wafford et al., 2009 
DS2 (δ-selective 
compound 2) 
α4β2/3δ ≈ α6β2δ >> α4β3γ2 
≈ α1β3γ2 
α4β2/3δ ≈ α6β2δ >> α4β3γ2 
≈ α1β3γ2 
Wafford et al., 2009; 
Jensen et al., 2013 
*All data derived from heterologous expression systems in Xenopus oocytes or HEK293 cells.  
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Allopregnanolone-like neurosteroids are powerful anticonvulsants. Exogenously administered 
neurosteroids exhibit broad-spectrum anticonvulsant effects in diverse rodent seizure models 
(Reddy, 2010). Neurosteroids display rapid anticonvulsant activity and provide protection within 
minutes. Neurosteroids protect against seizures induced by GABAA receptor antagonists, 
including pentylenetetrazol and bicuculline, and are effective against pilocarpine-induced limbic 
seizures and seizures in kindled animals (Kokate et al., 1994; Belelli et al., 1989; Frye, 1995; 
Wieland et al., 1995; Reddy, 2004a,b; Reddy et al., 2010; Reddy and Rogawski 2010; Reddy and 
Kuruba, 2013). Like other GABAergic agents, neurosteroids are inactive or only weakly active 
against seizures elicited by maximal electroshock. Neurosteroids are highly active in the 6-Hz 
model, a paradigm in which limbic-like siezures are induced by electrical stimulation of lower 
frequency and longer duration than in maximal electroshock test (Kaminski et al., 2005, 2006). 
Neurosteroids are also highly effective in suppressing seizures due to withdrawal of GABAA 
receptor modulator drugs including neurosteroids, benzodiazepines, and alcohol, which may act 
in part through GABAA receptors, and cocaine, which does not (Tsuda et al., 1997; Devaud et 
al., 1996; Reddy and Rogawski, 2000a, 2001; Reddy et al., 2012). In contrast to 
benzodiazepines, where utility in the chronic treatment of epilepsy is limited by reductions in 
efficacy over time, anticonvulant tolerance is not obtained with neurosteroids (Kokate et al., 
1998; Reddy and Rogawski, 2000b). Thus, neurosteroids have the potential to be used in the 
chronic treatment of epilepsy, and this has been evident in clinical trials (Nohria et al., 2010). 
 
I.5 GABAA Receptor Pharmacology 
Each GABAA receptor has two α-β subunit interfaces. GABA binds to the α-β interface to allow 
channel opening such that two GABA molecules may gate the receptor. The two interfaces differ 
in local environment based on the adjacent subunits (γ and β or α and γ) and therefore display 
some differences in agonist preferences (Baumann et al., 2003). Muscimol is a potent agonist for 
the GABA binding site and is often used to quantify pharmacology regarding allosteric binding 
of GABAA receptors by other agents. 4,5,6,7-Tetrahydroisoxazolo[5,4-c]pyridine-3-ol 
(gaboxadol, THIP) is a hypnotic agent and a partial agonist for GABAA receptors with a higher 
selectivity for δ-containing receptors (Ebert et al., 1997; Wafford and Ebert, 2006; Herd and 
Belelli, 2007; Herd et al., 2008), but displays different degrees of agonist binding that is 
dependent on the α subunit isoform included (Stórustovu and Ebert, 2003). The involvement of 
the δ-subunit in GABAA receptors confers a high THIP potency (Meera et al., 2011). GABA and 
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THIP have higher potency on α4β3δ than α4β3γ2L recombinant receptors expressed in Xenopus 
oocytes (You and Dunn, 2007). Furthermore, THIP has a higher efficacy than GABA for δ-
containing receptors, but THIP has lower efficacy than GABA for γ2-containing receptors 
(Stórustovu and Ebert, 2006; Saarelainen et al., 2008). As potent receptor ligands, THIP and 
muscimol exhibit different degrees of agonist response in interaction with extrasynaptic function 
with high potency at α4/α6,β3δ receptors (Brown et al., 2002). High concentrations of THIP on 
α4β3δ receptors allow for longer and more frequent channel openings, while muscimol binding 
reduces the desensitization of the receptor (Mortensen et al., 2010). In comparison of α4β2δ and 
α4β3δ receptors, there does not seem to be a significant difference in the potency of GABA 
binding, signifying a less imperative role for β subunit variety dictating agonist binding 
properties (Mortensen et al., 2012). 
 
Extracellular concentration of GABA has been predicted to be 0.4 µM at resting membrane 
potential (-80 mV) and 3.1 µM during depolarization (+20 mV) (Attwell et al., 1993). 
Extracellular GABA in the rat hippocampus has been measured to be between 0.8 and 2.9 µM 
using microdialysis (Lerma et al., 1986). Extracellular concentrations of extrasynaptic GABA 
have been estimated to be approximately 160 nM in experimental slice preparations 
(Santhakumar et al., 2006). GABA transporters likely have an important and dynamic role in 
controlling extracellular levels of GABA responsible for tonic inhibition (Richerson and Wu, 
2003) (Figure 5). The prevalent perception is that surplus GABA spillover from vesicular 
synaptic release contributes to tonic current in neurons with δ-containing receptors (Hamann et 
al., 2002; Wei et al., 2003; Glykys and Mody, 2007). 
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Figure 5. The GABAergic synapse and GABA reuptake. GABA, which is released from presynaptic 
vesicles, serves as the main fast inihbitory neurotransmitter in the brain by activation of postsynaptic 
GABAA receptors. A variety of chemical compounds are capable of binding to GABAA receptors to 
modulate its chloride channel function. Apart from GABA agonist sites, the receptor has specific sites for 
benzodiazepines, barbiturates, and neurosteroids, which are allosteric sites of modulation. GABA 
transporters in neurons (GAT-1) and glia (GAT-2/3) remove synaptically released GABA, thereby 
limiting or terminating its inhibitory action. Reuptake into terminals permits immediate recycling by 
vesicular uptake, whereas reuptake into astrocytes leads to metabolism via GABA-transaminase (GABA-
T) and succinic semialdehyde (SSA) and glutamate. Binding of neurosteroids to their binding site(s) 
enhances the effect of GABA by increasing the frequency and duration of channel opening.  
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While there have been early attempts to determine binding patterns for neurosteroids, the true 
ligand-binding properties for neurosteroid-GABAA receptor interaction remain unclear. 
Neurosteroids have distinguishable binding sites from benzodiazepines, which act only on 
GABAA receptors containing γ subunits and those that do not have α4 or α6 subunits. 
Neurosteroids have been shown to possess a different binding site from barbiturates, though they 
share various similarities in receptor-mediated functions. The lipophilic properties of 
neurosteroids influence potency and affinity for GABAA receptors (Chisari et al., 2009). 
Molecular evidence shows that a C3,α-hydroxyl group and a C20 position ketone group on 
pregnane neurosteroids or a C17 ketone on androstane neurosteroids are essential for binding 
affinity (Mitchell et al., 2008). This suggests specificity in a binding pocket and interaction with 
certain residues yet to be fully clarified. Although the exact location of binding has not been 
mapped, it has been proposed that there are two distinct sites for neurosteroids that act as 
positive modulators: one for allosteric enhancement of GABA and another for direct activation 
of the receptor. There is also a negative modulatory site for sulfated neurosteroids involving the 
M2 region of the α subunit (Akk et al., 2001; Lambert et al., 2003; Hosie et al., 2006, 2007).  
Using site-directed mutagenesis, it has been shown that a highly conserved glutamine at position 
241 in the M1 domain (toward the intracellular side) of the α subunit plays a key role in 
neurosteoid modulation of GABA responses and is believed to contribute to the binding site for 
modulation (Hosie et al., 2009). Additional nearby residues in the M4 domain of the same α 
subunit (tyrosine 410 and asparagine 407, toward the extracellular side) have also been proposed 
to contribute to binding. Other investigators have found that mutations in serine 240 and 
tryptophan 245 of the α subunit interfere with neurosteroid potentiation. Multiple studies with 
structurally diverse steroids have led to the conclusion that the steroid binding pocket on the α 
subunit is more correctly viewed as a hydrophobic surface that can accommodate steroid 
molecules of different structures (Akk et al., 2009). Direct activation of the receptor, in contrast, 
has been proposed to be due to steroid binding at a site on the interface between β and α subunits 
formed by a threonine at position 236 in the α subunit and a tyrosine at position 284 in the β 
subunit (Hosie et al., 2007). However, more recent models of the GABAA receptor have 
questioned whether these residues reside at the β-α subunit interface. A photo-incorporable 
analog of the anesthetic etomidate appears to bind at the interface, but binding of this ligand is 
not competitively inhibited by neurosteroids (Li et al,. 2009). The β subunit has been less 
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prominently studied than α subunit in regard to neurosteroid binding. Early reports suggested 
that the β subunit does not appear to possess an influential role in neurosteroid interaction with 
GABAA receptors (Lambert et al,. 2003). However, β2 subunits are preferentially assembled in 
extrasynaptic channels with high neurosteroid affinity and β2 deficiency reduces tonic inhibition, 
while β3 subunit-containing receptors are mostly synaptic, based on dentate gyrus studies (Herd 
et al., 2008). Manipulation of the M1 domain of the β2 subunit has an effect on the spontaneous 
activity of extrasynaptic receptors (Baker et al., 2010). The extracellular domain loop 9 of the β2 
subunit has been shown to steady the closed-state gate of the α1 β2γ2S synaptic GABAA 
receptors, and this has indirect consequences on receptor efficacy in GABA activation and the 
allosteric modulation by propofol and pregnanolone (Williams et al., 2010).  
 
A recent report identified a novel β3 subunit transmembrane domain involved in neurosteroid 
binding (Chen et al., 2012). While β isoforms have been found to influence tonic current (Herd 
et al., 2008), it is still unclear if they significantly affect neurosteroid modulation. The δ subunit 
is integral to the high sensitivity of neurosteroid-receptor interaction (Brown et al., 2002). The δ 
subunit is not germane to the actual neurosteroid binding site for opening of the channel but 
rather is involved in the transduction of the GABA-gated response subsequent to initial binding 
(Hosie et al., 2009). Channels of α4β2δ do not differ in GABA potency from channel pentamers 
composed of α4β2 (Mortensen et al., 2012). Moreover, recombinant receptors modified to 
contain a single functional GABA agonist site and/or a single proposed allosteric site are 
adequate in elicting potentiation by AP, due to the potent sensitivity to steroids (Bracamontes et 
al., 2011). Physiological receptors have much more diverse kinetics relative to direct and 
allosteric neurosteroid binding, and the details surrounding those binding targets remain unclear. 
However, the δ subunit possesses an intrinsic property to increase channel opening probability in 
potentiating current. Therefore, the α-β interface without δ may permit neurosteroid affinity, but 
the δ incorporation provides a potentiating shift for longer channel opening and gating of current 
(Bianchi et al., 2002). Mutation in the M2 region of δ-containing receptors decreases the potency 
of the positive allosteric modulators THDOC and tracazolate, which typically potentiate GABAA 
receptors at low-efficacy (Zheleznova et al., 2008). In addition, the S238-V264 domain of the δ 
subunit (including M1 and the intracellular loop connecting to M2) has been identified to 
influence the high level of agonist sensitivity to α4β3δ receptors apparent in both measures of 
efficacy and potency (You and Dunn, 2007). Binding of receptor is not likely to occur at theses δ 
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subunit domains by either GABA or neurosteroid, but these domains nevertheless have profound 
tranduction effects on channel gating. 
 
Despite the fact that neurosteroid function diverges from the classical steroid role of diffusion 
across the membrane to act through nuclear receptors, the lipophilic structure of neurosteroids 
permits their movement in cells and the plasma membrane similarly to other steroids. 
Potentiation of GABAA receptor channels occurs upon application of AP to the inner leaflet of 
transfected membrane in an inside-out patch configuration (Akk et al., 2005). In conjunction 
with other data showing the ability of neurosteroids to reach receptors through lateral diffusion 
or from intracellular paths, this substantiates that neurosteroids are able to modulate current 
through routes other than extracellular access (Akk et al., 2009). Access via a hydrophobic 
pocket of the receptor within the membrane bilayer therefore remains a feasible biochemical 
explanation for mechanism of neurosteroid binding and affinity. 
 
I.6 Electrophysiological Basis of GABAergic Current 
 
Pharmacological modulation of GABAA receptors is measured by inhibitory conductance and 
channel kinetics, which provide important insights to the differences between phasic and tonic 
receptors. Neurons with high expression levels of extrasynaptic receptors involved in tonic 
current have distinct, unique properties from neurons with primarily phasic input (Stell and 
Mody, 2002). Single channel patches of neuronal membrane GABAA receptors possess channel 
gating properties of sensitivity and comparatively fast recovery of inward current. Synaptic 
inhibition is characterized by biphasic (fast followed by slow) desensitization and delayed 
deactivation of the channel’s inward current in response to GABA, and this is typified by the αβγ 
population of receptors which are prominent at the postsynaptic membrane. In contrast, 
extrasynaptic receptors are exemplified by a single phase of decay, more rapid deactivation, and 
a lesser degree of desensitization to GABA-induced current (Bianchi et al., 2001; Brown et al., 
2002; Kaur et al., 2009). Specific residues of the δ subunit M1 domain and N terminus are 
necessary for the observed extrasynaptic desensitization kinetics, and mutations in the same 
region of γ2L result in increased fast deactivation (Bianchi et al., 2001). Endogenous 
neurosteroids modify neuronal GABAA receptor current by increasing the channel opening 
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duration, prolonging slow deactivation, and delayed recovery from desensitization (Zhu and 
Vicini, 1997; Wohlfarth et al., 2002). 
 
Since extracellular GABA is responsible for setting the inhibitory tone, GABA transport and its 
maintenenance within brain have large bearing on the control of tonic current. Depletion or 
inhibition of GAT-1 raises levels of GABA, and this has been explored as a therapeutic target for 
anxiolytic, depressive, and epileptic disorders (Kristensen et al., 2011). The GABA transporters 
may serve roles beyond recylcing GABA into the axon terminal for vesicular release. GABA 
transport and reuptake also displays a significant role in modulating the level of baseline tonic 
current for dendritic regions of the neuron. Furthermore, allosteric modulators of tonic current 
undergo regulation of receptor binding sensitivity due to GABA transporters (Fleming et al., 
2011). Altered sodium electrochemical gradients may contribute to ambient extracellular GABA 
by reversing the direction of GAT-1 transport (Attwell et al., 1993; Wu et al., 2006, 2007). In 
addition, GABA synthesis itself is significant in extrasynaptic function, as lack of GAD65 
reduces tonic inhibition (Walls et al., 2010). 
 
GABAA receptor-mediated tonic currents function based on a mechanism of control derived 
from channel properties and other exogenous stimuli (McCartney et al., 2007; Ransom et al., 
2010). Certain neuronal regions exhibit high degrees of tonic inhibition determined by channel 
opening kinetics, even though tonic inhibition is observed throughout the brain. Neurosteroids 
have been shown to selectively potentiate GABAA receptor inhibition in a fashion independent to 
subunit composition, as revealed by switching the polarity of efficacy in αβγ and αβδ 
populations (Bianchi and Macdonald, 2003). The intrinsic low-efficacy activity of physiological 
δ-containing receptors is exemplified by brief channel openings and low levels of 
desensitization. The low-efficacy characteristics enable neurosteroids to increase the mean 
channel open time in their potent modulation of receptors. Neurosteroids acting on α4β3δ 
receptors display a greater efficacy than on α4β3γ2 receptors (Brown et al., 2002). Mutation of 
residue L286S of the δ subunit modifies GABAA receptors to higher efficacy and channel 
characterisitics similar to that of γ-containing receptors (Zheleznova et al., 2008). Furthermore, 
differences in gating are expressed through altering α subunit isoforms. With a saturating 
concentration of GABA (1 mM), α1β3δ channels desensitize slowly, deactivate rapidly, and 
exhibit peak-amplitude voltage-dependence. In contrast, α6β3δ channels have voltage-dependent 
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desensitization and slower deactivation but do not show rectification (Bianchi et al., 2002). 
Therefore, it is not necessarily the subunit composition per se that confers the neurosteroid 
capacity to modulate tonic current. The channel efficacy properties of the subunit phamacophore 
confer the potent affinity  for endogenous neurosteroids. As neurosteroids interact with 
extrasynaptic GABAA receptors, the high-affinity binding increases gating efficacy and is 
manifested as potent inhibitory function. 
 
Tonic current is typically quantified through whole-cell, voltage-clamp recording of a brain slice 
preparation. Inhibitory activity is represented in terms of conductance which is normalized by 
cell membrane capacitance as current density (pA/pF). This allows for control of variability 
based on the membrane surface area contributing to overall capacitance. Baseline currents are 
initially measured and averaged form epoch increments to signify GABAergic-mediated current. 
Saturating concentrations of GABAA receptor antagonist bicuculline or gabazine (SR-95531) are 
then applied to the recording chamber to identify the loss of current due to blocking of the ion 
channel. Extrasynaptic channels have been previously classified as relatively insensitive or 
resistant to gabazine due to inability to inhibit GABAA receptors that are active in the absence of 
GABA (Bai et al., 2001; Yeung et al., 2003; McCartney et al., 2007). However, these data were 
based on pyramidal cell tonic currents, which display lower levels of chloride conductance than 
δ-containing DGGCs, and gabazine antagonism is largely concentration dependent (Stell and 
Mody, 2002; Stell et al., 2003; Houston et al., 2012). Upon pharmacological antagonism, the 
change in current from active to blocked condition is quantified to calculate the tonic 
conductance for the cell. GABA transporter and uptake blockers, such as the GAT-1 inhibitor 
NO-711, may maintain or increase exogenous levels of GABA and may even enhance tonic 
inhibition without altering phasic current (Nusser and Mody, 2002). 
 
I.7 Functional Characteristics of δ-containing Receptors 
In addition to distinctive pharmacological affinities, δ-containing GABAA receptors also possess 
unique current-gating properties that play a role in control of neuronal excitability. Knockout 
mouse models allow for disambiguation of properties influencing GABAergic current. At the 
time of the creation of the first δ knockout (δKO) mouse in 1999, little was known about the 
extent of neurosteroid interaction with δ-containing GABAA receptors. The construction and 
classification of the δKO was seminal in discerning the true activity and physiology of 
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neurosteroids at GABAA receptors. The initial δKO demonstrated that removal of δ subunit 
substantially diminishes neuronal sensitivity to neurosteroids (Mihalek et al., 1999). Alfaxolone 
potentiation is lessened in δKOs, accompanying reduction in hippocampal expression of α4 
subunit (Spigelman et al., 2003). The hypnotic activity of THIP is reduced when administered to 
δKO mice, signifying high affinity for THIP at δ-containing receptors (Boehm et al., 2006; 
Meera et al., 2011). The δKO mice display lower behavioral impairment and reduced binding 
sensitivity to muscimol, the high-affinity GABAA receptor agonist (Chandra et al., 2010). The δ-
specific profiles confirm shifts in channel gating due to endogenous neurosteroid modulation 
(Wohlfarth et al., 2002), which is attenuated in the δ-deficient model (Stell et al., 2003). 
 
Knockout constructs and electrophysiology have revealed that the dentate gyrus has high levels 
of GABAA receptor expression (Pirker et al., 2000; Peng et al., 2002). α4βδ extrasynaptic 
receptors comprise a majority of the tonic current observed in DGGCs (Sun et al., 2004; Chandra 
et al., 2006; Herd et al., 2008). Receptors containing α5βγ2 are responsible for a minor residual 
tonic current in DGGCs of δKO animals, but represent a majority of tonic current in CA1 
pyramidal neurons (Glykys et al., 2008). In addition, dentate gyrus molecular layer interneurons 
(MLI) are composed of α1βδ receptors (Glykys et al., 2007; Wei et al., 2013). Concomitant with 
δKO characteristics, α4 knockout mice display decreased GABAergic potentiation by synthetic 
alfaxalone in DGGCs (Liang et al., 2008). This mirrors physiological deficits of neurosteroid 
potentation in mice lacking δ subunit and provides evidence for steroidal selectivity. 
 
The expressional differences of δ subunit between DGGCs and CA1 pyramidal cells may reveal 
an important clue to understanding extrasynaptic receptor activity and function. The estrous 
cycle serves as a useful model because tonic inhibition changes are dependent on cell-type and 
receptor-type specificity. Due to changes in steroid hormone levels during the estrous cycle, 
neurosteroid sensitivity is modulated differently in DGGC and CA1 in conjunciton with GABAA 
receptor plasticity. DGGC tonic conductance is increased in diestrus, but no cycle-dependent 
changes in conductance are observed in CA1 pyramidal cells (Maguire et al., 2005; Wu et al., 
2013). Whole-cell, GABAergic currents from native, adult rat DGGCs are highly sensitive to 
positive modulation by AP and negative modulation by PS (Mtchedlishvili et al., 2003). Tonic 
current in DGGCs is mediated by δ-containing receptors and is sensitive to neurosteroid; 
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however, tonic current in CA1 pyramidal cells is not mediated by δ-containing GABAA receptors 
(Stell et al., 2003; Glykys et al., 2008). 
 
Mice deficient in δ subunit also exhibit pathologically relevant changes in conjuntion with 
reduced neurosteroid sensitivity. The GABA antagonist pentylenetetrazol elicits a significantly 
greater number of clonic seizures in δKO mice compared to control animals (Mihalek et al., 
1999; Spigelman et al., 2002). This indicates a higher degree of acute seizure susceptibility 
marked by loss of δ-mediated inhibition. Hippocampus kindling has not yet been implemented 
within the δKO model to further typify limbic epileptiform activity. Furthermore, DGGCs from 
δKOs demonstrate faster current decay rates of mIPSCs and evoked IPSPs, but there have been 
no observed changes in frequency, rise time, or amplitude (Spigelman et al., 2002). DGGCs 
from δKO mice have highly attenuated tonic current, and α5/δ double knockout mice effectively 
lack any tonic inhibition within hippocampal neurons (Stell et al., 2003; Glykys et al., 2008). 
CA1 pyramidal cells possess GABAA receptors with a lower amount of α4βδ compared to 
DGGCs (Peng et al., 2004), and the relatively low tonic conductances are not changed between 
wild-type and δKO mice (Stell et al., 2003; Maguire et al., 2005). The δ-containing receptors 
have high sensitivity to Zn
2+
, and wild-type mice DGGCs experience reduced spontaneous IPSC 
decay time in response to ZnCl2 application. In contrast, spontaneous IPSC decay time is not 
affected by ZnCl2 in δKO neurons (Saxena and Macdonald, 1996; Wei et al., 2003). These 
findings convey a reduced ability of extrasynaptic, tonic current to control excitability, owing to 
an important niche role for δ-containing receptors. Two missense mutations have been identified 
from generalized epilepsy febrile seizure plus human patients (Dibbens et al., 2004). In addition, 
a homozygous δ subunit mutation was found in a case of juvenile myoclonic epilepsy. In a 
recombinant system, α4β2δ receptors with similar mutations were examined regarding their 
channel gating characteristics (Feng et al., 2006). These receptor variants display decreased 
GABA current amplitudes and decreased single channel mean open times. These reports suggest 
that heritable GABAA receptor δ subunit gene (Gabrd) variations can produce a higher 
susceptibility to excitation and epileptic seizures. 
 
I.8 Subunit Expressional Plasticity 
Subunit expression differences within GABAA receptors are reflected by conditional changes 
such as development, stress, pregnancy, partruition, and ovarian/hormonal cycling. These plastic 
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changes are contextually relevant to further elucidating the function of neurosteroids on 
GABAergic neurons (Smith et al., 2007; Belelli et al., 2009). Pathophysiology studies 
corroborate evidence that irregular, dysfunctional states of neural networks like epilepsy involve 
alterations in subunit expression. Many studies report compensational changes of subunit 
expression due to genetic, functional, or pharmacological changes to the control of GABAergic 
inhibition (Peng et al., 2002; Liang et al., 2008; Gangisetty and Reddy, 2010; Uusi-Oukari and 
Korpi, 2010; Suryanarayanan et al., 2011; Kuver et al., 2012). Evidence for neurosteroid-
dependent modulation of receptor plasticity is beginning to emerge. Therefore, in conditions 
where there is a substantial change in endogenous neurosteroid levels, receptor subunit 
reconfigurations could occur. 
 
Initial electrophysiology studies on DGGCs in δKO mice reported that there was no overarching 
change in synaptic inhibition, but an observed faster rate of decay for mIPSCs, suggesting that 
structural receptor modifications might occur (Mihalek et al., 1999). Molecular anaysis of 
mRNA from δKOs reveals a localized shift in which expression of γ2 subunit increases and α4 
subunit expression levels decrease in the forebrain, implicating functional compensation in 
response to the loss of δ (Korpi et al., 2002; Peng et al., 2002). Hippocampal GABAA receptor 
subunit protein levels of δKOs also demonstrate that with constitutive loss of δ subunit, α4 levels 
are diminished, coupled to observed decreases in inhibition (Spigelman et al., 2003). In α4 
knockout mice, γ2 subunit levels increase within the hippocampus, further signifying a 
modulatory mechanism for balancing inhibition within this brain region (Liang et al., 2008). The 
compensational changes to other subunits has been a challenge to understanding the putative role 
of δ-subunit receptors. Increasing evidence suggests that δ-containing receptor function affects 
key aspects of hippocampal neurotransmission, however other compensatory mechanisms may 
persist within the null transgenic mice.  
 
While receptor expression data from knockout mice show signs of compensatory adaptation, the 
regulatory processes involved in subunit assembly and incorporation of receptors into the 
membrane remain to be discovered. It is possible that neurons with high extrasynaptic function 
depend on endogenous neurosteroids to adjust baseline inhibition. These neurons cannot rely on 
synaptic GABAergic transmission for inhibitory set point control due to the transient availability 
of synaptic GABA and the considerable distance from the synapse. However, extrasynaptic 
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receptors are fine-tuned to allow modulation by secondary ligands that adjust channel gating. It 
appears that certain subunit isoforms are preferentially assembled together, and their location on 
neuronal membrane reflects the regulatory needs of the neuron (Bogdanov et al., 2006). 
Conditional changes that augment expressional regulation provide a larger understanding of 
functional maintenance of GABAA receptors and how neurosteroids influence this plasticity. 
I.8.1 Development 
Formation of neural networks in the hippocampus has provided insight into receptor plasticity in 
the developing brain. In CA1 pyramidal neurons of embryonic and postnatal rats, a form of tonic 
inhibition is observed even before synapses are formed (Demarque et al., 2002). Interestingly, 
this mechanism of inhibition precludes the requirement of transient, synaptic GABA release to 
be goverened by Ca
2+
 influx and GABA reuptake controlled by GAT-1. Tonic inhibition is also 
active at early developmental stages of the dentate gyrus and is important in regulating the 
excitation/inhibition balance in the maturing hippocampus (Holter et al., 2010). Within rat 
hippocampus, α4 and δ subunit proliferation of expression occurs late in postnatal development 
and into adulthood (Laurie et al., 1992). By the time adult age is reached, synaptic α and γ2 
containing receptors are already highly expressed and established within the brain. Both α2 and 
α5 subunit expression increases in the mouse hippocampus in the initial postnatal months of 
brain development and reach and maintain peak levels during adulthood. The γ2 subunit 
expression declines in the aging brain (Yu et al., 2006). This study implies that gene expression 
of α2 and α5 is induced, and γ gene expression is down-regulated due to the large changes across 
neural development in multiple brain regions. In DGGCs, the GABAA receptor-mediated 
currents have been found to increase in sensitivity to AP as rats mature, wherein α1 expression 
also increases from birth to adulthood (Brooks-Kayal et al., 2001; Mtchedlishvili et al,. 2003). 
There are also developmental changes from α5 subunits α1, α2, and γ2 in DGGC, linked to high 
zinc sensitivity of receptors, which subsequently declines and becomes channel blocking as 
neurons mature (Galanopoulou, 2008ab). As the brain establishes the structural and chemical 
foundations critical for neuronal activities, neurosteroid synthesis and modulation of GABAA 
receptors likely play a role in shaping function. 
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I.8.2 Estrous cycle 
Exploration into the fluctuations in steroid synthesis and circulation during the ovarian cycle has 
yielded critical information as to the function of neurosteroids on GABAA receptors. The ovarian 
cycle progresses with consequent endocrine changes in estradiol and progesterone levels. In the 
rodent estrous phase, progesterone levels are typically low and estrogen levels are high. During 
the diestrous phase, heightened levels of progesterone induce its metabolite, AP, to increase 
during luteal surges within the ovary and plasma (Reddy and Kulkarni, 1999; Reddy, 2009a). 
GABAA receptor subunit gene expression is affected by oscillations in the ovarian cycle due to 
this rise in neurosteroid concentration not only in peripheral tissue but also in the brain. This 
expressional response promotes gene activation and results in a change in amount of specific 
receptors that are functional on the neuronal membrane. During the diestrous phase, receptor 
protein levels of δ subunit increase in the hippocampus compared to the estrous phase, and this is 
coupled to significant increases in GABAergic tonic conductance in DGGCs (Maguire et al., 
2005; Wu et al., 2013). In kindling studies, susceptibility to hippocampus epileptogenesis has 
been lower in mice during diestrus. Levels α4 do not change significantly between these two 
phases of the cycle. The mirrored compensation of specific subunit isoform up-regulation in 
response to neurosteroid deficit in the central nervous system implicates a substantial system of 
neuromodulatory control of GABAergic inhibition. Over the course of the cycle, neither 
progesterone receptor antagonist RU846 nor estrogen receptor antagonist tamoxifen affects 
regulation of GABAA receptors in the brain, suggesting neurosteroid-dependent plasticity 
(Maguire and Mody, 2007; Reddy et al., 2010; Wu et al., 2013). Control of GABAA receptor 
populations in puberty and into adulthood may be maintained by an overarching feedback 
mechanism involving the neuroendocrine axis balance of hormones. Therefore, developmental 
defects or pathophysiological onset of disorder within this system could greatly alter the 
excitability of the brain, such as in catamenial epilepsy, premenstrual syndrome, and migraine 
(Reddy, 2013a). 
 
I.8.3 Neurosteroid treatment 
Treatment of animals with steroid mimics subunit expression compensation and plasticity. 
Administration of preogesterone or pregnenolone selectively and substantially increases 3α,5α-
reduced neurosteroid levels in both rodents and humans and can be measured in the plasma by 
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high throughput methods (Porcu et al., 2009). Gonadotropin treatment increases AP levels 
(Reddy et al., 2012). Progesterone and AP treatment can up-regulate α4 and δ in the 
hippocampus, documented in both in vitro and in vivo functional studies (Biggio et al., 2006; 
Uusi-Oukari and Korpi, 2010). Up-regulation of δ subunit in hippocampus after AP treatment is 
significant for channel kinetics regarding potentiation; both efficacy and potency to THIP 
increase following neurosteroid administration. This direct alteration of GABAA receptor 
plasticity reflects subunit targeting specificity in which δ is involved, but it also modifies the 
functionality of receptors where α4 and γ2 are coexpressed. In response to neurosteroid 
treatment, CA1 synaptic current decay time is reduced (Hsu et al., 2003). A brief 48-h treatment 
with AP highly increases the expression profiles of the α4 and δ composition and decreases 
expression of the typically synaptic α1 and γ2 subunits within rat CA1 (Shen et al., 2005). 
However, δ-containing receptors are not as functionally significant at CA1 as compared to the 
dentate gyrus subfield, where expressional and functional changes to GABAA receptors have a 
higher impact on network excitability. Neonatal exposure to estradiol in female rats decreases 
brain levels of progesterone and AP in addition to increasing the quantity of synaptic α1, α2, γ2 
subunits with no change to α3, α4, α5, or δ subunits (Calza et al,. 2010). An increase in 
anxiolytic behavior results when diazepam is applied to estradiol-treated animals, but there is 
little change by AP. This estradiol-modulated, increased sensitivity exhibits subunit plasticity-
directed specificity to allosteric ligands concerning broader GABAA receptor gating. These 
observations are clinical relevant during chronic neurosteroid therapy. 
 
I.8.4 Neurosteroid withdrawal 
Withdrawal from endogenous neurosteroids has striking impact on subunit plasticity within the 
hippocampus. Neurosteroid withdrawal (NSW), which occurs during the perimenstrual period, is 
linked to catamenial epilepsy and increased incidence of seizure susceptibility in women (Reddy 
et al., 2001; Reddy, 2013a, b). In rat hippocampal cultures, withdrawal following chronic 
exposure to either progesterone or AP causes a transient increase in δ subunit expression 
(Mostallino et al., 2006). Induced neurosteroid withdrawal following chronic doses of 
progesterone or AP in rodents has shown to increase the expression of α4 subunit approximately 
3-fold (Smith et al., 1998b; Gangisetty and Reddy, 2009, 2010). Progesterone and neurosteroid 
withdrawal models exhibit an up-regulation in α4 and δ subunits with effects on current, 
pharmacology, and seizure susceptibility (Sundstrom-Poromaa et al., 2002; Reddy et al., 2012). 
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Due to NSW-dependent increases of α4 and δ subunits, fully kindled mice experience enhanced 
sensitivity to the antiseizure effects of AP (Reddy et al., 2012). There is no observed 
compensational shift in α1, α2, β2, γ2 subunits in response to withdrawal. This may represent a 
divergent mechanism of expression for synaptic and extrasynaptic receptors. 
 
Increase in seizure activity and excitation of the brain has differential effects on GABAA receptor 
physiology of CA1 and DGGCs (Gibbs et al., 1997). Progesterone withdrawal has been linked to 
α4-dependent increase in CA1 pyramidal neuron excitability (Hsu and Smith, 2003). In CA1 
subfield, GABAergic inhibition is primarily mediated by other subunits (Caraiscos et al., 2004; 
Prenosil et al., 2006). The α4 subunit is more prevalent in dentate gyrus than in the CA1 region 
(Pirker et al., 2000). Alterations to receptor function within the dentate gyrus have severe effects 
on the control of epileptiform spread of hyperactivity (Coulter and Carlson, 2007). Extrasynaptic 
profiles of δ-containing receptors reflect considerable plasticity to neurosteroid withdrawal that 
influences their channel opening probability (Bianchi and Macdonald, 2003). Phasic and tonic 
GABAA receptors may rely on disparate mechanisms that control expression based on neuronal 
requirements to maintain network inhibition. Due to the high neurosteroid sensitivity to GABAA 
receptors mediating tonic current within the dentate gyrus, it is probable that neurosteroids drive 
expressional changes to regulate baseline inhibition. 
 
I.8.5 Epilepsy 
Epilepsy is a neurological disease characterized by recurrent seizures resultant from aberrant 
hyperexcitability within the brain. While there are many types of epileptic seizures, certain types 
may be studied to elucidate the nature of the disease and formulate appropriate treatments in 
control of seizures. Receptor plasticity has been reported in several models of epilepsy, 
implicated to play a role in the molecular changes that promote seizure susceptibility. Alterations 
to the function of GABAA receptors through a pilocarpine-induced model of temporal lobe 
epilepsy (TLE) reveal that CA1 neurons from epileptic animals undergo a reduced maximal 
efficacy (decrease of 45%) to GABA without a change in potency and increased sensitivity to 
zinc blockade of current (Gibbs et al., 1997). Epileptiform bursting activity promotes cellular 
internalization of GABAA receptors and has consequent effects on synaptic GABA transmission 
in reducting inhibition (Goodkin et al., 2005). Both mature and newborn dentate cells undergo 
reductions in spine density and number in response to induced status epilepticus (Santos et al., 
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2011). Hippocampal neurons possess varying GABAA receptor compositional changes in 
response to hyperexcitability of the brain. The foundation for greater seizure susceptibility is 
maintained by the larger decrease in available neurosteroid in the brain, altered receptor 
expression level on the neuronal surface and reduced overall GABAergic inhibition. 
 
Catamenial epilepsy is characterized by increased seizure frequency due to menstrual cycle-
related hormonal fluctuations (Reddy, 2007, 2009a; Reddy et al., 2012). Deficits in cyclical 
fluctuations in steroid hormones and receptor plasticity play a central role this condition. The 
seizures produced by the disease are believed to result from a cyclic, temporal deficit of 
circulating neurosteroid, which in turn increases seizure susceptibility in conjunction with a 
dearth of GABAergic inhibitory control over excitability (Reddy 2004ab; 2009a; 2013ab). The 
δ-containing receptors are crucial mediators of tonic inhibition and limbic epileptogenesis and 
are regulated within the estrous cycle (Reddy et al., 2012; Wu et al., 2013). In women  with 
perimenstrual catamenial epilepsy, overall THDOC levels and DHEAS/cortisol ratio are 
reduced, but the pregnane steroids progesterone, pregnenolone, and AP are not different 
compared to control groups (Tuveri et al,. 2008). However, in the perimenstrual part of the cycle, 
the luteinizing surge produces a rapid flux in progesteone and its metabolites that afterward 
sharply decrease (Reddy, 2009a). Partruition is also associated with a substantial decrease in 
progesterone and AP levels, and there is a postpartum increase in α4 and γ2 subunit expression, 
but decrease in δ within the hippocampus (Sanna et al., 2009). Thus, epilepsy may cause a 
different compensational mechanism of GABAA receptor plasticity within the brain compared to 
the physiological condition of progesterone withdrawal in order to allow for parturition to 
proceed. 
 
Treatment with neurosteroids has shown to reduce seizure activity in several epilepsy models 
(Lawrence et al., 2010; Reddy and Jian, 2010; Reddy et al., 2010). Noda model epileptic rats 
have decreased δ subunit expression in DGGCs along with decreased tonic current, smaller tonic 
response to AP (Pandit et al., 2013). Furthermore, in Noda rat slices, AP prolonged synaptic 
receptor decay in DGGC similarly to the normal Wistar strain counterparts. Pilot studies from 
our lab show that AP retains its antiepiletic efficacy in this animal model of TLE and is 
successful in suppressing the occurrence of spontaneous seizures in chronically epileptic rats 
(Reddy et al., 2005). Better discernment of the role of neurosteroid-receptor interactions in the 
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context of epilepsy necessitates that in vitro studies are corroborated with in vivo studies that 
typify the whole network response to GABAA modulation. 
 
The physiological, intrinsic low excitability of the dentate gyrus has an important role in the 
filtering of excitatory activity from the entorhinal cortex and regulating propagation of current 
that passes through to other hippocampal neuronal tissue (Heinemann et al., 1992; Lothman et 
al., 1992; Coulter and Carlson, 2007). DGGCs from TLE rats have increased synaptic efficacy, 
exemplified by increase in number of postsynaptic channels, but not channel conductance (Otis 
et al., 1994). However, these changes to miniature IPSC amplitude do not take into account 
possible alterations in extrasynaptic GABAA receptors. Kainate treatment to induce seizures 
decreases frequency of miniature IPSCs, but does not change the frequency of action potential-
dependent, spontaneous IPSCs (Shao and Dudek, 2005). While IPSC recordings do not provide a 
comprehensive view of how epilepsy modifies GABAergic inhibition, these findings denote 
compensatory effects within the hippocampus to maintain inhibitory current. Observed 
reductions in phasic inhibition in epileptic animals agree with evidence that γ2-containing 
receptors may increasingly shift to extrasynaptic sites and assemble with α4 subunits. DGGC 
receptor plasticity in epileptic mice is reported to have static α4 expression, δ down-regulation, 
and γ2 increase in dendritic areas of neurons (Zhang et al., 2007). 
 
In contrast, epileptiform DGGCs have been found to display increased inhibition of mIPSCs and 
altered GABAA receptor sensitivity to zinc and benzodiazepine pharmacology, also associated 
with increased membrane receptors (Cohen et al., 2003). There are various contrasting findings 
regarding changes in dentate gyrus inhibition that could be interpreted by the location of the 
synaptic inhibition recording (Zhang et al., 2007). Pharmacological and electrophysiological 
evidence of pilocarpine-induced status epilepticus also suggests enhanced tonic, GABAergic 
inhibition, largely modulated by L-655,708-sensitive α5-containing receptors in lieu of δ-
containing receptors (Zhan and Nadler, 2009). There is still considerable uncertainty regarding 
how receptor physiology influences GABAergic inhibition in epileptic animals; however, the 
rodent model of TLE provides indication of compensatory shifts in subunit composition that 
influences tonic current (Mody, 2012). Nevertheless, pharmacological shifts in receptor subunit 
sensitivity are concomitant with changes in receptor subunit composition. 
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CHAPTER II 
AIMS AND OBJECTIVES 
 
The main objective of this dissertation research is to understand the role of δ-subunit-containing 
GABAA receptors in the hippocampus dentate gyrus in mediation of tonic inhibition and 
epileptogenesis using a combination of electrophysiological, behavioral, and pharamcological 
techniques. Transgenic mouse models including germline δ-subunit knockout mice (δKO) were 
used to elucidate the behavioral and physiologic sensitivity to neurosteroids as targets for 
extrasynaptic GABAA receptors within the hippocampus as a key brain structure for the 
pathophysiology of epilepsy. The research is organized into three specific aims. 
 
II.1 Specific Aim 1 
 
The first specific aim investigates the plasticity and function of δ-containing GABAA receptors 
in the hippocampus in a perimenstrual-like model of neurosteroid withdrawal.  
 
Neurosteroids play a key role in the pathophysiology of catamenial epilepsy, a menstrual-cycle 
related disorder characterized by seizures that cluster most often during the perimenstrual or 
periovulatory period, when progesterone levels are low (Herzog and Frye, 2003; Herzog et al., 
2004; 2011; Reddy et al., 2012). Presently there is no approved drug therapy for catamential 
epilepsy. Progesterone is a precursor for the synthesis of neurosteroids such as allopregnanolone 
in the brain (Reddy et al., 2004; Tuveri et al., 2008). AP and related neurosteroids have 
anticonvulsant properties and protect against seizures. Although the exact cause of catamenial 
epilepsy is poorly understood, there is growing evidence suggesting perimenstrual neurosteroid 
withdrawal (NSW) may be a key triggering factor for catamenial seizures (Smith et al., 1998ab; 
Reddy et al., 2001, 2012; Reddy, 2009ab; Gangisetty and Reddy, 2010; Pack et al., 2011). We 
previously developed an animal model of catamenial epilepsy (Reddy et al., 2001; 2012; Reddy 
and Zeng, 2007). In this rodent model, there is a marked reduction in the antiseizure potency of 
benzodiazepines and valproate, which is consistent with clinical evidence on resistance of 
catamenial seziures to conventional antieplielptic drugs (Reddy and Rogawski, 2001; Reddy et 
al., 2012). However, neurosteoids including AP and synthetic analogs such as ganaxolone have 
enhanced activity in the catamenial epilepsy model (Reddy and Rogawski, 2000; 2001; Reddy et 
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al., 2012). Neurosteroid replacement therapy for prevention of catamenial seizures has been 
previously proposed (Reddy and Rogawski, 2009; Reddy, 2013). However, the molecular 
mechanisms underlying enhanced anticonvulsant activity of neurosteroids in catamenial epilepsy 
remain unclear. 
There is indication that steroid hormone fluctuations affect δ-subunit plasticity (Smith and Gong, 
2005; Reddy et al., 2012). Therefore, we hypothesized that the enhanced potency of 
neurosteroids in catamenial epilepsy may be due to a relative increase in the expression of 
extrasynaptic, δ-containing GABAA receptors in the hippocampus. In the first specific aim, we 
tested this hypothesis by investigating the NSW-induced changes in GABAA receptor δ-subunit 
expression and tonic inhibition in the dentate gyrus in a perimenstrual mouse model. 
 
II.2 Specific Aim 2 
 
The second specific aim investigates the specific structure-activity relationship of neurosteroid 
for modulation of tonic inhibition in mice in wildtype condition as well as germline deletion of 
δ-subunit-containing GABAA receptors. 
 
Tonic currents were investigated as a basis for the structure-specific neurosteroid modulation on 
extrasynaptic receptors within the dentate gyrus. In case of synaptic receptors, neurosteroids bind 
to GABAA receptors via a hydrophobic pocket within the neuronal plasma membrane. There are 
two discrete binding sites, including an allosteric site in the α-subunit transmembrane domain 
and a site of direct activation at the α-β subunit interface (Hosie et al., 2006; 2007; 2009). The 
C3α-hydroxyl group is essential for the binding affinity and the receptor-enhancing function by 
neurosteroids (Harrison et al., 1987; Mitchell et al., 2008). The C20 position ketone (pregnane) 
or C17 group (androstane) is important for binding affinity of neurosteroids, however receptor 
modulation is highly reduced for androstane compared to pregnane neurosteroids (Upasani et al., 
1997; Reddy and Jian, 2010). These structural regions provide hydrogen bond acceptor and 
donor interactivity with the transmembrane region of the GABAA receptor, thereby conferring 
specificity and potency (Hosie et al., 2007). Hydrogen bonding by the 17β-group does not appear 
to be critical for channel modulation (Li et al., 2009), however it may be important for the 
improved potency and efficacy of neurosteroids at synaptic receptors (Gee et al., 1988). 
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The pharmacophore profile of δ-containing extrasynaptic receptors and the specific structure 
properties of neurosteroids required to modulate the current-transduction remain unclear. 
Neurosteroids bind all GABAA receptors, but they display high affinity for δ-subunit receptors 
(Brown et al., 2002). Morever, physiological conditions that increase δ-subunit expression 
enhance neurosteroid sensitivity (Wu et al., 2013). Conversely, conditions of deficient δ-subunit 
expression reduces sensitivity to neurosteroid modulation (Mihalek et al., 1999; Spigelman et al., 
2003; Stell et al., 2003). Allosteric steroid binding to low-efficacy, GABA-gated receptors 
results in a pronounced conformational change of the channel. This transduction induces greater 
GABAergic inhibition above partial agonism at δ-containing receptors (Bianchi and Macdonald, 
2003). There has not been direct evidence in support of a δ-subunit binding site for 
neurosteroids. Point mutations to the Gabrd gene have been shown to result in reduced GABAA 
receptor currents, linked with cases of generalized epilepsies (Dibbens et al., 2004; Feng et al., 
2006). Therefore, decreased extrasynaptic inhibitory currents could have cascading effects on 
seizure susceptibility and pathophysiological restructuring of the brain. Previous structure-
activity relationship studies have not investigated the putative tonic current modulation by 
neurosteroids (Akk et al., 2007; Harrison et al., 1987; Kokate et al., 1994; Qian et al., 2014). 
Therefore, structure-activity specific for δ-containing extrasynaptic receptors warrants further 
investigation.  
 
In this study, we sought to determine the structure-activity relationship of neurosteroids at δ-
subunit extrasynaptic GABAA receptors-mediating tonic current in the dentate gyrus, a key 
structure for the pathophysiology of epilepsy and excitability disorders. We utilized structurally 
distinct natural and synthetic neurosteroids to assess fractional tonic currents in native, murine 
DGGCs using hippocampus slice electrophysiology. We also evaluated the structure-activity 
relationship of neurosteroids for behavioral antiseizure potency in the 6-Hz seizure model in a 
gender-dependent fashion. It was intended to reveal the key structural features for neurosteroid 
functional activity at δ-containing GABAA receptors towards developing a consensus 
pharmacophore pocket. 
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II.3 Specific Aim 3
The objective of the third specific aim is to investigate the functional role of tonic inhibiton in 
the hippocampus epileptogenesis in mice with germline deletion of δ-containing GABAA 
receptors. 
Currently, there are no specific drugs for preventing or curing epilepsy. The mechanisms 
underlying the development of acquired epilepsy are not well understood. The term 
“epileptogenesis” is used to describe the complex plastic changes in the brain that, after a 
precipitating event, convert a normal brain into a brain debilitated by recurrent seizures 
(Pitkänen et al., 2009). Limbic epilepsy is caused by diverse cascading factors such as brain 
injury, stroke, infections, or prolonged seizures. The kindling model has provided a conceptual 
framework for the idea that “seizures beget seizures” and for developing new molecular targets 
for preventing epilepsy (Goddard et al., 1969; McNamara et al., 1992). Kindling is the most 
widely used model of epileptogenesis in which repeated stimulation of limbic structures triggers 
progressive intensification of behavioral and electrographic seizure activity. The progression of 
seizures occurs at a subthreshold of motor seizures until propogation advances into later stages 
of epileptogenic activity. The progressive induction of electrical seizures in the rodent kindling 
model shares many features with human complex partial seizures (Löscher, 2002). The fully 
kindled state in animals allows studying the persistence of epilepsy weeks or months after 
development. In addition, therapeutic interventions can be used to understand disease-modifying 
criteria necessary for impeding, preventing, or protecting against seizures. 
Using a combination of behavioral and pharmacological studies, we explored the progression of 
kindling epileptogenesis and developmental defects that may alter brain function within the 
germline δ-subunit knockout mouse model. We hypothesized that mice with a targeted, germline 
deletion of δ-subunit in the brain exhibit a markedly increased propensity for the development 
and persistence of kindling epileptogenesis. We provide a rationale for seeking an improved 
trangenic mouse model under conditional deletion of δ-subunit for further investigation of the 
functional role of δ-subunit expresssion in the hippocampus. 
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CHAPTER III 
MATERIALS AND METHODS 
 
III.1 Experimental Animals 
 
Animals. Wildtype (WT) adult female C57BL/6 mice, 25 to 30g each were used in this study. 
GABAA receptor δ-subunit knockout mice (Gabrd
-/-, δKO) were also used (Mihalek et al., 1999). 
All strains were maintained on a hybrid C57BL/6-129SV background. All mice were housed 
four to a cage with access to food and water ad libitum. The mice were housed in an 
environmentally controlled animal facility with a 12 h light/dark cycle. The animals were cared 
for in strict compliance with the guidelines outlined in the National Institutes of Health Guide for 
the Care and Use of Laboratory Animals. All animal procedures were performed in a protocol 
approved by the university’s Institutional Animal Care and Use Committee. 
 
III.2 Perimenstrual Model of Neurosteroid Withdrawal 
 
A state of perimenstrual-like neurosteroid withdrawal (NSW) hormonal condition was induced 
in animals by a standard progesterone-finasteride regimen as described previously (Gangisetty 
and Reddy, 2010), which was based on published protocols for induction of NSW (Smith et al., 
1998ab; Moran et al., 1998; Moran and Smith, 1998). Adult female mice were given 
subcutaneous injection of progesterone (25 mg/kg) twice-daily for seven days. On the final 
injection, finasteride (50 mg/kg, i.p.) was administered to block 5α-reductase activity for 
inhibiting progesterone conversion to AP and related neurosteroids. Progesterone was 
administered rather than allopregnanolone because circulating levels of progesterone, such as 
those found during the luteal phase, are readily converted to neurosteroids in the brain regions 
that express neurosteroid synthesizing enzymes (Mellon et al., 2001; Agís-Balboa et al., 2006). 
The progesterone administration protocol results in a high physiological concentration of 
allopregnanolone in plasma, and acute withdrawal is evident by a nearly complete decline in 
allopregnanolone 24 hours after finasteride administration (Gangisetty and Reddy, 2010). 
Control mice were administered 15% β-cyclodextrin vehicle with the same frequency for the 
seven day injection period. Experimental studies were carried out 24 hours following the final 
finasteride or vehicle injection. 
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III.3 Immunohistochemistry and Confocal Microscopy 
Adult mice were anesthetized by an intraperitoneal injection of ketamine (100 mg/kg) and 
xylazine (10 mg/kg). Transcardial perfusion of saline followed by 4% paraformaldehyde was 
completed to preserve the rodent brain. 
 
Immunohistochemistry. Following cryoprotection of brain, the tissue was rapidly frozen in 
isopentane pre-cooled to -70˚C. The frozen tissue was then cut in 20 µm tranverse sections on a 
cryostat and mounted on gelatin-coated slides.  Sections were processed for distribution of 
GABAA receptor δ-subunit using a specific Gabrd primary antibody (1:250) (Millipore, 
Billerica, MA), according to the avidin-biotin-complex method (Hsu et al., 1981). Technical 
assitance was provided by FD Neurotechnologies (Maryland). 
 
Immunocytochemistry and confocal microscopy. The δ-subunit distribution in the hippocampal 
neurons was determined by immunocytochemistry (Mangan et al., 2005; Wu et al., 2013).  
Acutely dissociated hippocampal CA1 pyramidal cells (CA1PCs) and dentate gyrus granule cells 
(DGGCs) from adult, female mice in the vehicle and NSW groups were fixed with 4% 
paraformaldehyde for 15 min followed by several glycine-PBS washes. Cells were 
permeabilized with ice-cold methanol for 3 min at 4 C followed again by several rinses with 
PBS. Cells were then incubated with blocking solution containing 1% bovine serum albumin 
(Vector Laboratories, UK), 2.5% normal goat serum and 0.1% Triton X-100 for 1 h. After the 
blocking, the cells were incubated together with primary rabbit GABAAR -subunits (1:100, 
PhosphoSolutions) or control rabbit IgG (1:100, Santa Cruz Biotechnologies) for 1 h at room 
temperature. Samples were rinsed and then incubated with Alexa Fluor® 555 labeled secondary 
antibodies of goat-anti-rabbit IgG (1:200, Molecular Probes, Invitrogen) for 1 h in the dark, 
washed extensively, and treated with ProLong AntiFade (Molecular Probes, Invitrogen). Serial 
image sections through focus with step size of 0.1-0.3 µm thickness were collected and analyzed 
using Nikon confocal microscope with NIS-Elements software suite (Nikon Instruments Inc., 
Melville, NY). The parameters for the confocal microscopy included pinhole =1 AU, the pixel 
dwell time =0.5 frame/sec, gain (HV) at same level for sample and control IgG, power for the 
laser = 5%, objective = Plan Apo VC 60x Oil DIC N2 (Magnifying factor = -1.00, numerical 
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aperture (NA)=1.40, refractive index (RI)=1.51, Olympus, Tokyo, Japan).The normalized mean 
intensity was used as the ratio from mean intensity of GABAA receptor δ-subunits minus 
background to mean density of control antibody minus background. Mean intensity is a ratio of 
integrated density of the signal divided by region of interest.  Then normalized mean intensity 
from treatment group (NSW group) was used to compare with normalized mean intensity from 
control group. 
 
Western blot analysis. Western blot analysis of GABAA receptor subunit protein expression in 
the hippocampus was performed using affinity-purified rabbit polyclonal antibodies for GABAA 
receptor δ-subunit (PhosphoSolutions, Aurora, CO). Hippocampi were homogenized in RIPA 
buffer (Pierce), and the extracted protein (100 μg) was loaded onto 10% Tris-HCl gels and 
subjected to electrophoresis. Blots were then transferred to a polyvinylidene fluoride membrane 
(Bio-Rad). Membranes were blocked in 5% nonfat milk at room temperature for 1 h. Membranes 
were then incubated with GABAA subunit-specific antibody (1:1000) or a mouse monoclonal β-
actin antibody (1:1000) at 4°C overnight. Membranes were washed and incubated with an anti-
rabbit antibody (1:1000) conjugated to horse radish peroxidase for 1 h at room temperature. 
Receptor subunit bands were detected using enhanced chemiluminescence reagent (Perkin-
Elmer, Shelton, CT). Protein bands were quantified using Alpha Imager software (Alpha 
Innotech, San Leandro, CA). All values were normalized to β-actin expression in the same 
samples to control for loading amount variability and then expressed as a percent change with 
respect to mean control values. Brain tissue samples were collected from a group of 6-10 mice 
for each treatment. 
 
Timm staining procedure. Timm staining was conducted as described previously (Cavazos et al., 
1991). Mice were deeply anesthetized with ketamine/xylazine mix and transcardially perfused 
with 75 mL 0.9% saline solution followed by 100 mL 1% sodium solfide solution. Perfusion of 
100 mL of 4% paraformaldehyde in 0.1 M phosphate buffer (7.4 pH) followed, and a final 
perfusion with 50 mL 1% sodium sulfide was carried out. The brain was dissected and postfixed 
in 4% paraformaldehyde overnight at 4˚C. Brains were then processed with phosphate buffer and 
sucrose treatment and cut in 20 μm transverse sections with a cryostat. Slices were then dry 
mounted onto slides and allowed to dry overnight. Gum arabic, citrate buffer, hydroquinone, and 
silver lactate reagents were mixed mechanically on the day of staining. Mounted slides were 
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uniformly soaked in the Timm stain in dark for 3.5 hours. Slides were then washed with distilled 
water and counter-stained with 0.1% cresyl violet, if desired. Slides were permanently fixed with 
DPX mountant (Sigma) and allowed to dry before imaging and analysis. 
 
Densitometric analysis. Staining intensity for Timm and δ-subunit antibody histology was 
quantitatively measured by densitometric analysis. Densitometry was completed in hippocampus 
regions of interest with Photoshop software. Mean density of gray-scale staining was normalized 
to area and white background. Densitry scores were then non-parametrically graded using a 
linear scale. 
 
III.4 Electrophysiology Studies 
 
Hippocampal slice preparation. Transverse slices (300 m thickness) of hippocampus were 
prepared using standard techniques from adult mice. Mice were anesthetized with isoflurane, and 
brains were excised rapidly and placed in cold (4 °C) artificial cerebrospinal fluid (ACSF) buffer 
containing 0.3 mM kynurenic acid (Tocris Bioscience, MN). ACSF buffer was composed of (in 
mM): 126 NaCl, 3 KCl, 2 CaCl2, 2 MgCl2, 26 NaHCO3, 1.25 NaH2PO4, 11 glucose (pH adjusted 
to 7.35-7.40 with 95% O2 – 5% CO2, 305–315 mOsm/kg). Hippocampal slices were cut with a 
Vibratome in cold ACSF (model 1500 with 900 Refrigeration System; Leica Microsystems, Inc., 
Bannockburn, IL). For electrophysiology and immunocytochemistry studies, microdissected 
subfield hippocampal slices were equilibrated in ACSF at 24°C and continuously bubbled with 
oxygen (95% O2-5% CO2).  For each electrophysiology experiment, 3-4 animals were used for 
each group and drug concentration tested. 
 
Dissociation of neurons. Hippocampus CA1PC and DGGC dissociation was prepared by the 
standard dissociation technique described previously (Kay and Wong, 1986; Reddy and Jian, 
2010; Wu et al., 2013). The hippocampal pieces of the CA1 or DG region were microdissected 
carefully under a microscope (model SMZ 647; Nikon, Tokyo, Japan) and incubated in ACSF 
for 1 h at 24°C. The isolated slices were transferred into an enzymatic solution consisting of 
ACSF with protease XXIII (3 mg/ml, Sigma-Aldrich, St. Louis, MO). The slices were then 
incubated for precisely 23 to 25 min at 24°C. The remaining slices were rinsed twice with ACSF 
and gently triturated through three increasingly smaller, fire-polished Pasteur pipettes to yield 
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single cells. For each batch, slices were triturated five or six times with each pipette in 
approximately 1 ml of ACSF. Then, the solution was allowed 1 min for the tissue to settle down, 
and the suspension of freshly dispersed cells were carefully plated onto the recording chamber 
(Warner Instruments, Hamden, CT) for electrophysiology and immunocytochemistry 
experiments. 
 
Recording of GABA-evoked currents. Electrophysiological recordings were performed in the 
whole-cell patch-clamp configuration (Reddy and Jian, 2010; Wu et al, 2013). All 
electrophysiological experiments were performed at 22-24 °C. The recording chamber was fixed 
into the stage of an inverted microscope with phase-contrast and differential interference contrast 
optics (model IX71; Olympus, Tokyo, Japan). The physiological bath solution for whole-cell 
recording had the composition (in mM): 140 NaCl, 3 KCl, 10 HEPES, 2 MgCl2, 2 CaCl2, and 16 
glucose (pH adjusted to 7.4 with NaOH, osmolarity, 315–325 mOsm/kg). Cells were visualized 
and images were acquired through video camera CCD-100 (Dage-MTI, Michigan City, IN) with 
FlashBus Spectrim 1.2 software (Pelco, Clovis, CA). Recording pipettes were pulled from 
capillary glass tubes (King Precision Glass, Claremont, CA) using a P-97 Flaming-Brown 
horizontal puller (Sutter Instrument Company, Novato, CA). The pipette tip resistances were 2 to 
4 M for single cell recording and 4 to 6 M for slices recording. The recording pipettes were 
filled with a cesium pipette solution containing (in mM): 124 CsCl, 20 tetraethylammonium, 2 
MgCl2, 10 EGTA, 10 HEPES, 0.1 GTP, 4 ATP (pH adjust to 7.2 with CsOH, osmolarity, 295–
305 mOsm/kg). In slice recordings, 5 mM lidocaine N-ethyl bromide (QX-314) was added to the 
pipette solution. Currents were recorded using an Axopatch 200B amplifier (Molecular Devices, 
Sunnyvale, CA). The membrane capacitance, series resistance, and input resistance of the 
recordings were monitored by applying a 5-mV (100-ms) depolarizing voltage step from a 
holding potential of -70 mV for dissociated cells and -65 mV for slice recordings. Signals were 
low-pass filtered at 2 kHz and digitized at 10 kHz with Digidata 1440A system. The current 
values were normalized to cell capacitance (an index of cell size) and expressed as current 
density (pA/pF). For whole cell current from isolated single cells, fractional potentiation 
produced by AP was calculated as IA/IGABA, where IGABA was the response of peak amplitude at 
the application of GABA (3 M) and IA is the response of peak amplitude at the co-application 
of GABA and the neurosteroid AP (0.01 to 1 M).  For fast application of test drugs, the 
perfusion pipette was positioned <200 µm away from the cell in the dish. GABA, 
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allopregnanolone, and GABAAR competitive antagonist bicuculline (10 M) were applied using 
a multi-channel perfusion system (Automate Scientific, Berkeley, CA).   
 
Tonic current recording and analysis. The GABAA receptor mediated tonic current recording and 
analysis were made as described previously (Mtchedlishvili and Kapur, 2006; Wu et al., 2013). 
Hippocampal slices (300 µm) for were maintained in continuously oxygenated ASCF at 32°C in 
a holding chamber for 60 min, and then recorded from were made at room temperature. 
Hippocampal CA1PCs and DGGCs were visually identified with an Olympus BX51 microscope 
equipped with a 40x water-immersion objective, infrared-differential interference contrast optics, 
and video camera (Kay and Wong, 1986). Tonic current and phasic, miniature inhibitory 
postsynaptic currents (mIPSC) of GABAARs were recorded in the presence of tetrodotoxin 
(TTX, 0.5 M, Na+ channel blocker and inhibition of action potential-evoked neurotransmitter 
release), D,L-2-amino-5-phosphonovaleric acid (APV, 40 M, N-methyl-D-aspartate channel 
blocker, Sigma), and 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 M, non-N-methyl-D-
aspartate glutamate receptor blocker). The competitive antagonist gabazine (SR-95531, 50 µM) 
was added to perfusion after slice recordings to confirm block of GABAergic currents. 
  
Off-line current analysis was performed with pClamp 10.2 software (Molecular Devices, 
Sunnyvale CA) and in-house software. To study the tonic inhibition, transient events were 
manually removed from the current trace, so that it consisted only of membrane current in the 
voltage-clamp mode (Mtchedlishvili and Kapur, 2006; Wu et al., 2013). Averaged amplitude of 
tonic current shift in conductance and root-mean-square noise amplitude were measured. The 
GABAA receptor tonic current was expressed as the outward shift in holding current after 
application of gabazine (50 µM). Currents for a single cell were normalized to membrane 
capacitance for that cell (pA/pF). The amplitude of root-mean-square (Irms) is the noise 
conductance from chloride ions passing through the opened channels and in proportion to the 
chloride driving force. Itonic was measured and averaged in 100 ms each epoch with 1 sec interval 
between epochs for 30 epochs. The measurements were taken 30 s before and 2-3 min after 
application of a drug. Irms was studied in 50 ms each epoch with 500 ms interval between epochs 
for 30 epochs before and after drug application in each cell. To assess the effect of a drug on Irms 
in an individual neuron, the distribution of Irms in 30 epochs before the application of a drug 
(during the baseline period) was compared with that after drug application by a Student’s 
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independent t-test. To compare data obtained from a group of neurons, Irms values in individual 
epochs before and after drug application were averaged. Changes in Itonic or Irms are expressed in 
pA of current. 
 
For measurement of desensitization of extrasynaptic current, traces were fit using a standard 
exponential function ( f(t) = A * e
-t/τ 
+ C ) with the Chebyshev fitting method in Clampfit 10.2 
software (Molecular Devices, Sunnyvale, CA) with r
2
  ≥ 0.95. The asymptote of desensitization 
was described with regression analysis. The time point reaching within 10% of the arbitrary 
finite limit was designated the beginning time point measurement for the desensitized tonic 
current, averaged in 100 ms epochs with 1 sec intervals between epochs. Percent change of tonic 
current at the peak and desensitized points was then compared. 
 
Miniature postsynaptic current data analysis. mIPSCs were detected using off-line analysis with 
Mini-Analysis software (Synaptosoft, Leonia, NJ), with the threshold for detection set at least 
three times the baseline root mean square noise. mIPSC characteristics of amplitude, frequency, 
and decay time constants were determined and compared between groups as described 
previously (Dubois et al., 2013), adapted for granule cells. mIPSCs were acquired for 3 min for 
each drug response and condition. The decay of averaged mIPSC within dentate gyrus granule 
cells was best fit with a double exponent time constant (Stell et al., 2003). Non-overlapping 
events with single-peaks were used to generate an ensemble average mIPSC by aligning the 
rising phase, and the 10-90% decay phase for each neuron and fit with the bi-exponential 
function: I(t) = A1 *e
(-t/τ1)
 + A2 *e
(-t/τ2)
, where A1 and A2 are the fast and slow component 
amplitudes, and τ1 and τ2 are their respective time constants. A mean weighted decay constant 
was determined as τw = (A1* τ1 + A2 * τ2) / (A1 + A2), as previously specified (Sun et al., 2007).  
The mean values in response to drug application were established for each recorded neuron, and 
the results are expressed as mean ± S.E.M. for each group, with comparisons between groups 
made using Student’s t-test. Comparisons of cumulative probability distributions were made 
using the Kolmogorov-Smirnov test.  Results were considered significant if the two-tailed p 
values were < 0.05. 
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III.5 Behavioral Studies 
 
Hippocampus kindling seizures. The rapid kindling model of epileptogenesis was utilized for 
assessment of seizure susceptibility in case of the NSW model. This model allows accelerated 
evaluation of experimental manipulations during the progression of seizure induction (Reddy 
and Mohan, 2011; Wu et al., 2013). For checking the rate of epileptogenesis in knockout mice, a 
standard once-daily stimulation protocol was adapted. 
 
Electrode implantation and stimulation procedures for mouse hippocampus kindling were 
performed as described previously (Reddy and Mohan, 2011). Mice were anesthetized by an 
intraperitoneal injection of ketamine (100 mg/kg. i.p.) and xylazine (10 mg/kg, i.p.).  A 
stimulation-recording bipolar electrode (model MS303/1; Plastics One, Roanoke, VA) was 
stereotaxically implanted in the right ventral hippocampus (2.9 mm posterior, 3.0 mm lateral, 
and 3.0 mm below dura) using the Franklin and Paxinos atlas (1997). The electrode was 
anchored with dental acrylic to three small screws placed in the skull. After a postoperative 
recovery period of at least 1 week, the electrographic afterdischarge threshold was determined by 
an application of 1 ms duration of biphasic rectangular pulses at 60 Hz for 1 s, beginning at 25 
A by using an isolated pulse stimulator (A-M Systems, Sequim, WA). Afterdischarge duration 
was the total duration of hippocampus electrographic spike activity (amplitude > 2 x baseline) 
occurring in a rhythmic pattern at a frequency >1 Hz. Additional stimulations increasing in 
increments of 25 A were given at 5 min intervals until an electrographic afterdischarge duration 
lasting at least 5 s was detected using the digital EEG system (Astro-Med, West Warwick, RI). 
For subsequent stimulations, mice were stimulated at 125% afterdischarge threshold (1 ms 
duration pulse, 60 Hz frequency for 1 s). Two different stimulation protocols were used, 1) rapid 
kindling for seizure progression in neurosteroid withdrawal paradigm,  or 2) regular, daily 
kindling for standard epileptogenesis. For rapid kindling experiements, mice were stimulated at 
30-min intervals until they showed stage 5 motor seizures. Stimulations were delivered every 30 
min until stage 5 seizures were elicited on 3 consecutive trials. For allopregnanolone treatment 
studies and regular kindling epileptogenesis tests, mice were stimulated once per day until stage 
5 seizures were elicited on 3 consecutive days. In either case of kindling epileptogenesis, 
stimulations were iterated  until each mouse reached stage 5 seizures, which is considered the 
fully-kindled state (Reddy and Mohan, 2011). The electrographic activity and afterdischarge 
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duration were acquired from the hippocampal electrode using Axoscope 8.0 software with 
Digidata 1322A interface (Molecular Devices, Sunnyvale, CA) through a Grass CP511 
preamplifier (Astro-Med, West Warwick, RI). Behavioral seizures were rated according to 
Racine’s scale (Racine, 1972) as modified for the mouse: stage 0, no response or behavior arrest; 
stage 1, chewing or facial twitches; stage 2, chewing and head nodding; stage 3, forelimb clonus; 
stage 4, bilateral forelimb clonus and rearing; stage 5, rearing and falling. During each 
stimulation session, the behavioral seizure score and the afterdischarge duration were recorded. 
Rate of kindling development, that is numbers of stimulation required to induce stage 5 seizures, 
was determined in rapidly kindled mice subjected to NSW. Cumulative afterdischarge duration 
was calculated as an index of total seizure activity required to reach stage 5 seizure. Kindling 
experiments were conducted in a group of mice consisting of 6-15 mice for each treatment or 
genotype. 
Six-Hertz seizure model. The 6-Hz model of partial seizures was used according to previously 
described protocol (Barton et al., 2001, Kaminski et al., 2004). WT mice were stimulated with a 
constant-current device delivered via corneal stimulation with 0.2 ms-duration monopolar 
rectangular pulses at 6 Hz for 3 seconds (World Precision Instruments, Sarasota, FL). Ocular 
anesthetic (0.5% tetracaine) was administered as an anti-pruritic to the corneas 10 min before 
stimulation. Immediately prior to stimulation, the corneal electrodes were wetted with 0.9% 
saline solution. Mice were manually restrained during the 6-Hz stimulation, and they were then 
immediately released into an observation chamber. Seizures were frequently preceded by a brief 
period of locomotor convulsion and hunched posture. Animals exhibited various combinations of 
stunned posture, rearing (bipedal standing), forelimb automatic movements, clonus, twitching of 
vibrissae, and Straub-tail. The seizure activity duration ranged from 20 to 40 sec in untreated, 
control animals. The resumption of normal exploratory behavior signified the completion of the 
seizure. For CC50 determination (current producing seizures in 50% of animals), different current 
intensities in the range of 6 to 44 mA were administered to control groups of animals. 32 mA 
was determined to elicit seizures in 100% population of male and female C57BL/6-129SV (WT) 
control mice. A fixed current of 32 mA was delivered as the standarized intensity for comparing 
all mice across structure-activity responses of drugs. In treatment studies, protection from seizure 
activity was designated as the experimental end point of anticonvulsant treatment as maximally 
effective dose. Animals were considered to be protected if they resumed exploratory behavior 
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within 10 sec of the stimulation. Eight to ten animals were used for each dose of anticonvusant 
drug treatment. 
Pentylenetetrazol seizure model. Mice were injected with pentylenetetrazol (PTZ) subcutaneous 
injection and monitored for seizures as adapted from a previous PTZ seizure susceptibility study 
(Ferraro et al., 1999). Latencies to focal (partial clonic), generalized (generalized clonic), and 
maximal (tonic-clonic) behavioral seizures were recorded. Three mice were observed 
simultaneously with seizure latencies derived using individual digital timing devices. A dose-
response was compiled with male and female mice from both WT and δKO strains in order to 
determine a dose of PTZ that best distinguished their seizure sensitivity. At the end of the 30 
min. observation period, mice were killed by cervical dislocation. Four stages of seizure 
behavioral response to subcutaneous PTZ injection were defined as follows: 1) hypoactivity 
characterized by progressive decrease in motor activity until the animal came to rest in a 
crouched or prone position, 2) myoclonic and jerking spasms characterized by brief focal 
seizures lasting 1 sec or less, 3) generalized clonus characterized by sudden loss of upright 
posture, all four limb and tail clonus, rearing, and autonomic signs, and 4) tonic-clonic seizure 
characterized by generalized seizure followed by tonic hindlimb extension. Six to eight mice 
were used per group. Latencies to each seizure stage were summed to assign each mouse a 
seizure score that was used as a quantitative trait measure for dose-response according to the 
equation: 
Seizure score = (0.2) * (1/partial clonus latency) + (0.3) * (1/generalized clonus latency) 
+ (0.5) * (1/tonic-clonic latency) 
The weighting factors (0.2, 0.3, and 0.5) were included as a means of incorporating a measure of 
the progressive nature of the PTZ-induced seizure phenotype into the severity rating because 
generalized clonus is regarded as a more significant event than partial clonus, and tonic hindlimb 
extension is regarded as the most severe component of the phenotype. In this way, the seizure 
score reflects the degree of progression of the seizure syndrome in each mouse, as previously 
described (Ferraro et al., 1999). 
Porsolt forced swim (depression) test. The latency to first immobility and the total duration of 
immobility of mice were measured using the Porsolt’s forced swim test (Porsolt et al., 1978). 
Each mouse was placed individually in a glass cylinder (21 x 12 cm) containing 9 cm of water at 
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22 ± 1 °C. The immobility time was recorded during a 6 min forced swimming test. Each mouse 
was judged to be immobile when it ceased struggling and remained floating motionless in the 
water, making only those movements necessary to keep its head above water. To assess any 
differences in strain, adult WT and δKO mice were compared, as well as male and female of 
each strain. 
Elevated plus maze test. Cognitive behavior was evaluated by using the elevated plus-maze 
learning task (Itoh et al., 1990), which measures spatial long-term memory. Transfer latency (the 
time in which the mouse takes to move from the open arm to the enclosed arm) was utilized as 
an index of learning and memory processes. The apparatus consisted of two open arms (30.5 x 
7.6 cm) and two enclosed arms (30.5 x 7.6 x 22.8 cm) elevated to a height of 30 cm from the 
floor. The test consisted of placing a mouse end an open arm facing away from the center and 
the transfer latency was recorded on the first day. If the mice did not enter the closed arm within 
90 s, they were placed into the closed arm for exploration. In this case, the transfer latency was 
recorded as 90 s. The animals were allowed to explore the apparatus for 60 s to become 
acquainted with the maze. On the second day, 24 h after the first exposure, transfer latency was 
again recorded. Each animal was used only once for acquisition and retention trials. 
Allopregnanolone (1 mg/kg, s.c.) was administered 15 min prior to the assessment of the first 
day trial in the treatment group. An increase in acquisition/learning processes was defined as a 
decreased transfer latency on the second day trial relative to the first day trial. Failure to decrease 
the transfer latency on the second day trial was interpreted as an impairment of learning process. 
The test platform was wiped down with a damp cloth after each trial. Mice which fell off the 
maze were exluded from the experiment. 
III.6 Drugs and Reagents
Electrophysiology reagents. All chemicals used in the electrophysiology studies were purchased 
from Sigma-Aldrich unless otherwise specified. Stock solutions were diluted in the external 
perfusion solution to the desired concentration for electrophysiological use. Allopregnanolone 
(3α-hydroxy-5α-pregnan-20-one, AP), THDOC (3α,21-dihydroxy-5α-pregnan-20-one), 
ganaxolone (3α-hydroxy-3β-methyl-5α-pregnan-20-one, GNX), 5β-AP (3α-hydroxy-5β-
pregnan-20-one), 3β-AP (3β-hydroxy-5α-pregnan-20-one), androstanediol (3α-hydroxy-5α-
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androstane-17β-diol, AD), androsterone (3α-hydroxy-5α-androstane-17-one, AN), 
etiocholanolone (3α-hydroxy-5β-androstane-17-one, ETIO), alfaxolone (3α-hydroxy-5α-
pregnan-11,20-dione, ALFX), and ORG-20599 (2β,3α,5α-21-Chloro-3-hydroxy-2-(4-
morpholinyl)pregnan-20-one), and DS2 (4-chloro-N-[2-(2-thienyl)imidazo[1,2-a]pyridin-3-
yl]benzamide) were prepared in dimethyl sulfoxide for electrophysiology experiments. The 
concentration of dimethyl sulfoxide in final solution was less than 1%. Neurosteroids, 
progesterone, and finasteride (N-(1,1-dimethylethyl)-3-ox-(5α,17β)-4-azaandrost-1-ene-17-
carboxamide) were acquired from Steraloids (Newport, RI). Stock concentrations of GABA, SR-
95531, bicuculline methiodide, APV (D,L-2-amino-5-phosphonovaleric acid), DNQX (6,7-
dinitroquinoxaline-2,3-dione), TTX (tetrodotoxin), and THIP (4,5,6,7-tetrahydroisoxazolo[5,4-
c]pyridin-3-ol hydrochloride) were dissolved in water. Kynurenic acid, DS2, GNX, and THIP
were acquired from Tocris. TTX was acquired from Calbiochem. 
Drug injections. Progesterone (25 mg/kg) and finasteride (50 mg/kg) solutions were made in 
15% β-cyclodextrin w/v in water for the neurosteroid withdrawal paradigm. For behavioral 
experiments involving neurosteroids, drug was dissolved in 0.9% NaCl and suspended in 20% β-
cyclodextrin. Drugs were administered to animals subcutaneously or intraperitoneally in a 
volume equaling 1% of the animal’s body weight.  
III.7 Statistical Analysis
Group data were expressed as the mean ± S.E.M. For whole-cell current recordings, fractional 
potentiation produced by neurosteroid was calculated as INS/IGABA, where IGABA is the peak 
current amplitude of the control GABA response and INS is the peak current response of the co-
application of GABA and the allosteric  drug. A control GABA concentration of 3 μM evoked 
10% of the maximal inhibitory current (EC10), as determined previously in native, murine CA1 
pyramidal cells (Reddy and Jian, 2010) and DGGCs (Wu et al., 2013). The concentration of 
allosteric modulator producing half of the maximal increase in the amplitude of the GABA 
response (EC50) was determined by fitting the concentration-response relationships to the 
following nonlinear sigmoid Hill function: I/Imax = [1 + (EC50 / [A])
n
]
-1
, where A is the allosteric
modulator concentration, Imax is the current evoked by GABA in the presence of a maximal 
potentiating concentration of allosteric modulator, I is the current produced by GABA in the 
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presence of a concentration A, EC50 is the concentration of A required to produce half of its own 
maximal GABA potentiating effect, and n is the Hill coefficient.  
 
For electrophysiology and pharmacology studies, concentration-response curve data were 
subjected to non-linear, logistic fitting. A Hill curve fitting was acquired only for concentration-
responses that achieved a plateau in maximum current response. Statistical comparisons of 
parametric measures including electrophysiology and expressional data were performed using an 
independent two-tailed Student’s t-test followed by Tukey’s HSD test post hoc. In all statistical 
tests, the criterion for statistical significance was p < 0.05, unless otherwise specified. 
 
In case of behavioral observations including kindling data, group data were expressed as mean ± 
S.E.M. The Kruskal-Wallis ANOVA and Mann-Whitney U test were used to analyze significant 
differences in seizure stages between gender and genotypes. Significant differences in 
afterdischarge durations between genotype and treatment groups were assessed by the Student’s 
upaired t-test, repeated measures ANOVA, or one-way ANOVA followed by Dunnett’s test. 
Dose-response curves and their ED50 values in the 6-Hz test were analyzed for significance using 
the Litchfield and Wilcoxon test. Differences were considered statistically significant at p < 0.05. 
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CHAPTER IV 
RESULTS
*
 
IV.1 Plasticity and Function of δ-containing GABAA receptors in the Hippocampus in a 
Perimenstrual Model of Neurosteroid Withdrawal 
IV.1.1  NSW induces up-regulation of GABAA receptor δ-subunit expression
To simulate the perimenstrual-like hormonal milieu in mice, we first created a condition of 
prolonged, elevated progesterone and neurosteroids to model the luteal phase and then induced 
an abrupt decline in neurosteroid levels to more closely model perimenstrual changes in women 
(Figure 6). This paradigm is consistent with perimenstrual catamenial epilepsy in which patients 
experience neurosteroid withdrawal (NSW) (Reddy et al., 2012). 
Figure 6.  Overview of AP synthesis and perimenstrual-like NSW paradigm.  A, Abrupt inhibition of 
5α-pregnan-3α-ol-20-one (allopregnanolone; AP) synthesis was accomplished by pharmacological 
blockade of 5α-reductase activity with finasteride in adult, female mice. B, In the perimenstrual model, 
progesterone was administered twice-daily for seven days and finasteride was administered on the final 
day, resulting in systemic and brain neurosteroid withdrawal. Molecular, electrophysiology, and 
behavioral studies were conducted 24 hours following induction of withdrawal. 
*
Reprinted with permission from “Perimenstrual-like hormonal regulation of extrasynaptic δ-containing 
GABAA receptors mediating tonic inhibition and neurosteroid sensitivity by Carver CM, Wu X, 
Gangisetty O, Reddy DS, 2014. Journal of Neuroscience, 34(43), 14181-14197, Copyright [2014] by 
Carver, Wu, Gangisetty, and Reddy. 
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To determine the withdrawal-induced changes in δ-subunit plasticity in the hippocampus, δ 
subunit expression was explored. Protein levels of δ-subunit in the DG were increased in NSW 
animals relative to controls as detected by western blot analysis with a -specific antibody 
(relative protein expression: 1.00 ± 0.11 control vs. 4.56 ± 0.22 NSW, p = 0.0001, Figure 7). 
Immunohistochemistry was carried out on brain slices from NSW and control mice.  Brain tissue 
slices were processed with the Gabrd antibody, specific for the GABAA receptor δ-subunit in a 
1:250 fraction. Brain sections derived δKO mice did not produce exhibit staining with the Gabrd 
antibody. Images of the hippocampus were collected and analyzed with densitometry using 
Photoshop software (Figure 8A). Staining densities from the CA1 pyramidal layer, stratum 
radiatum, and DG molecular and granule layer subregions were quantified (Figure 8B). NSW 
WT mice displayed significantly greater antibody staining intensity than control WT mice in the 
DG molecular layer. No antibody staining was detected from NSW or control δKO mice. 
Overall, these findings indicate a marked increase in the extrasynaptic expression of δ-subunit in 
the dentate gyrus after NSW in the mouse perimenstrual-like paradigm. 
To confirm the elevation of δ-containing receptors within the hippocampus, we visualized and 
determined the single cell distribution of δ-subunit by fluorescent immunocytochemistry using a 
δ-specific primary antibody. Staining with the antibody showed broad distribution of δ-subunit 
on the soma, axon, and dendritic regions of acutely dissociated CA1 pyramidal cells and DGGCs 
acquired from NSW and control mice (Figure 8C). The normalized mean intensity, expressed as 
percent change in fluorescence mean intensity of δ-subunit staining relative to the mean intensity 
of control IgG (see Method section III.3), was significantly greater in DGGCs of NSW mice as 
compared to control animals (Figure 8D, p < 0.05). Percent change of immunofluorescence 
between control and NSW DGGC (77.1 ± 1.3 %) was significantly greater than the change in 
CA1 cells due to NSW (13.4 ± 2.1 %; p < 0.05). The δ-subunit protein was concentrated on cell 
membrane from X-Z and Y-Z axes obtained from confocal microscopy, as demonstrated 
previously (Wu et al., 2013). 
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Figure 7.  Up-regulation of GABAA receptor δ-subunit expression in the hippocampus of NSW mice.  
Control and NSW protein levels as detected by western blot of protein using a δ-subunit-specific 1˚ 
antibody. Protein loaded was normalized to amount of β-actin. NSW increased δ-subunit protein levels in 
DG compared to control animals as denoted by representative western blot analysis and relative 
quantification.  * p < 0.05 vs. control (n = 6-10 mice per group). 
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Figure 8.  Distribution of δ-subunit in hippocampal CA1 neurons and DGGCs in control and NSW mice. 
A, Mouse hippocampus tissue staining for δ-subunit-specific antibody (1:250) from control and NSW mice. B, 
Quantification of densitometric distribution of δ in the hippocampus subregion ROI stratum radiatum (CA1SR), 
pyramidal layer (CA1PL), dentate granule cell layer (DGGL), and the dentate molecular cell layer (DGML). 
The DGML displayed robust increase to density of δ-subunit in the dendritic region of granule cells and had 
significantly greater percent change to antibody staining (n = 8 – 10 slides per group). C, Immunocytochemistry 
distribution of CA1 vs DGGC principal cells. DGGCs displayed significantly greater normalized integrated 
density of antibody fluorescence in NSW compared with controls. Bar = 10 μm. * p< 0.05 vs. control;  # p< 
0.05 vs. CA1 in NSW (n = 6-24 cells per group). 
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The lack of significant increase to δ-subunit expression in CA1 is contradictory to previous 
findings of increased δ and α4 in CA1 of steroid withdrawn pubertal mice (Shen et al., 2007). 
However, our findings represent plasticity in adult females, and the discrepancies could be 
related to age differences between the mouse models used or other experimental factors. From 
mouse neonates to adulthood, granule cells undergo increased GABA and AP affinity and 
potency, denoting substantial GABAA receptor expressional changes across development 
(Mtchedlishvili et al., 2003). Our data is consistent with the expression pattern of δ-subunit, 
which is expressed in relative abundance in dentate gyrus compared to other hippocampus 
subfields (Brickley and Mody, 2012). 
IV.1.2  NSW confers enhanced sensitivity to AP potentiation of whole-cell GABA-gated currents
in DGGCs 
To confirm a functional role for NSW-induced expression of δ-containing GABAA receptors, we 
recorded whole-cell, GABA-gated currents in acutely dissociated DGGCs and CA1 pyramidal 
neurons with voltage-clamp patch electrophysiology (Figure 9). There are previous reports of δ-
subunit-containing receptors with sub-micromolar GABA affinities (Mortensen et al., 2010; 
Meera et al., 2011); however, these aforementioned studies were conducted in heterologous 
expression systems using recombinant GABAA receptors. The effective concentration value 
depicted in the dissociated experiments in Figure 9 was derived from concentration-response 
curves for native, murine hippocampal neurons (Reddy and Jian, 2010; Wu et al., 2013). This 
range of GABA affinity is consistent with previous reports within adult mouse granule cells in 
which the GABA EC50 is between 18-20 μM and the EC10 value is greater than 1 μM 
(Mtchedlishvili et al., 2003). 3 µM GABA is at the upper limit of the detected range of 
extracellular GABA in vivo (Lerma et al., 1986), and δ-containing receptors shift from low-
efficacy to high-efficacy gating upon neurosteroid interaction (Bianchi and Macdonald, 2003).  
Thus, 3 μM GABA (EC10) was applied to establish a control agonist current for each cell without 
producing significant receptor desensitization (Reddy and Jian, 2010). Increasing concentrations 
of AP (0.01 to 1 μM) were then co-applied with 3 μM GABA. A two minute washing interval 
was implemented between each neurosteroid application for adequate drug removal and 
minimization of receptor desensitization. 
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AP elicited a concentration-dependent potentiation of GABA current in both CA1 and DGGC 
(Figure 9A). These currents were blocked by bicuculline and gabazine, indicating that they are 
mediated by GABAA receptors. Rapid application of AP in the absence of GABA did not 
produce gating of current. Allosteric potentiation of receptors by AP was measured as fractional 
potentiation IA/IGABA, where IGABA was the peak current amplitude response to 3 μM GABA 
alone, and IA was the peak current amplitude of GABA co-applied with AP (Wu et al., 2013). 
Data were compiled from 8 to 16 cells for each AP concentration and neuron type. CA1 
pyramidal cells from control and NSW animals displayed similar levels of AP-mediated 
fractional potentiation with no significant differences between conditions at any of the tested 
concentrations (Figure 9B). In NSW DGGC, AP (0.1 to 1.0 µM) produced a greater potentiation 
of GABAergic current than in the vehicle control DGGCs (Figure 9C). There was no current-
response plateau despite increasing concentration of AP. AP concentrations greater than 1 μM 
were not tested due to neurosteroid ability to directly activate GABAA receptors at higher 
concentrations via a separate binding domain (Majewska et al., 1986; Wohlfarth et al., 2002). 
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Figure 9.  NSW enhances pharmacological sensitivity to allopregnanolone (AP) through allosteric 
potentiation of GABA-gated currents in dissociated DGGCs but not CA1 neurons. A, Representative 
whole-cell current recordings of CA1 pyramidal cells and DGGCs in the NSW paradigm. Neurons 
displayed concentration-dependent responses to AP potentiation of 3 µM GABA (EC10). B, C, Averaged 
concentration-response curves for fold-potentiation of AP (0.01 – 1.0 µM), normalized to baseline GABA 
EC10 (IA/IGABA). Potentiation was averaged for cells of similar condition and concentration following 
normalization to GABA response. NSW DGGCs displayed greater positive potentiation of GABAergic 
current by AP. Recordings in whole-cell mode, voltage clamped at -70 mV. * p< 0.05; ** p< 0.01 vs. 
control (n = 8-16 cells per condition and drug concentration).  
 55 
 
IV.1.3  NSW confers enhanced extrasynaptic GABAA receptor-mediated tonic currents in 
DGGCs 
 
The dentate gyrus up-regulation of δ-subunit in NSW is most functionally significant at 
extrasynaptic sites, where these receptor subunits preferentially localize and co-assemble on the 
membrane surface (Sun et al., 2004), with a denser staining in the molecular layer than the 
granule layer (Peng et al., 2002).  To further confirm the functional significance of elevated 
levels of δ-subunit expression on extrasynaptic GABAergic network inhibition, we recorded 
GABA-gated tonic currents from WT DGGCs in a hippocampal slice preparation, in which 
synapses and dendritic connections remain functional. Bath perfusion of artificial cerebrospinal 
fluid contained 0.5 µM TTX to block action potentials. We examined tonic current modulation 
of GABA, THIP, and 1 µM GABA co-applied with AP. Gabazine (GZ, 50 µM) was applied to 
the slice perfusion to block phasic and tonic currents. Tonic current was measured as the shift in 
mean conductance before and after gabazine application.  Figure 10 depicts modulation of tonic 
current in granule cells during NSW. Endogenous tonic current was measured in the absence of 
GABA in the bath perfusion.  Control DGGCs displayed significantly greater endogenous tonic 
current than NSW (p = 0.0468, n = 7-8 cells per group, Figure 10C). We subsequently measured 
tonic current with perfusion of 0.3 μM, 1 μM, or 3 μM GABA for a comparative profile of 
GABA binding of extrasynaptic receptors (Figure 10C). Both 0.3 (p = 0.0398) and 1 μM GABA 
(p = 0.0480) elicited greater tonic current in NSW than control DGGCs (n = 5-6 cells per group 
and concentration). In response to 1 µM GABA + 100 nM AP or 1 μM GABA + 300 nM AP, 
NSW DGGCs experienced significantly greater enhancement of tonic current than control 
DGGCs (100 nM AP: p = 0.0088; 300 nM AP: p= 0.0167; n = 8-10 cells per group, Figure 10C).  
 
We measured the root-mean-square (RMS) channel conductance during each drug application of 
current recording. Endogenous RMS noise was significantly greater in control (4.0 ± 0.2 pA) 
than NSW (3.4 ± 0.1 pA) tonic recordings (p = 0.0274, n = 6-7 cells per group), however 1 µM 
GABA RMS noise was not significantly different between NSW (3.9 ± 0.1 pA) and control (4.2 
± 0.2 pA; p = 0.1567; n = 8-12 cells per group). AP significantly increased the RMS noise 
compared to 1 µM GABA baseline, similar to our previous report (Wu et al., 2013). 300 nM AP 
modulated RMS noise to 5.6 ± 0.3 pA and 6.3 ± 0.4 pA in control and NSW DGGC, 
respectively, but this was not significantly different between conditions (p = 0.1833). Gabazine 
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application reduced the RMS noise in a withdrawal-dependent manner. Gabazine produced a 
greater reduction of AP-modulated RMS in NSW compared with control at 100 nM AP (Δ-0.9 ± 
0.2 pA control vs. Δ-1.9 ± 0.2 pA NSW; p = 0.0030, n = 8-10 cells per group) as well as during 
300 nM AP (Δ-2.3 ± 0.3 pA control vs. Δ-3.4 ± 0.3 pA NSW; p = 0.0208, n = 8 cells per group). 
We explored THIP modulation of tonic current due to its high affinity and efficacy for δ-subunit 
extrasynaptic receptors (Mortensen et al., 2010; Meera et al., 2011) and different binding site 
than the allosteric site of neurosteroids (Brown et al., 2002; Stórustovu and Ebert, 2006). THIP 
was applied in an environment without exogenous GABA in the perfusion to allow for high 
GABAA receptor occupancy. A concentration-dependent response was examined for tonic 
current modulation by THIP in the range 0.03-1 μM, selective for δ-subunit binding (Figure 
10F). Tonic currents of NSW DGGCs displayed significantly greater sensitivity to THIP at 0.1 
and 0.3 μM concentrations than control DGGCs (p < 0.05, n = 4-6 cells per group and 
concentration). We observed desensitization of extrasynaptic current at 1 μM THIP (Figure 
10E). While it is possible that 1 μM THIP is beyond δ-subunit selectivity, it was of note that 
extrasynaptic desensitization to THIP was more pronounced in NSW native DGGCs (Bright et 
al., 2011; Brown et al., 2002; Pandit et al., 2013). Previous studies describe that under steady-
state conditions, THIP does not display super-agonist properties (Houston et al., 2012). 
Therefore, we measured peak tonic current 30 seconds after THIP administration, and we also 
measured tonic current at the time in which THIP-modulated conductance reached tonic 
desensitization. The criterion for determining the tonic desensitization is described in the 
Methods. Gabazine (50 μM) was applied after 2 minutes of recording to determine the total tonic 
current shift. We then compared the difference in peak and desensitized currents between control 
and NSW DGGCs (Figure 10E-F). The peak tonic current for 0.1 – 1 μM THIP was 
significantly different between control and NSW (p = 0.0051).  NSW, but not control DGGCs 
displayed significant desensitization compared to the peak current induced by 1 μM THIP (p = 
0.0238).  Percent change of THIP-dependent current desensitization was significantly different 
between control (27.5 ± 5.5 %) and NSW DGGCs (50.8 ± 4.7 %; p = 0.0229, n = 5 cells per 
group). Together, these electrophysiology studies indicate neurosteroid withdrawal confers 
greater sensitivity of extrasynaptic currents to AP and the δ-specific agent THIP within dentate 
gyrus granule cells. 
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Figure 10.  NSW enhances AP potentiation and THIP modulation of tonic currents in DGGCs in 
hippocampus slices. 
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Figure 10 Continued. A, Representative GABAergic tonic current recordings from DGGCs.  300 nM AP 
produced a further negative shift in holding current level, and 50 µM of the competitive antagonist gabazine 
(GZ) produced a positive shift in holding level, blocking both phasic and tonic currents. Tonic current shift 
(pA) was measured as the total current change before and after gabazine application. The first grey dotted 
line in each raw trace represents the mean holding current during gabazine application. B, Representative 
GABAergic tonic current recordings from CA1PCs in response to 0.3 µM THIP. C, Concentration-response 
of DGGC tonic current to GABA. Endogenous tonic current (no exogenous GABA) shift was greater in 
control condition than NSW; however, NSW DGGCs displayed greater tonic current at 0.3 μM GABA and 
1 μM GABA than control.  D, NSW DGGC tonic currents were more sensitive to modulation by AP than 
control at 100 nM and 300 nM AP potentiation of 1 μM GABA. E, Representative tonic current recordings 
from control DGGC (grey trace) and NSW DGGC (black trace) due to 1 µM THIP application. F, 
Quantification of tonic current during 0.03 to 1 μM THIP from CA1PCs and DGGC. 1 μM THIP 
administration at peak ( in Fig 5E) and desensitized ( in Fig 5E) tonic levels from DGGC were also 
compared. Whole-cell mode, voltage-clamp -65 mV. Data values represent mean ± S.E.M. *p < 0.05 vs. 
control DGGC current, #p < 0.05 vs. 1 μM THIP peak current, NSW (n=4 - 10 cells for each group and 
concentration). 
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IV.1.4  NSW does not confer enhanced extrasynaptic function in CA1 neurons
Previous models of NSW have suggested that increase to δ-subunit expression occurs in CA1 
pyramidal cells (Smith et al., 2007; Sundstrom-Poromaa et al., 2002). There is a lack of 
definitive evidence that increases to δ-subunit expression within hippocampus promote 
functional, extrasynaptic current within CA1. Having demonstrated that DGGCs undergo 
functional increase in sensitivity to THIP after NSW, we examined tonic current modulation in 
CA1PCs. There were no significant differences to THIP-induced tonic currents in CA1 between 
control and NSW mice (Figure 10F). We did not observe significant desensitization of CA1 
currents at 1 µM. This evidence further supports that δ-subunit expression up-regulation is 
functionally more significant to the granule cells of the dentate gyrus and not to CA1PCs. 
IV.1.5  NSW does not confer enhanced AP sensitivity in δKO mice
To further confirm whether NSW-induced increase in neurosteroid sensitivity is due to 
extrasynaptic δ-subunit GABAA receptors, we utilized knockout mice that lack expression of δ-
containing receptors in the brain as a robust genetic model. Neurons were acutely dissociated 
from δKO female mice treated in the perimenstrual-like withdrawal paradigm. Voltage-clamp 
recordings were obtained from DGGC neurons in response to AP co-applied with 3 µM GABA 
(Figure 11A), similar to the experiments performed in Figure 9. A concentration-response curve 
was derived for AP potentiation of GABAergic current (Figure 11B), and fractional current 
responses of AP were compared between NSW and vehicle-injected control δKO animals. In 
δKO granule cells, AP (0.05-0.30 μM) and GABA produced less modulation of GABAA receptor 
currents than that of GABA alone. NSW and control DGGCs from δKO mice displayed no 
significant differences at any of the concentrations tested (n = 8-12 cells per each group and drug 
concentration). In addition, modulation by AP was significantly lower in δKO DGGCs than in 
WT DGGCs.  
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Figure 11.  AP sensitivity is attenuated in δKO mice undergoing NSW.  A, Representative whole-cell 
current recordings of dissociated DGGCs from δKO mice. B, Concentration-response curve of δKO 
DGGCs due to AP modulation of GABA-gated current (IA/IGABA). AP potentiation was not significantly 
different between control and NSW DGGCs at any of the AP concentration tested (0.05 – 1 µM). C, Tonic 
current recordings from control and NSW DGGCs in hippocampus slices from δKO mice. The grey dotted 
line represents the mean holding current during gabazine (GZ) application. 50 µM gabazine antagonized 
phasic GABAA receptor currents but caused little to no shift in the tonic current holding level of δKO 
neurons. D, Tonic current shift due to gabazine is reduced and minimal in δKO DGGCs in control and 
NSW. There were no significant differences in tonic current between NSW and control DGGCs during 1 
µM GABA or during 1 µM GABA + 300 nM AP application. Data represent mean ± S.E.M. (n= 5-12 
cells). Whole-cell mode, voltage clamped at -70 mV (A-B) or -65 mV (C-D). 
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We acquired tonic current recordings from δKO DGGCs to ascertain the degree of AP sensitivity 
in a hippocampal network lacking δ-subunit (Figure 11C-D). Changes to tonic current, RMS, 
and enhanced AP sensitivity were not evident in δ-subunit knockout animals subjected to 
withdrawal. Tonic currents were highly attenuated, and control and NSW knockouts displayed 
no significant differences in 1 µM GABA (p = 0.8860; n = 5 cells per group) or 1 µM GABA 
and 300 nM AP (p = 0.9064; n = 6 cells per group). Overall, these results indicate a lack of 
NSW-induced function in δ-subunit knockout animals. The neurosteroid sensitivity present in 
withdrawn mice is attenuated when the δ-subunit is genetically and functionally removed from 
the hippocampus, disallowing plastic increase in δ expression. 
IV.1.6  NSW influences synaptic GABAA receptor mIPSC amplitude and kinetics
To determine the extent of withdrawal-induced modulation by allopregnanolone on synaptic 
receptors, GABAergic miniature IPSCs were recorded in DGGCs from brain slices in the 
presence of 0.5 μM TTX in perfusion and 5 mM QX-314 in the recording electrode pipette. The 
properties of amplitude, 10-90% rise-time, decay time constants, and inter-event interval (IEI, as 
a measure of frequency) were analyzed from mIPSCs (Table 2 and Figure 12). The average 
mIPSC from each neuron was best fit with a double-exponential decay curve, depicted as τ1 and 
τ2. A weighted decay constant, τw was also determined (see Methods section III.4). mIPSC 
frequency is related to functional number of synapse release sites and the rate of presynaptic 
release (Cherubini and Conti, 2001). GABAA receptor channel kinetics are highly influenced by 
receptor subunit composition (Carver and Reddy, 2013; Smith et al., 2007). Postsynaptic 
receptor density, synaptic vesicle GABA content, and dendritic cable properties contribute to 
mIPSC amplitude (Cherubini and Conti, 2001; Nusser et al., 1997). We hypothesized that NSW 
would not alter presynaptic GABA release properties; however, we proposed that NSW-induced 
sensitivity of allopregnanolone may affect postsynaptic current and kinetics due to the α4 and δ 
subunit expressional changes (Figure 12). Within recordings of endogenous (no GABA) or 1 
μM GABA perfusion, the amplitude, kinetics, and frequency were not significantly different 
between withdrawal and control DGGCs (Table 2). These experiments were repeated with 1 μM 
TTX to ensure the recorded IPSCs were action-potential-independent. There were no significant 
differences in amplitude, decay constants, and frequency of mIPSCs in comparison of 0.5 μM 
and 1.0 μM TTX. In the addition of 300 nM AP, peak amplitude was significantly greater in 
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withdrawal than control DGGCs (p = 0.0046; n = 5 cells per group). Neurosteroids such as AP 
increase the channel opening probability of GABAA receptors and prolong the decay kinetics 
(Carver and Reddy, 2013). The τw constant derived from τ1 and τ2 time constants of phasic 
GABAA receptors from DGGCs was consistent with previous reports (Sun et al., 2007).  AP 
(300 nM) resulted in a significant increase in τ2 and τw decay time constants of both control and 
NSW (p = 0.0011 vs. control 1 μM GABA; p < 0.0001 vs. NSW 1 μM GABA). Whereas the 
control mIPSCs exhibited an average 62.1 ± 6.0 % increase to τ2 decay upon AP modulation, the 
NSW mIPSCs exhibited an average 135.8 ± 5.2 % increase to τ2 decay. Control mIPSCs had an 
average of 33.1 ± 5.5 % increase to τw decay upon AP modulation, and NSW mIPSCs had an 
average 66.8 ± 6.3 % increase to τw decay. This difference in mean percent change of τ2 and τw 
was statistically significant between control and NSW groups (p < 0.0001 for τ2, p = 0.0008 for 
τw). Data represent mean values for 5-10 cells per group and application. 
In order to determine if the NSW-induced changes to synaptic activity we observed are related to 
δ-subunit expression, we recorded mIPSCs from δ-knockout mice subjected to the withdrawal 
paradigm. AP did not significantly prolong the decay in δKOs as that occurred in WT neurons, 
and there were no significant differences in mIPSC properties between control and withdrawal in 
knockout DGGCs (Table 2). In addition, during AP administration, δKO mIPSCs displayed 
faster τ2 and τw decay than WT mIPSCs in both control and withdrawal conditions. 
Our findings indicate that δ-containing receptors mediate the prolongation of mIPSC decay in 
the presence of AP. NSW-induced change to phasic decay kinetics did not occur with 1 μM 
GABA alone. However, NSW tonic currents displayed greater sensitivity to 1 µM GABA. This 
difference in activity may represent distinct receptor subtype compositions and their GABA-
gating properties within the native neuronal population (Mortensen et al., 2010). We 
demonstrated that AP is able to alter the efficacy state and channel opening of the phasic-
responding receptors in withdrawn animals above control conditions (Bianchi and Macdonald, 
2003). It is possible that a perisynaptic population of GABAA receptors could respond to 
synaptic spillover of GABA during up-regulated δ expression. However, there is evidence that 
suggests δ-containing receptors are relatively insensitive to phasic GABA activation that could 
occur through synaptic spillover (Bright et al., 2011). 
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Figure 12. mIPSCs are sensitive to AP in mice undergoing NSW. 
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Figure 12 Continued.  Phasic events were recorded from patch-clamped DGGCs in hippocampus slice. 
GABAA receptor synaptic activity was isolated using TTX, APV, and DNQX. Synaptic current was 
blocked with gabazine (50 μM). A, Representative traces of IPSCs before and after TTX application and 
mIPSCs in 0.5 µM or 1.0 µM TTX. B, mIPSC recordings during GABA and AP modulation. RMS channel 
noise increased during AP application. C, Averaged mIPSC events recorded from control and NSW 
DGGCs in the presence of 1 µM GABA (solid line) or 1 µM GABA co-applied with 300 nM AP (dashed 
line), and bi-exponential fitted for fast and slow decay time constants, τ1 and τ2 (gray dash lines), 
respectively. NSW DGGCs displayed significantly greater amplitude (p = 0.0046) and τ2 decay (p = 
0.0011) during application of 300 nM AP than control DGGCs (n = 5-10 cells per group) (Rt: downward 
rise time. see Table 2). Cumulative probability curves for wildtype control (D) and NSW (E) mIPSC 
amplitude, plotted from all events. Kolmogorov-Smirnov test was used to compare mIPSC before and after 
application of AP in DGGCs (n = 5-10 per group). D-E inlay, Mean peak amplitude of mIPSCs. * p < 
0.05. Recordings whole-cell mode, voltage-clamp -65 mV. 
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Table 2. GABAA receptor-mediated mIPSC characteristics in control and NSW mice 
Group (n) Amplitude 
(pA) 
Rise10-90% 
(ms)1 
Decay τ1 
(ms)1 
Decay τ2 
(ms)1 
Decay τw 
(ms) 
IEI  
(s)2 
WT Control endogenous (5) 
0.5 μM TTX 
30.8 ± 1.6 1.2 ± 0.2 12.6 ± 0.8 51.6 ± 3.9 27.2 ± 1.5 1.4 ± 0.1 
WT Control, endogenous (5) 
1.0 μM TTX 
27.3 ± 2.4 1.1 ± 0.2 10.2 ± 0.6 48.5 ± 5.8 25.2 ± 2.9 1.6 ± 0.1 
WT NSW endogenous (5) 
0.5 μM TTX 
30.3 ± 1.9 1.0 ± 0.1 11.5 ± 1.3 49.2 ± 5.5 25.3 ± 1.1 1.1 ± 0.2 
WT NSW, endogenous (5) 
1.0 μM TTX 
32.7 ± 1.4 0.9 ± 0.1 13.9 ± 1.1 49.0 ± 2.3 26.4 ± 2.8 1.4 ± 0.1 
WT Control:   +1 μM GABA (10) 33.7 ± 2.6 1.2 ± 0.3 12.4 ± 0.6 49.6 ± 3.3 26.0 ± 0.9 1.6 ± 0.3 
WT NSW: + 1 μM GABA (10) 33.8 ± 2.0 1.2 ± 0.2 14.4 ± 1.4 43.3 ± 4.2 25.3 ± 1.9 1.3 ± 0.2 
δKO Control: + 1 μM  GABA (9) 33.7 ± 2.2 1.3 ± 0.1 12.2 ± 0.9 47.8 ± 4.0 26.0 ± 2.6 1.8 ± 0.1 
δKO NSW:  + 1 μM  GABA (6) 32.4 ± 2.3 1.1 ± 0.2 11.7 ± 1.8 45.8 ± 6.0 22.5 ± 2.5 1.8 ± 0.6 
WT Control: + GABA+300 nM AP (5) 31.5 ± 0.8 1.4 ± 0.1 12.6 ± 1.8 *80.4 ± 8.3 *34.6 ± 1.4 1.7 ± 0.2 
WT NSW: + GABA +300 nM AP (5) *#40.5 ± 2.1 1.6 ± 0.3 16.5 ± 2.0 *102.1 ± 7.9 *42.2 ± 3.1 1.6 ± 0.3 
δKO Control: +GABA +300 nM AP(9) 34.8 ± 1.3 1.5 ± 0.2 15.3 ± 1.4 &58.5 ± 5.1 &29.5 ± 1.1 1.7 ± 0.3 
δKO NSW: + GABA +300 nM AP(5) &34.9 ± 2.0 1.0 ± 0.1 10.1 ± 1.0 &47.9 ± 7.5 &23.6 ± 2.3 1.6 ± 0.4 
mIPSCs were recorded in the presence of 0.5 μM TTX unless otherwise denoted. Groups denoted as + 
GABA + AP were recorded in the presence of 1 μM GABA and 300 nM AP. Recordings were from 
voltage clamped (-65 mV) dentate gyrus granule cells in hippocampus slices. 
1Rise time, decay τ1, and decay τ2 are represented as Rt, τ1, and τ2 in Fig 7C. Rise10-90% represents as duration 
for downward shift 10 to 90% of the amplitude. 
 2
IEI = Inter-event interval as a measure of frequency. 
* p < 0.05 vs. WT NSW + 1 μM GABA alone; # p < 0.05 vs. WT Control + GABA +300 nM AP; & p <
0.05 vs. WT NSW + GABA +300 nM AP; independent two-tailed t-test. 
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Since low, ambient GABA (1 µM) was unable to elicit a significant difference in the phasic 
current, we explored mIPSCs with higher concentrations of exogenous GABA to engender a 
condition of higher efficacy synaptic response in both WT and δKO DGGCs (Table 3). GABA 
concentrations of 3 and 10 μM were sufficient to significantly increase both the amplitude, τ2 and 
τw decay of mIPSCs from WT control DGGCs (3 μM GABA: amplitude: 44.0 ± 3.0 pA, τ1: 15.4 
± 2.2 ms τ2: 70.9 ± 3.8 ms, τw: 34.9 ± 2.3 ms; 10 µM GABA: amplitude: 54.1 ± 5.7 pA, τ1: 16.5 
± 2.7 ms, τ2: 109.8 ± 12.0 ms, τw: 45.7 ± 6.6 ms; n = 5-6 cells per concentration). Compared with 
1 μM GABA, WT DGGCs displayed an average 42.9 ± 2.6 % increase in τ2 in 3 μM GABA, 
whereas DGGCs in 10 μM GABA had an average 121.4 ± 10.2 % increase in τ2. We also 
explored mIPSCs within δKO DGGCs in response to 3 and 10 μM GABA (3 μM GABA: 
amplitude: 30.2 ± 1.0 pA, τ1: 18.6 ± 1.7 ms τ2: 57.8 ± 3.1 ms, τw: 32.4 ± 1.5 ms; 10 µM GABA: 
amplitude: 48.9 ± 6.8 pA, τ1: 15.7 ± 1.5 ms, τ2: 64.8 ± 5.8 ms, τw: 34.3 ± 1.0 ms; n = 4-5 cells per 
concentration). δKO DGGCs had an average 20.9 ± 1.4  % change in τ2 in 3 μM GABA and an 
average 35.6 ± 3.1 % change in τ2 in  response to 10 μM GABA when compared with 1 μM 
GABA. The difference in τ2 decay was significantly reduced in δKO DGGCs compared to WT 
for each GABA concentration (p < 0.05), denoting an increased contribution of δ-subunit to 
phasic currents in control conditions, albeit at supraphysiological concentrations of GABA. Our 
data provide pharmacologically significant evidence that δ-containing receptors require higher-
efficacy gating in order to mediate phasic currents, such as that occurring by neurosteroid 
potentiation of GABA (Bianchi and Macdonald, 2003). In our model, neurosteroid withdrawal is 
sufficient to promote prolongation of post-synaptic current decay and amplitude in response to 
AP, but not to low (≤ 1 μM), ambient GABA alone. 
Interestingly, 3 and 10 μM GABA significantly decreased mIPSC frequency, a measure of 
presynaptic GABA release when bath applied to hippocampal slices (Table 3). This suggests 
localized presynaptic depression  of GABAergic terminals synapsing to DGGCs in high 
concentrations of extracellular GABA, both in WT and δKO conditions. Another mechanism for 
lower mIPSC frequency could be that the higher receptor occupancy or continual activation at 
greater GABA concentrations results in reduced GABA gating by a diminished receptor pool. 
AP (0.3 µM) modulation of mIPSCs displayed a trend of decreased frequency, however it was 
not statistically significant (Table 2). 
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Table 3. GABAA receptor-mediated mIPSC characteristics in WT and δKO mice 
Group (n) Amplitude 
(pA) 
Rise10-90% 
(ms)1 
Decay τ1 
(ms)1 
Decay τ2 
(ms)1 
Decay τw 
(ms) 
IEI  
(s)2 
WT:   +1 μM GABA (10) 33.7 ± 2.6 1.2 ± 0.3 12.4 ± 0.6 49.6 ± 3.3 26.0 ± 0.9 1.6 ± 0.3 
WT:   +3 μM GABA (6) *44.0 ± 3.0 1.6 ± 0.4 15.4 ± 2.2 **70.9 ± 3.8 **34.9 ± 2.3 *2.6 ± 0.1
WT:   +10 μM GABA (5) *54.1 ± 5.7 *2.2 ± 0.5 16.5 ± 2.7 **109.8 ± 12.0 **45.7 ± 6.6 *2.8 ± 0.2 
δKO: + 1 μM  GABA (9) 33.7 ± 2.2 1.3 ± 0.1 12.2 ± 0.9 47.8 ± 4.0 26.0 ± 2.6 1.8 ± 0.1 
δKO: + 3 μM  GABA (4) 30.2 ± 1.0 1.5 ± 0.6 #18.6 ± 1.7 &57.8 ± 3.1 32.4 ± 1.5 #3.1 ± 0.2 
δKO: + 10 μM  GABA (5) #48.9 ± 6.8 1.8 ± 0.3 15.7 ± 1.5 #†64.8 ± 5.8 34.3 ± 1.0 #3.1 ± 0.7 
mIPSCs were recorded in the presence of 0.5 μM TTX. Groups denoted as WT were recorded from WT 
female mice whereas δKO denotes recordings from δ-subunit knockout female mice. Recordings were 
from voltage clamped (-65 mV) dentate gyrus granule cells in hippocampus slices. 
1Rise time, decay τ1, and decay τ2 are represented as Rt, τ1, and τ2, similar to that of Fig 7C. Rise10-90% 
represents as duration for downward shift 10 to 90% of the amplitude. 
 2
IEI = Inter-event interval as a 
measure of frequency. 
* p < 0.05 vs. WT: +1 μM GABA ; ** p < 0.01 vs. WT: +1 μM GABA ; # p < 0.05 vs. δKO: +1 μM
GABA ; & p < 0.05 vs. WT: +3 μM GABA; † p< 0.05 vs. WT: +10 μM GABA;  independent two-tailed t-
test. 
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IV.1.7  NSW causes increased susceptibility to hippocampus kindling seizures 
 
To investigate whether the NSW-induced changes in GABAA receptors mediating tonic 
inhibition affects neuronal network excitability in a seizure model, we studied the susceptibility 
of neurosteroid withdrawn mice to seizures in rapid hippocampus kindling (Reddy and Mohan, 
2011; Wu et al., 2013). Adult female mice were surgically implanted with a bipolar electrode in 
the hippocampus. Following surgery recovery and subsequent withdrawal paradigm, the mice 
were subjected to rapid kindling stimulations at 125% AD (afterdischarge) threshold at 30 
minute intervals until stage 5 seizures were consistently reached. The progression of rate of 
kindling, electrographic AD threshold, and cumulative AD activity time for kindling criterion 
were recorded as main indices of epileptogenesis (Figure 13). Mean rate of kindling was 
significantly faster in NSW animals (Figure 13B, p = 0.0098). Mean AD threshold current was 
significantly reduced in NSW mice (Figure 13C, p = 0.0149). Cumulative AD duration was not 
significantly different between control and withdrawal groups (Figure 13D, p = 0.1384). The 
amplitude of AD spike activity was markedly greater in NSW mice than in control mice (data 
not shown). The rapid kindling experiments were conducted in δKO mice with and without 
NSW induction. The δKO animals did not display significant differences in any of the seizure 
parameters between control and NSW groups (Figure 13B-D). Thus, these results are consistent 
with the increased excitability and susceptibility of animals undergoing NSW with δ-subunit 
intact, which is a key triggering factor for catamenial seizure exacerbation. 
 
IV.1.8  Fully-kindled, NSW mice exhibit increased sensitivity to antiseizure effects of AP 
 
To determine the therapeutic potential of neurosteroids in perimenstrual catamenial epilepsy, we 
tested the effect of neurosteroid AP on heightened seizures caused by perimenstrual-like 
neurosteroid withdrawal in fully-kindled mice exhibiting stage 5 seizures. Female WT and δKO 
mice were subjected to once-daily kindling until they exhibited stage 5 seizures for 3 consecutive 
days, which is considered the fully kindled state. WT mice reached the fully kindled state with 
consistent stage 5 seizures after 10 to 16 stimulations (Figure 13B), as reported previously 
(Reddy et al., 2012). Fully-kindled WT and δKO mice undergoing NSW condition were treated 
with AP or vehicle injections. Fifteen minutes after AP administration, animals were stimulated 
at their designated AD threshold. Behavioral seizure stage and electrographic AD duration were 
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evaluated as criteria of drug efficacy for sensitivity assessment (Figure 14). AP (1-10 mg/kg, sc) 
exerted dose-dependent suppression of the behavioral seizures (Figure 14A) and AD duration 
(Figure 14B) in WT control (non-withdrawal) mice. In contrast, after neurosteroid withdrawal, 
AP produced greater suppression of behavioral seizures and AD duration in WT mice with 
significant effects at 1 and 5 mg/kg compared with the control group (p < 0.01, n = 6-9 mice per 
group). These experiments were repeated in fully-kindled δKO mice. In contrast to WT 
counterparts, fully-kindled δKO mice undergoing NSW failed to exhibit any significant 
difference in seizure expression (Figure 14C) and AD duration (Figure 14D) following AP (1-
10 mg/kg, sc) treatment (n = 6-9 mice per group).  These results confirm enhanced neurosteroid 
sensitivity in WT mice due to up-regulation of δ-subunit.  However, the time-course profiles for 
onset and duration of seizure expression following AP (10 mg/kg) treatment were similar in WT 
and δKO mice (Figure 14E-F), indicating the lack of significant pharmacokinetic factors in drug 
sensitivity related to genotype. Moreover, plasma levels of AP achieved at various doses of AP 
treatment (10 mg/kg) were correlated with seizure protection in WT control and withdrawn 
groups (Figure 14E-F), indicating a linear pharmacokinetic-pharmacodynamic relationship. 
Overall, the neurosteroid AP produced enhanced antiseizure efficacy (50%) in WT NSW but not 
δKO NSW animals, confirming the δ-subunit related enhanced sensitivity to neurosteroids in the 
neurosteroid-withdrawal model of catamenial epilepsy (Reddy and Rogawski, 2001; Reddy et 
al., 2012). 
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Figure 13. Changes in susceptibility to hippocampus kindling epileptogenesis in NSW WT and δKO 
mice. Adult, female mice in the withdrawal paradigm were subjected to rapid kindling stimulations at 
125% afterdischarge (AD) threshold at 30 minute intervals until consistent display of stage 5 seizures. A, 
Representative electrographic AD seizure activity recorded immediately after kindling stimulation of the 
hippocampus, recorded in control and NSW wildtype mice. The black bar above the stage designation 
denotes the period of the electrograph in which the animal experienced seizure activity. B, WT mice 
experiencing NSW developed stage 4/5 seizures in significantly less number of stimulations than control 
mice, as denoted by rate of kindling. C, WT mice undergoing NSW mice showed a lower mean AD 
threshold than control mice, requiring less current stimulation to achieve epileptogenic seizure activity. 
Control δKO mice exhibited a more rapid kindling and had lower AD threshold than WT control 
counterparts. D, Cumulative AD duration was similar between control and NSW groups. * p < 0.05 vs. 
control of similar genotype, # p < 0.05 vs. WT control (n = 9-15 animals per group). 
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Figure 14. NSW confers antiseizure effects to AP in fully kindled WT but not δKO mice.  
Fully kindled mice undergoing NSW were utilized for testing the effect of allopregnanolone on seizure 
activity. A, Dose-response curves for AP-induced (1-10 mg/kg, s.c.) suppression of behavioral seizure 
stage and B, AD duration in WT mice. C, Dose-response curves for AP-induced (1-10 mg/kg, s.c.) 
suppression of behavioral seizure stage and D, AD duration in KO mice. There were no significant 
differences between KO control and NSW seizure modification by AP. E, Time-course correlation 
between plasma AP levels and seizure stage, and F, AD duration in WT and KO mice. Vehicle or AP 
was injected 15 min before kindling stimulations or plasma sample collection. (A-D) * p < 0.05 vs. 
control. (F) * p < 0.05 vs. WT (n = 6-9 animals per group). 
  
 72 
 
IV.2  Structure-activity Relationship of Neurosteroid Modulation of δ-containing 
Extrasynaptic GABAA Receptor-mediated Tonic inhibition in the Hippocampus DGGCs 
 
IV.2.1  GABA-gated whole-cell currents in acutely dissociated DGGCs in germline δKO mice 
 
To determine the impact of δ-subunit on GABA-gated current, we evaluated whole-cell GABA 
concentration-responses from acutely dissociated DGGCs in WT and δKO mice. Native DGGCs 
of δKO mice exhibited significantly greater GABA potency than WT (Figure 15A). WT 
DGGCs had an average GABA EC50 of 28.2 ± 0.9 µM and a Hill coefficient of 1.35 ± 0.04 (n = 
11), whereas δKO DGGCs had an EC50 of 15.7 ± 0.7 µM and a Hill coefficient of 1.21 ± 0.02 (n 
= 7). All cells displayed GABAA receptor current saturation at 1 mM GABA. From the same 
whole-cell currents, we measured the percent desensitization of the GABAA chloride channel 
macrocurrents subsequent to barrel-pipette application of GABA. In the granule cells, 0.1–10 
μM concentrations of GABA displayed little or no desensitization upon application. However, 
100 – 1000 μM GABA displayed peak current responses that rapidly desensitized and were 
curve fitted by the Chebyshev method with a single-exponent decay function.  We observed that 
δKO DGGC macro-currents had greater extent of desensitization than WT DGGCs due to 
GABA in the range of 100 - 1000 μM GABA  (Figure 15B). In addition, the average 10-90% 
decay time for macro-currents in saturating 1 mM GABA was significantly greater for WT 
DGGCs (7.53 ± 0.40 s) than δKO DGGCs (4.60 ± 0.50 s; p = 0.0002; n = 7-10 samples per 
group). 
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Figure 15. Reduced GABAergic inhibition from dissociated DGGCs in δKO mice by patch-clamp 
recordings. A, GABA concentration-repsonse curve of dissociated WT and δKO DGGCs. Each data point 
was fit according to the maximum GABA-gated current at the saturating concentration (1000 μM). EC50 
and Hill coefficient values are noted in the text. At 10 μM GABA, δKO responses were significantly 
greater than WT. B, Percent desensitization of GABAergic macrocurrent kinetics due to rapid application 
of 10 (-5 log Molar), 100 (-4 log Molar), or 1000 (-3 log Molar) μM GABA. δKO cells had significantly 
greater percent desensitization than WT. C, Representative traces of dissociated DGGC response to 
potentiation of 3 μM GABA (EC10) by AP in WT and δKO DGGC. D, Concentration-response 
quantification of fold-potentiation by AP. δKO cells had significantly reduced response to AP compared 
with WT. n = 8-10 cells per group. * p < 0.05, ** p < 0.01 by unpaired t-test. All cells dissociated from 
diestrus, WT female mice dentate gyrus. Recordings in whole-cell mode, voltage-clamp -70 mV.  
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IV.2.2 Diminished allosteric potentiation by AP in dissociated δKO DGGCs 
 
Pharmacological response to the AP potentiation of GABAA receptors was obtained in whole-
cell current recordings from dissociated DGGCs. GABA EC10 (3 μM) was bath applied to 
determine control current. Subsequently, increasing concentrations of AP were co-applied with 
GABA to achieve an allosteric concentration-response (Figure 15C). Fractional potentiation of 
GABAergic currents by AP is represented by mean fold-enhancement of the GABA EC10 
response. AP enhanced whole-cell current in a concentration-dependent manner in WT DGGCs. 
AP (0.1 – 1 μM) did not significantly potentiate currents in the absence of GABA, signifying a 
lack of direct activation of receptors at submicromolar concentrations in these cells. Thus, these 
responses represent an allosteric modulation by AP at the GABAA receptors. δKO cells exhibited 
significantly reduced AP potentiation of GABA current than WT (Figure 15D). At 0.3, 0.5, and 
1 μM AP, WT cells displayed enhanced GABA currents significantly greater than δKO 
counterparts. In addition, within δKO cells, only the 1 μM AP response elicited potentiation 
significantly above the 3 μM GABA control response. AP (1 µM) potentiated an average 3.20-
fold of current in WT DGGCs, whereas δKO DGGCs produced 1.87-fold of the GABA EC10 
response. 
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IV.2.3  Neurosteroid structure-activity relationship on extrasynaptic GABAAR-mediated tonic 
inhibition 
 
GABA-gated responses on tonic inhibition 
 
To obtain extrasynaptic GABAA receptor responses and derive a basal Itonic prior to neurosteroid 
exposure, we examined exogenous GABA in patch-clamp recordings from DGGCs in the 
hippocampus slice preparation. Following GABA perfusion, the competitive antagonist gabazine 
(50 μM) was applied to block all GABAA receptor-mediated current. The difference between 
holding current level before and after gabazine-induced blockade was determined as the tonic 
current shift (see Methods section III.4). The current shift was normalized in each neuron to the 
membrane capacitance as measure of current density (pA/pF), represented as Itonic. In WT 
DGGCs, GABA increased tonic current in a concentration-dependent manner (Figure 16). 
However, the average current was not significantly different between 0.3 μM and 1 µM GABA, 
which is within the physiological range of extracellular GABA (Lerma et al., 1986). A small 
degree of tonic current desensitization was observed at 10 μM, but not at lower concentrations. 
In contrast to WT controls, δKO exhibited significantly attenuated Itonic levels to GABA (0.1–3 
μM). GABA tonic currents of δKO cells in this range were not significantly different than the 
response without exogenous GABA. Only 10 μM GABA significantly increased current in δKO 
above the endogenous condition (p = 0.0092). In the presence of 10 μM GABA, tonic current 
was not significantly different between WT and δKO DGGC (p = 0.1260), signifying GABA-
gating of non-δ- (or γ2-) containing receptors.  
 
The criterion for determining the δ-containing, extrasynaptic EC100 was the highest GABA 
concentration at which tonic current in δKO DGGCs was not significantly different than the 
condition of no exogenous GABA. Therefore, EC100 denotes the GABA concentration at which 
synaptic non-δ-containing receptors do not significantly contribute to the hyperpolarization of 
tonic current. Therefore, 3 μM GABA was designated as the extrasynaptic EC100 (Figure 16C), 
however our previous study determined 3 μM as capable of modulating synaptic mIPSC 
amplitude and kinetics (section IV.1.6, Table 3). To delineate the synaptic/extrasynaptic 
receptor classes, we selected 1 μM GABA for further tonic current studies. Thus, 10 μM GABA 
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represents tonic current modulation whereby non-δ-containing receptors contribute to the 
response above the extrasynaptic GABA EC100 level in both WT and δKO DGGCs. 
 
 
 
 
Figure 16. Concentration-related responses of GABA on -subunit extrasynaptic receptor-mediated tonic 
inhibition. A, Representative whole-cell, voltage-clamp recordings of tonic current in DGGCs in response to GABA. 
After recording, gabazine was applied to measure total tonic shift. B, GABA concentration-response curves for 
normalized tonic current shift (pA/pF) in WT and δKO DGGCs. C, Percent tonic current contribution of δ-subunit-
containing and non-δ-containing receptors relative to the 3 μM GABA response. Percent values were determined from 
the mean values of WT and δKO cells in B. GABA concentrations less than 10 μM did not elicit significant responses 
in δKO DGGCs, thereby denoting majority tonic current contribution by δ-containing GABAA receptors. Recordings 
in whole-cell mode, voltage-clamp -65mV.  n = 6 – 10 cells per group and concentration.  
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Contribution of δ-containing receptors to GABAA receptor-mediated tonic inhibition 
 
To confirm the relative contribution of δ-containing receptors to total Itonic, we conducted whole-
cell, patch-clamp experiments measuring neurosteroid-mediated tonic current in WT and δKO 
DGGCs in slice. Exogenous GABA (1 μM) was applied as a non-desensitizing agonist that 
would continuously gate extrasynaptic receptors from WT DGGCs as previously demonstrated 
(Figure 16A). After establishing a baseline holding current in the presence of GABA, 
neurosteroid was applied to the bath perfusion. Excessive tissue accumulation of steroid was 
prevented by sustaining a high rate of perfusion (2 ml/min). For each cell, rate of change was 
monitored in real-time and recordings were allowed to reach an asymptotic, steady-state level of 
neurosteroid perfusion before complete block by gabazine (50 μM) to determine total tonic 
current shift. Recordings were omitted in which the holding current did not reach a steady state 
after 3 minutes of neurosteroid perfusion. Therefore, the current responses represent positive 
allosteric modulation by neurosteroid. Sigmoidal curves were fitted to the concentration-
response data for each drug to determine relative efficacy and potency of receptor modulation. 
Since a plateau response was not reached in the range of neurosteroid tested, the data could not 
be fit to a Hill-curve; therefore, the potency could not be determined. 
 
From the tonic response to GABA alone, we observed that 10 μM GABA elicited strong 
hyperpolarizing responses representative of continuous, non-desensitizing tonic current, even in 
δKO DGGCs (Figure 16B). Reduced tonic current and decreased neurosteroid sensitivity due to 
δKO is well documented (Carver et al., 2014; Mihalek et al., 1999; Stell et al., 2003; Glykys et 
al., 2008), however the modulatory effects on high-efficacy receptors have not been thoroughly 
explored. Therefore, we first assessed AP responses in WT and δKO DGGC to determine the 
extent of δ-subunit-specific allosteric modulation of extrasynaptic function (Figure 17). The 
average tonic response from 0.01 μM AP + 1 μM GABA application (0.86 ± 0.17 pA/pF, n = 8 
cells) was greater than, but not significantly different than 1 μM GABA alone in WT DGGCs 
(0.66 ± 0.22 pA/pF, n = 9 cells; p = 0.4912). Increasing concentrations of AP (0.1 – 3.0 μM) 
elicited enhanced, potentiated responses on tonic current. The tonic current produced by 
allosteric AP modulation was completely diminished in δKO granule cells compared with WT 
(Figure 17B). Three μM AP + GABA significantly potentiated current within δKO DGGCs, but 
the tonic current response of WT neurons remained significantly greater than δKO (p = 0.0008,  
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n = 5-6 cells per group). The criterion for determining the δ-containing, extrasynaptic EC100 for 
allosteric modulation by AP was the highest AP concentration at which Itonic in δKO DGGCs was 
not significantly different than condition of baseline 1 μM GABA. Based on these concentration-
response data, we investigated relative percent contribution of δ-containing and non-δ-containing 
receptors to AP-mediated Itonic, using 1 μM AP as the EC100 for allosteric activation (Figure 
17C). These results suggest that neurosteroid ≤ 1 μM is selective for δ-contianing extrasynaptic 
receptors in modulation of tonic current in the hippocampus slice preparation. 
 
Lack of tonic current response in dentate gyrus interneurons 
 
To investigate the tonic inhibition in distinct cell types within the DG, we recorded Itonic in a 
specific population of interneurons. Hippocampal interneurons have been reported to possess 
GABAA receptor-mediated tonic conductance, which can affect network excitability and the 
inhibitory drive to principal cells (Semyanov et al., 2003). Molecular layer interneurons express 
the α1βδ isoform extrasynaptically, but the contribution to network tonic conductance is not very 
well understood (Sun et al., 2004; Glykys et al., 2007). The α1βδ receptor isoform exhibits very 
little GABA-mediated current, but in the low-efficacy state it can be significantly potentiated by 
neurosteroids (Zheleznova et al., 2008; 2009). In order to better understand neurosteroid 
sensitivity of δ-containing extrasynaptic receptors, we compared tonic currents between WT 
principal granule cells and molecular layer (ML) interneurons in the slice (Figure 18). The cell 
types were visually identified by location and morphology using differential interference contrast 
microscopy within the slice. Whole-cell, voltage-clamp recordings were used to measure the 
tonic current conductances in the presence of 1 μM GABA + 3 μM AP to maximally drive 
channel potentiation (Figure 18A). DGGCs exhibited significantly greater tonic current 
sensitivity to AP than  ML interneurons (Figure 18B). Baseline tonic current with GABA alone 
was not significantly different between DGGC and ML interneuron. The mean fold-enhancement 
of tonic current  elicited by AP was 12.1 ± 3.1-fold increase in DGGC, whereas ML interneuron 
increase was only 4.3 ± 1.2-fold (p = 0.0409).These results are consistent with previous reports 
demonstrating that ML interneurons exhibit significantly less GABAergic tonic conductance 
than DGGCs (Glykys et al., 2008; Wei et al., 2013) and significantly lower modulation of δ-
containing receptors by the α4βδ-selective modulator DS2 (Wei et al., 2013). 
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Figure 17. Contribution of δ-containing extrasynaptic receptors to total tonic inhibition elicited by AP allosteric 
potentiation. A, Representative tonic current recordings from patch-clamped DGGCs in slice. AP was applied to the 
bath in addition to 1 μM GABA to measure allosteric enhancement of tonic current. 1 μM GABA, AP, and gabazine 
were sequentially applied in perfusion to measure tonic current shift. B, AP concentration-response curves from WT 
(squares) and δKO (circles) DGGCs. Tonic current (pA/pF) is normalized to cell capacitance as a measure of current 
density. δKO DGGCs displayed highly attenuated tonic currents compared to WT. C, Percent contribution of allosteric 
AP tonic current from δ-containing and non-δ-containing receptors, relative to 1 μM allosteric AP, which was 
determined to be the constrained maximum allosterically-active concentration. DGGCs from brain slice of diestrus 
female mice,  recorded in whole-cell mode, voltage-clamped at -65mV. n = 6-8 cells per concentration and group.  
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Figure 18. ML interneurons exhibit less tonic current modulation elicited by AP compared with 
DGGCs. A, Representative traces for 1 μM GABA + 3 μM AP application in slice recording of 
extrasynaptic, tonic current. Traces from dentate gyrus granule cell (black trace) and molecular layer 
interneuron (gray trace) are superimposed to show contrast, with equal scale. The red dashed line 
describes the holding current level after gabazine block of GABAergic current. The DGGC exhibited a 
robust response to 3 μM AP (Δ279 pA), whereas the ML interneuron cell had reduced tonic current 
response (Δ41 pA). B, Quantification of tonic current due to 1 µM GABA or 3 μM AP allosteric 
modulation of 1 µM GABA. Interneurons exhibited signficantly less normalized tonic current than granule 
cells (* p < 0.01 vs. GABA control, # p < 0.01 vs. DGGC + AP).  Mean tonic shift (pA) was also 
significantly different for AP potentiation (DGGC: 223.7 ± 26.6 pA, ML interneuron: 28.3 ± 1.8 pA; p < 
0.01). Cells were recorded from adult WT female (diestrous stage) hippocampus slices, voltage-clamped (-
65mV) in whole-cell mode. n = 5-6 cells per group.  
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Lack of δ-containing receptor-mediated tonic current response in CA1 pyramidal cells 
 
To ascertain whether CA1 pyramidal neurons exhibit any tonic conductances mediated by δ-
containing receptors, we recorded Itonic in CA1 cells in comparison with DGGCs. The α5βγ2 
receptor isoform contributes a majority of the extrasynaptic, tonic current in CA1 pyramidal cells 
(Glykys et al., 2008). The δ-containing receptors are neither highly expressed (Peng et al., 2002), 
nor functionally significant to tonic current modulation in CA1 (Glykys et al., 2008; Stell et al., 
2003; Carver and Reddy, 2013). In order to expound on the contribution of δ-containing 
receptors to regional specificity of extrasynaptic inhibitory function, we compared THIP 
modulation of tonic currents in CA1 pyramidal cells and DGGCs. Whole-cell, voltage-clamp 
recordings were obtained to measure THIP-dependent tonic current shift in the slice (Figure 19). 
We compared concentration-responses between 0.03 and 1 µM THIP to isolate a concentration 
range of the compound that is δ-selective (Meera et al., 2011). Across all concentrations, CA1 
pyramidal cells had a reduced tonic current response compared with DGGCs. At 0.3 and 1 µM 
THIP, the normalized tonic current was significantly different between CA1 and DGGC. 
Overall, these results confirm emerging evidence that δ-containing extrasynaptic receptors 
provide a unique inhibitory role that is region- and cell-specific within the hippocampus.  
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Figure 19. Lack of tonic inhibition mediated by δ-containing extrasynaptic receptors in CA1 
neurons elicited by δ-selective THIP. A, Representative traces of current recordings within slice of CA1 
pyramidal cell (gray trace) or DGGC (black trace) upon modulation of tonic inhibition by 1 μM THIP. 
The DGGC exhibits a robust increase to tonic current elicited by THIP, whereas the CA1 cell has very 
little response. B, Concentration-response to THIP in DGGC and CA1 principle cells as quantified by 
normalized tonic current (pA/pF). THIP responses were greater in DGGC cells at all concentrations, 
however, 0.3 – 1 μM THIP significantly enhanced extrasynaptic tonic currents in DGGCs above that of 
CA1 pyramidal cells. Cells were recorded from WT adult female (diestrous stage) hippocampus slices, 
voltage-clamped -65mV in whole-cell mode. * p < 0.05 vs. DGGC, n = 4-7 cells per concentration and 
cell-type.   
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Direct responses of neurosteroid on tonic inhibition 
 
We examined tonic currents of granule cells in which GABAA receptors are directly activated by 
neurosteroid without GABA gating. The concentration of neurosteroid able to directly gate 
GABAA receptors (≥ 1 μM) is greater than the observed physiological range of endogenous 
neurosteroids (0.1 – 0.3 μM) (Carver and Reddy, 2013; Majewska et al., 1986). However, 
exogenous or therapeutic administration of neurosteroids can reach sufficiently high 
concentrations within the brain to achieve direct activation of GABAA receptors, anticonvulsant 
activity, sedation, and motor impairment (Reddy, 2003ab). We explored a range of applied AP 
without exogenous GABA to assess the direct modulation of tonic current by this neurosteroid 
(Figure 20). AP alone significantly enhanced tonic current above the baseline control level. The 
concentration-response of directly-activating current was reduced compared to the allosteric 
curve. Next, we investigated the relative percent contribution of δ-containing and non-δ-
containing receptors to AP-mediated tonic current. We determined 3 μM AP to be the maximum 
concentration for direct activation of current. We demonstrate that at sub-micromolar 
concentrations, AP can enhance and potentiate tonic current in a GABA-deficient environment. 
However, accumulation of neurosteroid within the neuronal membrane likely contributes to this 
direct-binding activity, as enhancement of tonic current proceeds gradually (Akk et al., 2005). 
 
In δKO DGGCs, a small fraction of residual, extrasynaptic current remains, due to extrasynaptic 
α5-containing receptors (Glykys et al., 2008). However, the neurosteroid structure-activity for 
extrasynaptic α5- and γ-containing receptors is much lower than those incorporating δ (Brown et 
al., 2002; Stell et al., 2003). The residual tonic current response was measured in δKO DGGCs 
during application of AP without exogenous GABA. Direct tonic current recordings displayed 
striking attenuation of current response in δKO compared to WT DGGCs (Figure 20). In 
prolonged application of neurosteroid to allow membrane accumulation, we did not observe any 
gradual enhancement of extrasynaptic current by 1 μM AP in δKO cells. At 3 μM AP, δKO tonic 
current was significantly increased, however, non-δ-containing receptors only contributed to 
29.0 % of the tonic current achieved by δ-containing receptors from WT. Taken together, these 
results suggests an obligatory role of δ-subunit transduction for the neurosteroid direct activation 
of tonic currents. 
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Figure 20. Contribution of δ-containing extrasynaptic receptors to total tonic inhibition elicited by 
AP direct activation. A, Representative tonic current recordings from patch-clamped WT and δKO 
DGGCs in slice with AP (0.3 or 1.0 μM). AP alone (no GABA) followed by gabazine were applied to 
measure tonic current shift of extrasynaptic receptors directly-activated by AP. The bottom superimposed 
trace displays same-scale, 3 μM AP-dependent tonic currents from a WT DGGC (black trace) and a δKO 
DGGC (gray trace). The red dashed line indicates the holding current level upon gabazine block of 
GABAergic current. In addition, the increased RMS noise of channel conductance is apparent in the WT 
recordings, due to δ-containing receptor activation. B, Direct AP concentration-response curves from WT 
(squares) and δKO (circles) DGGCs. Direct activation denotes that the neurosteroid was applied to bath 
solution alone, without any exogenous GABA to measure directly-activating extrasynaptic currents. C, 
Relative percent contribution of δ-subunit and non-δ-subunit receptors to directly-activating tonic current 
by AP, relative to WT 3 μM AP alone.  
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Table 4. Chemical structures of neurosteroids tested for extrasynaptic activity 
 
Steroid C3 position 
(R1) 
C5 
position 
(R2) 
C17 position 
(R3) 
Key Structural 
Significance 
Allopregnanolone (AP) α-OH α-H -COCH3 3α-hydroxyl, 5α-
reduction,17-acetyl 
Ganaxolone (GNX) α-OH,  
β-CH3 
α-H -COCH3 3β-methyl 
5β-allopregnanolone (5β-AP) α-OH β-H -COCH3 5β-reduction 
3β-allopregnanolone (3β-AP) β-OH α-H -COCH3 3β-hydroxyl 
Tetrahydrodeoxycorticosterone 
(THDOC) 
α-OH α-H -COCH2OH 21-hydroxyl 
Alfaxolone (ALFX) α-OH α-H -COCH3 11-carbonyl 
Androstanediol (AD) α-OH α-H β-OH 17-hydroxyl 
Androsterone (AN) α-OH α-H =O 17-carbonyl 
Etiocholanolone (ETIO) α-OH β-H =O 17-carbonyl, 5β-
reduction 
ORG-20599 α-H α-H -COCH2Cl 2β-(4-morpholinyl), 17-
acyl chloride 
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Comparative allosteric responses of neurosteroids on tonic inhibition 
 
To identify the key neurosteroid structures contributing to GABAA receptor tonic inhibition, we 
compiled a library of neurosteroids with distinct structural features (Table 4). Each neurosteroid 
was evaluated for its ability to potentiate tonic current. Concentration-dependent, normalized 
tonic current responses are shown in Figures 21-23. 
 
The concentration-response of 3α5α-AP displayed significantly greater functional efficacy than 
other endogenous neurosteroids tested (Figure 21). THDOC, derived from deoxycortcosterone, 
modulated significantly less tonic current in the 0.1-0.3 μM range, compared with AP. However, 
at 1.0-3.0 μM, THDOC and AP potentiated similar levels of tonic current. 5β-AP, which differs 
from AP by a C5-position β-hydrogen, had a reduced tonic current response at all concentrations 
tested. The 3β-AP steroid, which was previously observed  to have reduced efficacy on whole-
cell or synaptic currents (Gee et al., 1988; Kokate et al., 1994), was not functionally active on 
tonic currents within the slice, even at 10 μM when applied with GABA (0.51 ± 0.14 pA/pF, 
mean tonic shift: 15.7 ± 4.3 pA). 
 
Next, synthetic neurosteroids were compared in their ability to enhance extrasynaptic tonic 
current (Figure 22). GNX differs from AP by the addition of a C3-position β-methyl group. The 
ORG-20599 compound includes a C2-position β-4-morpholinyl group as well as modification to 
the 17β group by acyl chloride. In comparison with synthetic neurosteroid structures, AP had 
similar response profiles to GNX and ORG-20599. However, ALFX, which includes a C11-
position ketone, displayed reduced tonic currents and an overall decrease in δ-mediated 
extrasynaptic receptor efficacy.  
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Figure 21. Pregnane neurosteroid structure-activity relationships on δ-subunit extrasynaptic 
receptor-mediated tonic inhibition.  Concentration-response curves of endogenous pregnane steroids as 
measured by tonic current from DGGCs (pA/pF) from patch-clamp recordings. Lines represent non-linear 
curve fit by the neurosteroids AP (solid), 5β-AP (dash), THDOC (dot), or 3β-AP (dash-dot). Application 
of 3 μM neurosteroid is signified by an exponential increase to tonic current.  X-axis: + 1 μM GABA 
denotes allosteric modulation by co-application of the drug compound with GABA in the bath perfusion. 
All data derived from female WT DGGCs. All cells voltage-clamped in whole-cell mode,  at  -65mV; n = 
5-10 cells per concentration and drug. 
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Figure 22. Synthetic neurosteroid structure-activity relationships on δ-subunit extrasynaptic 
receptor-mediated tonic inhibition. Concentration-response curves of synthetic pregnane steroids as 
measured by tonic current from DGGCs (pA/pF) from patch-clamp recordings. AP responses are included 
in the figure as a comparative, prototypical neurosteroid. Lines represent non-linear curve fit by the 
neurosteroids AP (solid), GNX (dash), ALFX (dash-dot), or ORG-20599 (dot). X-axis: + 1 μM GABA 
denotes allosteric modulation by co-application of the drug compound with GABA in the bath perfusion. 
All data derived from female WT DGGCs. All cells voltage-clamped in whole-cell mode,  at  -65mV; n = 
5-10 cells per concentration and drug. 
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The androstane neurosteroids display weakly positive allosteric modulation of GABAA receptors 
(Reddy and Jian, 2010), but have not been explored with regard to extrasynaptic structure-
activity. The 17β-ketosteroids androsterone (AN) and etiocholanolone (ETIO) are the main 
metabolites of testosterone. Androstanediol (AD) is derived from dihydrotestosterone, the 5α-
reduced metabolite of testosterone. We evaluated tonic currents from DGGCs in response to AD, 
AN, and ETIO (Figure 23). Compared with AP (1 μM), the average tonic currents of AD, AN, 
and ETIO were smaller by a factor of 3.1, 4.5, and 4.9, respectively. Overall, these steroids have 
lesser potency on δ-containing extrasynaptic receptors than the pregnane neurosteroids, 
suggesting weaker binding affinity and/or transduction. 
 
 
 
 
Figure 23. Androstane neurosteroid structure-activity relationships on δ-subunit extrasynaptic receptor-
mediated tonic inhibition. Concentration-response curves of endogenous androstane steroids as measured by tonic 
current from DGGCs (pA/pF) from patch-clamp recordings. The androstane neurosteroids have a right-shifted potency 
and extrasynaptic receptor affinity. + 1 μM GABA denotes allosteric modulation by co-application of the drug 
compound with GABA in the bath perfusion. All data derived from female (diestrous stage) WT DGGCs. All cells 
voltage-clamped in whole-cell mode,  at  -65mV; n = 4-8 cells per concentration and drug. AD = androstanediol 
(squares). AN = androsterone (circles). ETIO = etiocholanolone (triangles).  
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To compare the extrasynaptic, tonic current contribution of each structurally distinct 
neurosteroid, we analyzed the differences in fold-potentiation of the GABA (1 μM) response 
(Table 5). At the 0.1 μM concentration, AP (2.5-fold) displayed significantly greater 
potentiation, as GNX (1.6-fold) and ORG-20599 (1.9-fold) showed moderate potentiation of 
extrasynaptic GABA. At 0.3-3 μM concentrations, GNX and ORG-20599 exhibited comparable 
potentiation of tonic current to the responses by AP.  Interestingly, 0.1 μM THDOC did not elicit 
potentation of tonic current, indicating that the C21-hydroxylation modification confers lower 
extrasynaptic receptor efficacy or potency. This was confirmed by the diminished response of 
THDOC at higher concentrations, compared to the pregnane neurosteroids with C17 structural 
features similar to AP (see Table 4). At 0.3 μM and above, all pregnane neurosteroids tested 
except for 3β-AP exhibited significant potentiation of the extrasynaptic GABA response. 
Androstane neurosteroids did not significantly enhance GABAergic tonic current at 
concentrations under 1 μM, and only modestly potentiated current at 3 μM. 
 
Interestingly, 3 μM pregnane neurosteroids displayed exponential potentiation of tonic currents. 
This suggests that higher concentrations directly gate low-occupancy receptors, producing a 
biphasic effect of receptor activation. Therefore, we designated 1 μM pregnane neurosteroid to 
be the constrained maximum response for extrasynaptic receptors in allosteric activity. This was 
consistent in our extensive concentration-response study of both allosteric potentation and direct-
activation by AP in determination of δ-containing receptor contribution to tonic current (Figure 
17,18). However, relative efficacy of neurosteroid to potentiate functional inhibition was 
determined for each structure based on normalized data for the entire range of concentrations 
tested (0.1 - 3 μM). Higher concentrations exceed the physiological range of relevance of this 
study beyond that of feasible limits (Gee et al., 1988; Reddy and Rogawski, 2012), but 
pharmacological doses of neurosteroids remain salient to understanding their therapeutic 
application in the brain. 
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Table 5. Neurosteroid-mediated potentiation of extrasynaptic, tonic currents by 1 μM GABA. 
 
Compound 
0.1 μM 
neurosteroid 
potentiation 
0.3 μM  
neurosteroid 
potentiation 
1.0 μM  
neurosteroid 
potentiation 
3.0 μM  
neurosteroid 
potentiation 
AP 2.50 2.94 4.36 10.98 
5β-AP 0.76 1.88 2.24 6.47 
3β-AP 0.76 0.76 0.76 0.77 
THDOC 1.01 1.94 3.52 9.24 
GNX 1.61 2.76 3.47 8.89 
ALFX 0.88 1.32 1.98 7.30 
ORG-20599 1.88 3.32 4.70 9.41 
AD 0.94 1.09 1.30 2.95 
AN 0.92 n.d. 1.47 2.15 
ETIO 0.91 n.d. 1.20 1.97 
 
Values derived from fold-potentiation of mean, normalized tonic current response to 1 μM GABA, 
(INS/IGABA). INS is the mean, normalized tonic current response to neurosteroid at the given concentration + 
1 μM GABA from Figures 21-23. Tonic current responses were recorded from voltage-clamped(-65mV) 
DGGCs from WT, female (diestrous stage) mice. All mean values are representative of 4-8 cells per 
neurosteroid and concentration.  
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Tonic current responses of non-steroidal, δ-selective compounds DS2 and THIP 
 
We investigated DS2 (4-chloro-N-[2-(2-thienyl)imidazo[1,2-a]pyridin-3-yl]benzamide) as a 
comparative δ-selective agent and non-steroidal, allosteric modulator (Wafford et al., 2009; 
Jensen et al., 2013). DS2 selectivity was previously determined in recombinant cells expressing 
α4βδ receptors and thalamic relay neurons, however it has not been analyzed in tonic currents 
from native DGGCs in the slice. In extrasynaptic function as an allosteric modulator, DS2 was 
less potent in modulation and affinity than the pregnane class of neurosteroids, represented by 
the prototypical AP (Figure 24). In δKO DGGCs, DS2 did not significantly potentiate tonic 
current greater than the 1 μM GABA baseline responses (10 μM DS2 + 1 μM GABA: 7.3 ± 4.3 
pA, 1 μM GABA: 6.9 ± 2.1 pA; n = 6-7 cells per group, p = 0.9317). These responses confirm 
the δ-selectivity of DS2 in native DGGC in the slice. Previous studies established conservation 
of residues on the α4 subunit necessary for neurosteroid binding (Hosie et al., 2006; Jensen et al., 
2013). In mutation of these residues, Jensen and colleagues show that the GABA-enhancing 
action of DS2 did not rely on these residues, whereas the mutation of the α4 subunit resulted in 
AP insensitivity. Thus, the decreased potency of DS2 compared to neurosteroids suggests a 
lower affinity for extrasynaptic GABAA receptors and a different binding site from 
neurosteroids. 
 
THIP is a selective low-efficacy modulator of δ-containing receptors at sub-micromolar 
concentrations (Mortensen et al., 2010). THIP (no GABA in bath perfusion) was investigated for 
tonic current modulation and compared in its potency and efficacy with AP and DS2 (Figure 
24). The concentration-response of THIP in the  0.1 – 1 μM range was less efficacious than AP, 
but more potent than DS2 allosteric modulation. However, 1 μM THIP tonic current in δKO 
DGGCs (0.32 ± 0.08 pA/pF) was significantly lower compared to WT DGGCs (2.57 ± 0.48 
pA/pF, n = 6-7 cells per group, p = 0.0013). Increased concentration of THIP (10 μM) in δKO 
(2.68 ± 0.41 pA/pF) produced tonic currents comparable to 1 μM THIP in WT cells. These 
results indicate a single order of magnitude, rightward shift of THIP affinity for δ-deficient 
DGGCs.  
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Figure 24. Comparative efficacies of δ-subunit selective compounds on tonic inhibition mediated in 
DGGCs. Tonic current responses for the δ-selective compounds THIP (stars) via direct activation and 
DS2 (triangles) allosteric modulation in comparison with AP (squares). Both WT (closed symbols) and 
δKO (open symbols) DGGC responses are depicted. The AP concentration-response is from WT DGGCs. 
Legend: + 1 μM GABA denotes allosteric modulation by co-application of the drug compound with 
GABA in the bath perfusion, whereas THIP was applied alone in bath solution. All data derived from 
female DGGCs. All cells voltage-clamped in whole-cell mode, at -65mV; n = 6-10 cells per concentration 
and drug.  
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IV.2.4  Neurosteroid structure-activity relationship in the 6-Hz seizure model 
 
To study the in vivo anticonvulsant effects of neurosteroids for discerning structure-activity 
relationship, we used the 6-Hz model of partial seizures (Barton et al., 2001). Previous studies 
have used 6-Hz stimulation to characterize the anticonvulsant profiles of neurosteroids within 
mice (Kaminski et al., 2004). To test the behavioral sensitivity to 6-Hz stimulation, we first 
determined incidence of seizures as a function of current intensity in mice (Figure 25A). The 
CC50 value (current intensity at which 50% of the animals experienced seizure) was determined 
to be 16.5 mA for WT male mice and 10.4 mA for WT female mice (Figure 25B). Current 
intensity of 32 mA elicited seizures in 100% of the population of WT male and female control 
mice injected with vehicle, and further drug studies were conducted at this level of current. 
Interestingly, within δKO mice, we were unable to achieve a 100% seizure outcome in the 
animals, even in current intensities up to 100 mA in the 6-Hz model. Genetic background and its 
alteration have influence of seizure threshold (Leclercq and Kaminski, 2015). This suprising 
result precluded the further use of knockouts in the 6-Hz model, as the current intensity eliciting 
seizures in 100% of the population was necessary to gauge anticonvulsant effect of the 
neurosteroids. Therefore, seizure testing was carried out by other experimental means of 
convulsance for germline δKO mice in comparison with WT counterparts in later studies. 
 
WT mice were treated with neurosteroid 15 minutes prior to 6-Hz electrical stimulation. After 
each stimulation, incidence of seizure protection was recorded as an all-or-nothing event (see 
Methods section III.5 for scoring criteria). Dose-response curves were derived for each 
neurosteroid drug (Figure 26), and potency was determined as ED50 (effective dose), which 
represents the dose that is protective for 50% of the animals (Table 6). In WT female mice, 
GNX had the greatest potency in protecting from seizures. AP and its 5β epimer had similar 
potency in seizure control. THDOC potency was slightly right-shifted, wheras both AFX and 
ORG-20599 performed worse in control of seizures. Overall, these profiles are similar to 
previous reports of seizure modulation in the 6-Hz model in terms of relative structure-activity 
(Kaminski et al., 2004). Our experiments differ in that neurosteroid was administered 
subcutaneously, thereby providing a higher dose available to the brain. Based on our 
observations, the potency achieved through neurosteroid seizure protection is greater than 
previously attained in other reports due to experimental constraints.  
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Figure 25. Behavioral sensitivity of mice in the 6-Hz seizure model. A, Percent animals responding to 6-Hz 
stimulation as a function current intensity delivered through shock. 100% of WT animals had reliable seizure 
activity at 32 mA, whereas δKO mice did not respond to stimulations, even at 100 mA current. Therefore, EC50 
could not be derived for knockout animals. Dashed line perpendicular to the fitted data represents the current 
intensity at which 50% of animals experienced seizures. B, Stratified male and female WT mice response to 6-
Hz current-intensity. WT female mice were significantly more sensitive to stimulation, however 100% seizure 
response was reached at 32 mA current intensity. n = 10 animals per group. 
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Figure 26. Neurosteroid structure-activity curves in the 6-Hz seizure model. Dose-response curves for 
neurosteroid modultation of 32 mA, 6-Hz induced seizures in WT female mice. Neurosteroids were 
applied (s.c.) 15 min. prior to stimulation. Seven structurally distinct pregnane-class neurosteroids were 
compared in seizure protection, using potency (ED50, see Table 6) as the main index of anticonvulsance in 
vivo (3β-AP not shown as it did not provide full protection, even at 100 mg/kg dose). n = 10 animals per 
group.  
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Table 6. Correlation between neurosteroid modulation of tonic current and anticonvulsant profiles 
in the 6-Hz seizure model in mice. 
 
 
E1 μM values represent the mean normalized tonic current responses of drug at 1 μM concentration co-
applied with 1 μM GABA. GABA 1 μM tonic current: 0.66 ± 0.22 pA/pF, 19.6 pA. 
E3 μM values represent the mean normalized tonic current responses of drug at 3 μM concentration co-
applied with 1 μM GABA. GABA 3 μM tonic current: 1.35 ± 0.23 pA/pF, 33.5 pA. 
EF values represent the effective functional concentration of drug (nM) required to double or triple the 1 
μM GABA response.  
6-Hz test ED50 values represent the dose in milligrams per kilogram that protected 50% of animals in the 
6-Hz seizure stimulation test. 95% confidence intervals are listed in parenthesis, according to a normal 
distribution.   
Compound E1 μM 
(pA/pF) 
E1 μM 
(pA) 
E3 μM 
(pA/pF) 
E3 μM 
(pA) 
EF(2-fold 
GABA) 
(nM) 
EF(3-fold 
GABA) 
(nM) 
6-Hz test 
ED50 
(mg/kg) 
AP 2.88 ± 
0.50 
100.6 7.25 ± 
0.40 
223.7 80 290 4.2 
(2.7-5.8) 
GNX 2.29 ± 
0.41 
64.0 5.87 ± 
0.50 
176.1 290 650 1.5 
(1.3-1.7) 
5β-AP 1.48 ± 
0.13 
44.4 4.27 ± 
0.25 
181.7 780 1380 7.7 
(6.6-8.8) 
3β-AP 0.50  ± 
0.12 
15.3 0.51 ± 
0.14 
15.7 > 10000 > 10000 > 100 
 
THDOC 2.32 ± 
0.43 
66.6 6.10 ± 
0.68 
183.0 410 760 5.0 
(2.6-7.4) 
ALFX 1.31 ± 
0.19  
40.9 4.82 ± 
0.53 
144.6 990 1500 8.8 
(6.1-11.4) 
ORG-20599 3.10 ± 
0.54  
86.4 6.21 ± 
0.42 
186.3 120 310 18.6 
(16.6-20.6) 
AD 0.86 ± 
0.19 
33.2 1.95 ± 
0.29 
49.9 1710 3120 44.0 
(30.2-58.8) 
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Differences in neursosteroid sensitivity could be related to alterations in GABAA receptors as the 
primary targets of neurosteroid anticonvulsants, as previously determined (see section IV.1.8 and 
Figure 14). We quantified sex-specific dose-dependent responses of neurosteroid in 
anticonvulsant control of 6-Hz seizures (Figure 27). Neurosteroid sensitivity in seizure 
protection was measured in terms of drug potency (ED50) between male and female WT mice. 
AP dose-response curves revealed no significant differences between male (ED50: 4.0 ± 0.4 
mg/kg) and female (ED50: 4.5 ± 0.5) potency (p = 0.4450). Conversely, GNX treatment prior to 
stimulation displayed greater sensitivity in female (ED50: 1.5 ± 0.1) mice than in males (ED50: 
2.9 ± 0.4; p = 0.0032). We observed similar incidence of 6-Hz seizure protection by androstane 
AD in both males and females as denoted by potency (males: 47.8 ± 4.1 mg/kg, females: 44.0 ± 
2.2 mg/kg; p = 0.4248, n = 10 animals per group). The overall potency of AD was significantly 
less than pregnane steroid counterparts, as expected from its less potent effect in tonic current 
modulation (Figure 23) and relatively lower affinity for GABAA receptors (Reddy and Jian, 
2010). 
 
Previous study of motor toxicity with 3α,5α-pregnane steroids demonstrated that motor 
impairment is relatively low at doses that confer seizure protection (Kokate et al., 1994). In 
addition, the TD50 (95% confidence limit) value for androstanediol in males was previously 
determined to be 148 (96-226) mg/kg (s.c.) (Reddy and Jian, 2010). Reports have demonstrated 
that treatment with 5α-reduced compounds produce lower incidence of motor toxicity compared 
to the 5β-epimers (Kokate et al., 1994). This is relevant for the protective index (TD50/ED50) of 
neurosteroids in their clinical use for antiseizure therapy, however subcutaneous treatment of the 
maximum efficacy dose did not exhibit a plateau or full motor toxicity in our experiments. The 
experimental rate of absorption for subcutaneous injection of steroid was relatively slower, and 
therefore we did not observe significant toxicity in animals at maximally effective doses for 
anticonvulsant effect. A previous study examination of loss of righting reflex as a measure of 
AP’s anesthetic effect found minimal impairment at 10 mg/kg (s.c.) in WT male and female 
mice (Reddy and Zeng, 2007). Therefore, the ED100 of neurosteroid may be representative of 
binding and modulation of a more specific GABAA receptor population. 
 
To better understand the structure-activity of neurosteroids at extrasynaptic receptors, we sought 
to correlate the anticonvulsant responses of neurosteroids and the positive modulation of tonic 
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current inhibition. We tabulated the previously described E1 μM and E3 μM values for neurosteroid 
modulation of tonic current, the effective functional concentrations required for the doubling 
(EF2-fold GABA) or tripling (EF3-fold GABA) of the baseline 1 μM GABA response, and the potency of 
seizure protection in the 6-Hz model (Table 6). The EF2-fold GABA concentration for ALFX was 
significantly greater than responses for allosteric AP and GNX, denoting detriment of the C11 
structural modification to extrasynaptic receptor efficacy. Interestingly, the ORG-20599 
compound had a high extrasynaptic receptor efficacy comparable to that of AP, however the 
anticonvulsant potency was highly reduced. This may be due in part to the pharmacokinetic 
differences of the compound’s access to the brain subsequent to injection. GNX displayed the 
highest potency and had slightly lower tonic current efficacy than AP. 
 
Overall, these results suggest that tonic current function is highly dependent on δ-subunit-
containing extrasynaptic receptors. These receptors have strong affinity for neurosteroids which 
are able to robustly enhance tonic currents leading to anticonvulsant effects mostly via network 
GABAergic inhibition.  
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Figure 27. Neurosteroid structure-activity between male and female WT mice in the 6-Hz seizure 
model. Dose-dependent neurosteroid anticonvulsant responses in vivo from WT male and female mice. 
Neurosteroid was administered subcutaneously 15 min. prior to corneal stimulation. The endogenous 
neurosteroids AD (blue) and AP (black), and the synthetic neurosteroid GNX (red) were compared in 
terms of antiseizure potency within WT males (triangle symbols and dashed-lines) and females (circle 
symbols and solid lines).  AD and AP had similar profiles across gender, whereas females had greater 
sensitivity to GNX protection than males. 6-Hz potency ED50 values represent the dose in milligrams per 
kilogram that protected 50% of animals in the 6-Hz seizure test. n = 8 – 10 mice per group.  
 101 
 
IV.3 Alterations in Hippocampus Epileptogenesis and Behavior in Mice with Deletion of 
δ-subunit-containing GABAA Receptors 
 
IV.3.1  Accelerated kindling epileptogenesis in germline δKO mice 
 
To investigate the role of the δ-subunit in suceptibility to epileptogenesis, we studied the 
development of hippocampus kindling in germline δKO mice. The kindling model of 
epileptogenesis is a robust model of complex partial seizures (Goddard et al., 1969; Löscher, 
2002; McNamara et al., 1992). We have already demonstrated in the rapid kindling model that 
naïve δKO mice exhibit faster rate of kindling and lower threshold for eliciting electrographic 
afterdischarge than WT mice (Figure 13). We sought to compare WT and δKO mice in the 
regular hippocampus kindling model to determine differences in epileptogenesis. Mice were 
implanted with an electrode in the right hippocampus and allowed to recover from surgery (see 
Methods section III.5). Next, mice were stimulated with increasing current amplitudes in order to 
determine the afterdischarge threshold, which is the synchronous electrographic waveform upon 
stimulation of the hippocampus (Figure 28). Stimulation resulted in immediate electrographic 
activity, monitored in real-time. For kindling epileptogenesis of WT and δKO mice, we used the 
regular kindling model of epileptogenesis, in which stimulations were delivered once per day. 
Subsequent behavioral seizures were scored according to Racine’s scale as modified for the 
mouse: stage 0, no response or behavioral arrest; stage 1, chewing or facial twitches; stage 2, 
chewing and head nodding; stage 3, forelimb clonus; stage 4, bilateral forelimb clonus and 
rearing; stage 5, rearing and falling (Racine, 1972). Consistent stage 5 motor seizures represent a 
fully kindled state and behavioral end-point for the experiment. Three key parameters were 
assessed as criteria for seizure susceptibility: 1) Afterdischarge threshold current for 
electrographic seizures, 2) stimulation-induced electrographic afterdischarge duration, and 3) 
behavioral seizure intensity over number of stimulations. 
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Figure 28. Electrographic afterdischarge of brain activity recorded from hippocampus kindling 
epileptogenesis mice. Representative electrographic afterdischarge recordings from hippocampal, bipolar 
electrode in WT or δKO female mice immediately after kindling stimulation. The arrows denote the 
stimulus artifact occuring at the instant of stimulation and switching to recording mode. Synchronous 
network activity is apparent immediately after stimulation as the electrical afterdischarge. Current 
stimulation eliciting afterdischarge of at least 5 sec was determined on day 0 of kindling. Daily kindling 
stimulation was given at 125% afterdischarge threshold using an isolated pulse stimulator. Stimulations 
were delivered daily until stage 5 behavioral seizures were consistently achieved, signifying a fully 
kindled state. The top row depicts traces acquired from animals during the first stimulation in which no 
overt motor seizures followed from the afterdischarge. The bottom row depicts traces from the same 
animals during their 15
th
 stimulation, in which the WT mouse displayed stage 3 seizures, and the δKO 
mouse displayed stage 5 fully-kindled seizures subsequent to the afterdischarge. Properties of 
afterdischarge and behavioral seizure were simultaneously recorded for each stimulation. Mean group data 
are reported in subsequent figures.  
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Figure 29. Accelerated epileptogenesis in δKO mice in the hippocampus kindling model of 
epileptogenesis. A, Kindling progression of behavioral seizure development in female WT and δKO mice 
as average seizure stage on stimulation. δKO mice had lower mean seizure stage than WT at the 
corresponding stimulation session. Single asterisks indicate that the mean value is significantly different 
between groups (p <0.05 vs. WT). B, Afterdischarge duration is prolonged in δKO animals compared to 
WT. C, Mean overall rate of kindling development (number of stimulations for stage 4/5 seizures) was 
significantly faster in δKO mice. D, Mean cumulative afterdischarge duration was significantly greater in 
δKO mice. Values represent the mean ± SEM (* p < 0.05; n = 14-16 mice per group).  
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The progression of electrographic afterdischarge activity, behavioral seizures, and the rate of 
kindling were recorded as main indices of epileptogenesis. The mean seizure stage and 
afterdischarge duration for each genotype were plotted according to the stimulation number for 
direct comparison of kindling progression (Figure 29A-B). The δKO mice exhibited accelerated 
kindling development as demonstrated by fewer stimulations required to elicit behavioral 
seizures and lower mean seizure stage at the corresponding stimulation session. The rate of 
kindling was determined as the total number of stimulations required to elicit stage 4/5 seizure 
(Figure 29C). Electrographic activity differences between genotypes were also evident, as δKO 
mice had a significantly prolonged afterdischarge duration compared to WT controls. The 
cumulative afterdischarge duration was also significantly greater in δKO mice, indicating that 
compared with WT mice, the knockouts had prolonged synchronous activity over a substantially 
shorter period of time (Figure 29D). 
 
There has been previous evidence to suggest inherent sex-specific differences in seizure 
susceptibility (Galanopoulou, 2008ab, Reddy, 2009b), although this aspect of epileptogenesis is 
not widely investigated. To determine a possible role of δ-subunit in the sex-dependent effects 
on epileptogenesis, we analyzed seizure progression profiles in male and female δKO mice 
(Figure 30). Among the δKO animals, we observed that male mice exhibited more rapid and 
intense epileptogenesis than female mice. However, WT male mice similarly displayed an 
increased rate and propensity of seizure than WT females. Male mice experienced faster kindling 
rate and exhibited generally longer electrographic afterdischarges throughout the progression of 
epileptogenesis.  
 
Furthermore, accelerated epileptogenesis was evident in both male and female δKO mice 
compared to WT counterparts of same gender. Male δKO mice displayed significantly greater 
mean seizure stage for stimulations 8-16 than male WT mice (p < 0.05, n = 16 animals per 
group). Similarly, female δKO mice displayed signficantly greater mean seizure stage for 
stimulations 11-17 (p < 0.05, n = 14-16 animals per group). These stimulations represent late-
stage epileptogenesis responses (stage 4-5 seizures) for δKO animals, but mid-kindling 
responses (stage 2-3 seizures) for WT animals. Overall, mean number of stimulations required to 
reach stage 5 seizures was significantly lower in δKO animals (Figure 30C). 
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Figure 30. Male mice exhibit more rapid and intense epileptogenesis than female mice, independent 
of genotype. A, Gender and genotype comparison of kindling epileptogenesis progression. B, 
Afterdischarge duration for WT and δKO. Knockouts display prolonged afterdischarge diuration vs. WT. 
Males display prolonged afterdischarge duration vs. females. C, Mean number of stimulations required to 
reach a fully kindled state (stage 5 seizure) in mice (*p < 0.05 vs. WT of same gender, #p < 0.05 vs. males 
of same genotype). D, Afterdischarge threshold sensitivity expressed by stimulation-response curves from 
δKO male and female 30 days after kindling. n = 8 – 16 mice per group.   
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To investigate retention of kindling hyperexcitability, the afterdischarge threshold sensitivity 
was determined in δKO mice thirty days after attaining the fully kindled state. Our aim was to 
explore the sensitivity to convulsant stimuli in which epilepsy-prone circuits are already 
established within the brain. In analysis of stimulation response curves due to increasing current 
intensity (μA), we found that male mice possessed greater sensitivity than females in the 
exacerbation of seizures (Figure 30D). The CC50 (convuslant current) value was determined for 
each group, which was the current required to elicit stage 5 seizures in 50% of animals 30 days 
after kindling. The CC50 value for female δKO mice was 208 ± 33 μA, whereas the CC50 for 
male δKOs was 118 ± 7 μA (p = 0.0184, n = 8 -12 mice per group). These data signify that male 
δKO mice have a higher seizure retention rate and greater sensitivity than females. Furthermore, 
the hyperexcitability attributed to deletion of the δ-subunit may be exacerbated disparately, 
according to sex-specific characteristics in the brain. This may be attributed to distinctive 
neuroendocrine phyisiologies that may influence the balance of inhbition and excitation within 
the brain. Our hypothesis is consistent with previous reports, suggesting that GABAA receptor 
expression may contribute to sex-specific alterations in the brain that may be significant to 
epileptogenic activity (Galanapoulou, 2008ab). 
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IV.3.2 Neurosteroid disease-modification of kindling epileptogenesis 
 
Retarding of kindling epileptogenesis by AP is diminished in δKO female mice 
 
We sought to ascertain the in vivo role of neurosteroids as disease-modifying agents in the 
progression of epileptogenesis in δ-subunit knockout. Neurosteroid exposure produces an 
anticonvulsant, protective function in fully kindled animals (Reddy et al., 2012), but we sought 
to investigate neurosteroid-mediated prolongation of the hippocampal kindling epileptogenesis 
process. We administered AP (0.5 mg/kg, s.c.) to WT and δKO female mice prior to each daily 
stimulation in the regular kindling paradigm. AP significantly impeded the kindling progression 
in both WT and δKO mice (Figure 31). However, we observed that the neurosteroid-induced 
retardation of epileptogenesis was diminished in δKO mice. WT mice experienced a slower rate 
of kindling (stage/stimulation or slope of progression) than δKO mice in the AP treatment group. 
Afterdischarge duration was similar between genotypes. All mice reached stage 5 seizures within 
30 stimulations, signifying an inability of this relatively low dose of AP to fully oppose the 
epileptogenic activity. In comparing the neurosteroid-mediated delay between control and AP 
treatment groups, we found the percent change in rate of kindling to be similar between WT 
(34.6% retardation of slope by AP) and δKO (39.2% retardation of slope by AP). 
 
To investigate the rate of kindling more critically, we then parsed the rate slope into two 
segments: stimulation 1 to 14 and stimulation 14 to end point stage 5 seizures (Figure 31D). The 
rate of kindling for the first 14 stimulations ( ≤ stage 2 seizures in each strain) were not 
significantly different between WT and δKO in the AP treatment group (WT: 0.09 ± 0.01 
stage/stimulation, δKO: 0.12 ± 0.03 stage/stimulation). However, stimulation 14 to the fully 
kindled state revealed a significantly greater rate of kindling for δKO mice (0.36 ± 0.07 
stage/stimulation) compared with WT (0.18 ± 0.02 stage/stimulation, p = 0.0330; n = 6 mice per 
group). Therefore, late-stage kindling progression (stage 14+) in δKO animals displayed more 
accelerated epileptogenesis during neurosteroid AP treatment.  
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Figure 31. Allopregnanolone-induced retardation of epileptogenesis is diminished in female δKO 
mice. A, Kindling progression in AP-treated female WT and δKO mice. B, Treatment with AP reduced the 
afterdischarge duration in δKO mice to levels comparable to WT mice. AP was administered (0.5 mg/kg, 
s.c.) 15 minutes before each daily kindling stimulation. C, Slope parameter for rate of kindling 
epileptogenesis in control and AP-treated mice (*p < 0.01 vs. WT + AP; # p < 0.001 vs. WT control). D, 
Rate of kindling for AP –treated mice for stimulations 1-14 and stimulation 14 to stage 5 seizure. (*p < 
0.05 vs. WT S14 to Stage 5). n = 6 -13 mice per group. 
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IV.3.3 Seizure activity-induced mossy fiber sprouting is enhanced in δKO mice 
To explore structural changes associated with epileptogenesis, mossy fiber sprouting was 
analyzed in WT and δKO mice that experienced regular kindling progression of epileptic 
seizures (Figure 32). Timm staining is a technique of histochemical labeling of the synaptic 
terminals of mossy fiber axons projecting from DGGCs (Cavazos et al., 1991). This 
histochemical reaction is possible due to the high zinc granule content in mossy fibers. Previous 
electroconvulsive kindling models in rodents have reported mossy fiber sprouting into the 
granule layer and greater zinc granule accumulation in the hilus (Gombos et al., 1999; Watanabe 
et al,. 1996). We processed Timm-staining of hippocampus mossy fibers in the dentate gyrus in 
sections from control and kindled animals. Rather than using non-parametric Timm index 
scoring criteria, we analyzed the histology with densitometry software (see Methods section 
III.3). We used this approach to avoid observational bias, and in addition, the observer was blind 
to the tissue genotype and condition in densitometric analysis. Average normalized stain 
intensities from dentate hilus and the granule layer were acquired from WT and δKO mice 
experiencing sham control or kindling conditions. The mossy fibers were evident in projection to 
the CA3 region by the darkly stained zinc granules originating in the dentate hilus (Figure 32A). 
Staining was significantly denser in the hilus than the granule layer in all conditions. Both 
kindled genotypes displayed increased histochemical density in the hilus. Furthermore, the δKO 
mice subject to kindling had significantly greater staining intensity in the granule cell layer than 
seizure-naïve δKO control animals, indicative of seizure activity-induced mossy fiber sprouting. 
In analysis of WT granule layer staining, little or no sprouting could be observed, and control 
mice did not display signficantly different densitometry scores than WT kindled mice. We did 
not observe any differences to granule cell density, cell number, or hilus volume, consistent with 
previous report (Watanabe et al., 1996). Interestingly, the axonal projections of CA1 and CA3 
principal neurons also exhibited greater staining density in kindled animals compared with 
control. This increase in zinc content could be indicative of axonal sprouting brought on by the 
repeated, convulsive seizures. 
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Figure 32. Seizure activity-induced mossy fiber sprouting is enhanced in δKO mice. A, Timm stain 
histological sections of mouse hippocampus displaying mossy fiber zinc granules in the dentate hilus. B, 
Averaged densitometry of dentate hilus or granule layer stain intensity within the dentate gyrus. Each 
intensity score was normalized to length of dentate gyrus. Scores compiled for 3 animals in each group (* 
p < 0.05 vs. WT of same condition, # p < 0.05 vs. control of same genotype, n = 9 sections per group, 
independent t-test). Sections were analyzed with the experimenter blinded to the genotype and condition.  
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IV.3.4  Pentylenetetrazol chemoconvulsant seizure suceptibility 
To comparitively determine seizure susceptibility with an acute measure of epileptic seizure 
onset, we tested the sensitivity of WT and δKO mice to the chemoconvulsant pentylenetetrazol 
(PTZ) (Figure 33). PTZ is a GABAA receptor antagonist thought to block the channel pore, 
similar to the action of picrotoxin (Squires et al., 1984), although the mechanism of action 
resulting in systemic convulsive activity is not well understood (Papp et al., 1987). Previosuly, 
PTZ low-dose hypoactivity was examined in conjunciton with GNX pro-absence effects on δKO 
(Mihalek et al., 1999), but it has not been extensively studied as a model of generalized seizures 
in germline δKO mice.  
 
The convulsant sensitivity of PTZ varies according to the mouse strain being tested (Kosobud 
and Crabbe, 1990). Therefore, we first determined the convulsant sensitivity of PTZ in mice. 
Seizure phenotype was scored by the latency to seizures in behavioral response to subcutaneous 
PTZ injection (see Methods section III.5). Latency to jerking spasms, latency to generalized 
clonus, and latency to tonic-clonic seizures were recorded for each mouse. A single score of 0 
denotes no incidence of behavioral seizure, whereas score is directly proportional with seizure 
severity. Low-dose, 30 mg/kg PTZ resulted in mild hypoactivity onset for all mice several 
minutes after injection. Jerking spasms and sporadic clonus were observed in animals at 50 
mg/kg PTZ.  At 75 mg/kg, convulsant activity consistently culminated in tonic-clonic seizures. 
The 90 mg/kg dose resulted in lethality in all animals in all groups, and we took this represent 
the maximum convulsant dose (CD99) in both genotypes. 
 
Experimental mice were demarcated into sex-specific groups for analysis of PTZ-induced 
seizure severity (Figure 33A). The δKO mice displayed similar pharmacological profiles of PTZ 
convulsant sensitivity to WT counterparts. The δKO female mice displayed significantly greater 
seizure severity than WT at 60 mg/kg PTZ. There were no other significant difference in seizure 
score severity between δKO and WT animals. However, at 60-90 mg/kg PTZ, we observed 
higher seizure severity and toxicity in female mice compared with males. This sex-specific PTZ 
susceptibility was evident in both WT and δKO females when compared to male gentoype 
equivalents.  
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We determined the percent clonic seizure and percent tonic-clonic seizure occurrence in WT and 
δKO mice as parallel measures of the dose-dependent response of PTZ-induced seizures (Figure 
33B,C). A clearly defined, significant effect of gender was observed in the appearance of 
generalized clonic seizures as females exhibited higher clonus occurrence. There were no 
significant differences in occurrence of clonic seizures between WT and δKO mice at higher 
concentrations (60 – 90 mg/kg). In addition, females experienced higher incidence of tonic-
clonic seizures than male mice. 
 
 
 
 
 
Figure 33. PTZ-induced seizure severity in germline δKO mice. A, Seizure severity scores from WT and δKO 
male and female mice. Latency to jerking spasms, latency to clonus, and latency to tonic-clonic seizures were scored 
based on a weighted mechanisms to produce seizure severity. WT and δKO mice displayed similar seizure severity at 
higher convulsant doses of PTZ (75-90 mg/kg). However, sex-specific, significant differences were evident in seizures 
severity of WT mice (* p < 0.05 vs. male of same genotype and dose, # p < 0.05 vs. WT female at 60 mg/kg, n = 6-8 
animals per group). B, Percent clonic seizure occurrence or C, percent tonic-clonic seizure occurrence in WT and δKO 
mice in the PTZ (50, 60, 75, and 90 mg/kg, s.c.) test. Each mouse was evaluated for generalized clonic seizing and 
tonic-clonic hindlimb extension following PTZ injection (n = 6-8 animals per group).  
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IV.3.5  Developmental phenotype and cognitive behavior in germline δKO mice 
 
Immunohistochemistry staining of δ-subunit in germline δKO mice 
 
To confirm the deletion of δ-subunit in the δKO mice, we processed brain tissue sections with a 
δ-specific antibody in comparison with WT mice. The δKO sections did not reveal any immuno-
reactivity, as represented in the hippocampal sections (Figure 34). The thalamus contains high 
expression of δ-containing receptors (Pirker et al., 2000; Wafford et al., 2009). Thalamic 
regional expression δ-subunit pattern was also ablated upon knockout. 
 
 
 
 
 
Figure 34. Immunohistological confirmation of δ-subunit deletion in germline δKO mice. GABAA 
receptor δ-subunit (Gabrd) antibody (1:250) was used for staining the δ-subunit pattern in transverse 
sections of hippocampus. Immuno-staining was completely absent in sections from δKO mice. In the WT, 
δ-positive section, strong staining is evident in the dentage gyrus molecular layer and thalamus (THAL). 
Only background, non-specific staining was evident in the δ-null sections (right image). This non-specific 
staining was lighter in intensity in smaller titres of antibody staining.  
 114 
 
\  
Figure 35. Morphological profile of δKO and WT mouse hippocampus. Nissl-stained sections of WT 
and δKO mice reveal no overt abnormalities in the cytoarchitecture in the dorsal hippocampus. Nissl-
stained neurons within the dorsal hippocampus CA1, CA3, and DG regions were similar in WT and δKO 
mice. Scale bars: Top two panels, 400 μm; CA1, CA3, and DG panels, 50 μm.  
 115 
 
Histological comparison of brain morphology 
 
There have not been any previous reports of histological or anatomical brain differences of 
germline δKO. We performed cytochemical studies with Nissl-stained δKO and WT mouse 
brain to ascertain any morphological differences. Histological analysis revealed normal 
architecture of the ventral and dorsal hippocampus, amygdala, neocortex, and hypothalamic 
regions in δKO mice. The pyramidal layers at the CA1 and CA3 subfields, and hilar and granule 
cells of DG in the δKO mouse appeared normal, and were similar to age-matched WT control 
(Figure 35). However, CA3 and DG regions of the dorsal hippocampus had greater dispersion of 
principal neurons in δKO mice.  Overall, hippocampal cell architectual abnormalities were not 
evident in δKO mice. 
 
Fecundity and development of δKO mice 
 
The key limitation of the germline δKO mouse model is developmental defects that could 
confound the phenotype. Therefore, neonatal and recently-weaned germline δKO mice were 
examined to ascertain any developmental impairment in the transgenic strain. Previously reports 
found that approximately 5% of knockout pups die before weaning, and in addition, knockout 
breeders produce fewer pups per litter overall compared to WT breeders (Mihalek et al., 1999). 
Consistent with this finding, we report fewer mice per litter from homozygous knockout 
breeding pairs (δ-/-)  (5.39 ± 0.27, n = 60) than WT breeding pairs (δ+/+) (7.21 ± 0.34, n = 92; p = 
0.0002) (Figure 36A). An average 25.3 ± 5.3 % of δKO mice were lost prior to weaning, 
whereas an average of 4.2 ± 2.0 % WT mice died before weaning (Figure 36B). Measurements 
of weight were taken for mice twice a week for 80 days after weaning. In the first 14 days after 
weaning, male and female δKO mice displayed significantly lower weights than WT 
counterparts (Figure 36C). Our findings are consistent with previously published data that 
suggests the deletion of the δ-subunit has a critical impact on reproduction, and we uncover 
further developmental defects of the transgenic δ-subunit mutant. 
 
 116 
 
 
 
Figure 36. Developmental alterations in germline δKO mice. A, Histogram depiction of the number of 
pups per litter born to WT or δKO breeding pairs. A left shift in normalized frequency is evident in the 
δKO group. Mean mice per litter was significantly lower in δKO mice compared with WT mice (see text).  
B, Mean percentage of pups per litter that died prior to weaning (* p < 0.05 vs. WT, n = 60 δ-/- litters, 92 
δ+/+ litters). C, Average mouse weight of WT and δKO pups from 0-80 days after weaning (* p < 0.05 vs. 
δKO, n= 23 δKO mice, n=31 WT mice). D, Sex-specific comparison of weights 0-20 days after weaning 
for WT and δKO mice. Males exhibited significantly greater weights than females. (* p < 0.05 for male 
WT vs. δKO comparison, # p < 0.05 for female WT vs. female δKO comparison). WT and δKO weights 
normalized 12 days after weaning, and were not significantly different 12-80 days after weaning.  
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Porsolt forced swim test 
 
To investigate changes in behavioral depression, the Porsolt forced-swim test was performed in 
both male and female WT and δKO mice (Figure 37). The Porsolt test is the accepted paradigm 
for studying depression in mouse models (Porsolt et al., 1978). Mice were placed in an 
inescapable cyllinder of water for 6 minutes, and latency to the first immobility and total 
duration of immobility were measured. A mouse was determined to be immobile when it ceased 
all active behaviors and remained passively floating or making minimal hind-limb movements 
necessary to maintain nostrils above the water. WT mice exhibited a lower average latency to 
first immobility (24.6 ± 1.9 s) than δKO mice overall (60.8 ± 3.2 s), signifying a faster rate of 
passivity (Figure 37A). Mean latency to first immobility for male and female WT mice was 21.9 
± 2.4 s and 26.9 ± 2.8 s, respectively. Latency to first immobility for male and female δKO mice 
was 59.0 ± 5.3 s and 62.6 ± 3.8 s, respectively (n = 17-19 mice/group). These results signify that 
male mice had significantly faster rate of first immobility than the female counterparts. 
Fractional percentage of time spent immobile in the swim test is shown in Figure 37B. The δKO 
mice spent significantly less time immobile than WT mice, with no significant effect of gender 
(female δKO: 252.7 ± 4.9 s, male δKO: 255.5 ± 5.0s, female WT: 283.9 ± 5.0 s, male WT: 288.4 
± 4.7s). Furthermore, δKO mice had more initiations of active escape behavior than WT mice 
after initial immobility. These results suggest potential differences in depression behavior in 
δKO mice due to the constitutive removal of the δ-subunit-containing GABAA receptors. 
 
Elevated plus-maze test 
 
We used the elevated plus-maze learning task to determine if δ-subunit deficiency produces 
cognitive deficits in knockout mice (Figure 38). Female WT and δKO mice displayed 
significant differences in the Day 1 transfer latency, however male mice displayed similar times. 
We did not observe a significant effect of gender, although female mice had a shorter Day 1 
transfer latency compared to males among both WT and δKO mice. Day 2 transfer latencies did 
not display a significant effect regarding either strain or gender. The difference in transfer 
latency between the acquisition (Day 1) and retention (Day 2) trial was not significantly affected 
by gender or strain. Therefore, we conclude that baseline conditions of memory consolidation 
tested by the elevated plus maze are not significantly effected by δ-subunit germline deletion.  
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Figure 37. Porsolt forced swim test of depression behavior in δKO mice. A, Quantification of latency 
to first time of immobility in WT and δKO mice, stratified by sex. B, Fraction of time spent immobile in 
the 6 minute Porsolt forced swim test, expressed as a percentage for WT and δKO, stratified by sex. All 
animals were 2 months old. * p < 0.05 vs. δKO counterpart of same sex, n = 17 – 19 animals per group. 
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Figure 38. Elevated plus maze test of cognitive behavior in δKO mice. Transfer latency for WT and 
δKO mice as the time required for a mouse to travel to an enclosed arm of the plus maze when placed at 
the end of a plus arm. Day 1 (white bars) represents acclamation to the environment and learning the 
environment. Day 2 (black bars) represents memory retention of the maze. All groups developed mean 
reduction in transfer latency from Day 1 to Day 2. WT and δKO mice were experimentally naïve on Day 1 
and group-matched for age and sex. (* p < 0.05 vs. Day 1; # p < 0.05 vs. WT female). n = 9 animals per 
group.  
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CHAPTER V 
DISCUSSION 
 
V.1 Role of δ-subunit Plasticity in Neurosteroid Withdrawal  
 
Perimenstrual-like withdrawal from neurosteroids results in striking increase in extrasynaptic δ-
containing GABAA receptors in the dentate gyrus, a key limbic subregion associated with 
epilepsy pathology. Up-regulation of δ-subunit confers increased sensitivity to AP potentiation 
of GABAA receptor-mediated tonic inhibition in DGGCs. The prominent increase in δ-subunit 
expression specific to the dentate gyrus exemplifies its “gate-keeping” function in controlling 
baseline inhibition and network inputs in the hippocampus (Coulter and Carlson, 2007).  These 
findings provide a molecular mechanism for enhanced anticonvulsant activity of neurosteroids in 
perimenstrual models of catamenial epilepsy and thereby strengthen the rationale for 
neurosteroid therapy of catamenial epilepsy. 
We observed significant up-regulation of δ-subunit expression in the hippocampus during 
perimenstrual-like NSW, confirming the role of extrasynaptic GABAA receptors in response to 
fluctuating neurosteroid levels in the brain. This novel observation is consistent with the ovarian 
cycle-linked regulation of the plasticity and function of extrasynaptic GABAA receptors (Reddy 
et al., 2012; Wu et al., 2013). While other regions within the hippocampus had marginally 
increased expression of δ-subunit, the withdrawal-induced δ levels and membrane surface 
insertion were directed most significantly within the dentate gyrus. This in turn resulted in 
functional increase to neurosteroid potentiation of extrasynaptic receptors. Previous reports of 
NSW-induced up-regulation of GABAA receptors have focused on expressional changes within 
CA1 pyramidal neurons (Smith et al., 1998b; Smith et al., 2007; Sundstrom-Poromaa et al., 
2002). NSW-induced increase to δ-subunit has not previously been shown within the dentate 
gyrus. Our findings of δ-specific perimenstrual up-regulation in DGGCs confirm a functional 
role for α4βδ receptors in modulating excitability in catamenial epilepsy. 
The mechanisms underlying perimenstrual δ-subunit plasticity remain unclear. The early growth 
response factor-3 pathway is implicated in NSW-induced α4 subunit up-regulation and this has 
been found to occur independently of any PR interaction (Gangisetty and Reddy, 2010). The up-
regulation of δ-subunit was also evident in PR knockout mice experiencing NSW. Thus, it is 
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likely that the δ-subunit plasticity is neurosteroid-dependent and not due to PR activation by 
progesterone in the perimenstrual model. It is likely that cellular machinery involved in protein 
and receptor trafficking may have an important role in the expression of GABAA receptor 
subunits (Jacob et al. 2008). 
 
AP was utilized as a prototype neurosteroid to study the function of GABAA receptors in the 
perimenstrual model. Other neurosteroids could have a role in modulating neuronal excitability 
(Tuveri et al., 2008; Reddy and Ramanathan, 2012), but the clear correlation between cyclic 
progesterone and perimenstrual seizure susceptibility led us to hypothesize that NSW and 
subsequent sensitivity to AP is strongly mediated by δ-containing receptors (Reddy, 2009ab). 
Finasteride inhibition of 5α-reductase results in decreased AP synthesis in mice (Reddy et al., 
2012). This directed decline in AP was employed to determine the basis for neurosteroid 
sensitivity similar to that occurring in women experiencing perimenstrual withdrawal.  
 
Consistent with previous studies of α4,δ-containing, recombinant receptors (Brown et al., 2002), 
our findings in native DGGCs indicate a significant increase in receptor function by AP in the 
withdrawal model. Physiological concentrations of AP (100-300 nM) produced significantly 
greater GABAA receptor current modulation in NSW compared to control mice (Figure 9,10). 
Furthermore, δKO DGGCs did not display enhanced sensitivity to AP upon withdrawal, 
suggesting that NSW-induced functional changes are δ-directed. This signifies a key role by 
extrasynaptic, δ-containing receptors in response to endogenous neurosteroids in the dentate 
gyrus during withdrawal despite a pathological susceptibility to seizures (Stell et al., 2003). 
 
The up-regulation of δ-subunit was substantial enough to allow for a detectable change in AP 
potentiation of whole-cell GABAA receptor current in DGGCs but not in CA1PCs. Although we 
observed significant increases to δ-subunit expression in CA1, this did not result in increased AP 
potentiation of GABAA receptor current within these neurons.  It has been previously reported 
that δ-containing receptors do not contribute to neurosteroid sensitivity or inhibitory tonic 
current within the CA1 (Stell et al., 2003; Glykys et al., 2008). Within male mice under control 
conditions, tonic inhibition in CA1 neurons is primarily modulated by α5βγ2 receptors (Glykys et 
al., 2008). We found that NSW does not convey functional increase to extrasynaptic current in 
CA1, as demonstrated with δ-sensitive pharmacology (Figure 9B,F). Membrane surface 
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expression of δ-containing receptors is profuse within dentate gyrus but is sparse within the 
CA1, CA2, and CA3 regions (Pirker et al., 2000; Peng et al., 2002). We previously reported the 
estrous cycle-dependent δ-subunit plasticity and function were specific to DG and not to CA1 
neurons (Wu et al., 2013). The large difference in AP modulation between DGGC and CA1 
neurons suggests region-specific plasticity of GABAA receptors and neurosteroid sensitivity in 
this perimenstrual-like model of epilepsy. 
 
In the NSW model, we investigated the tonic current function of extrasynaptic GABAA receptors 
in DGGCs. Low, extracellular GABA (0.3 – 1.0 µM) produced greater tonic current in NSW 
condition than control. The AP potentiation of tonic current in withdrawal DGGCs was also 
significantly greater than control DGGCs. Within δKO DGGCs, the substantial reduction of 
tonic current typical for the knockout model did not revert to higher levels upon NSW, 
confirming that withdrawal-associated potentiation of tonic current is δ-mediated. We also 
explored THIP modulation of tonic current and found that NSW DGGCs had enhanced tonic 
current at THIP concentrations reported to be δ-subunit selective (Meera et al., 2011). These 
findings signify enhancement of neurosteroid sensitivity to promote extrasynaptic receptor 
function and defines a functional role of δ-sensitive agents to modify network inhibition of the 
hippocampus. 
 
Up-regulation of δ-subunit expression may affect postsynaptic function. In the NSW model, 
GABAA receptor mIPSC properties were unaltered in DGGCs. However, in response to AP, 
mIPSCs displayed increased amplitude and prolonged decay kinetics. We did not observe any 
similar AP-sensitivity changes to mIPSC properties in the δKO mouse upon withdrawal. In fact, 
decay kinetics were modestly reduced in δKO DGGCs during AP application (Table 2). 
Therefore, withdrawal-induced increases in δ levels confer higher synaptic sensitivity to 
neurosteroids. Our findings are consistent with previous reports of AP-modulated changes in 
postsynaptic function (Sun et al., 2007). Our results show that AP only potentiated mIPSC 
amplitude from NSW but not from control cells. Neurosteroids prolong the kinetics of synaptic 
GABAA receptor channels, resultant from longer channel gating time in open configuration 
(Bianchi and Macdonald, 2003). Due to heightened neurosteroid sensitivity in NSW, there is 
preferential enhancement of the low-efficacy state during neurosteroid binding, thereby 
contributing to the AP-sensitive phasic currents gated by GABA. We found this modulation of 
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phasic current to be neurosteroid- and δ-subunit-dependent.  mIPSCs from δ-knockout mice 
DGGCs have a faster decay time constant (Mihalek et al., 1999), and neurosteroid modulation of 
synaptic currents is reduced (Spigelman et al., 2003). We did not detect changes to subunits in 
the hippocampus primarily assembled at the synapse (α1, α2, β2, γ2). Therefore, it is unlikely that 
the increase of α4 and δ subunits promotes compensational changes to other subunits in the 
withdrawal model. Moreover, previous studies suggest that α4βγ2 receptors exhibit faster 
desensitization than α4βδ but exhibit slower decay kinetics (Brown et al., 2002; Smith and Gong, 
2005). Overall, these results expand on previous findings by presenting a novel model in which 
strong δ-up-regulation promotes neurosteroid sensitivity on phasic receptors. 
 
Despite increased awareness of neurosteroids, the molecular pathophysiology of catamenial 
epilepsy remains unclear. A decline in neurosteroid in the brain and subsequent reduction of 
GABAA receptor-mediated inhibition can create an environment of hyperexcitability within the 
limbic network. Mice that experience inhibition of AP synthesis show enhanced susceptibility to 
limbic epileptogenesis (Reddy, 2009b; Reddy et al., 2012). We induced neurosteroid withdrawal 
in an in vivo rapid kindling paradigm to explore acute epileptogenesis during the dynamic 
GABAA receptor plasticity. Despite up-regulation of extrasynaptic receptors, wildtype mice 
undergoing NSW experienced heightened seizure susceptibility. This could be due to the lack of 
modulatory control of inhibition consequent of imbalance of GABA and glutamate 
neurotransmitters upon kindling (Minamoto et al., 1992). In limbic epilepsy, tonic inhibition 
mediated by δ-containing receptors remains intact; moreover, GABA uptake by transport 
proteins also retains function (Pavlov and Walker, 2012; Pavlov et al., 2011), preventing 
accumulation of extracellular GABA that could increase inhibitory gain. Our reported decrease 
in endogenous tonic current during NSW suggests extrasynaptic receptors experience less 
inhibitory modulation due to the altered hormonal environment. Pathophysiological mechanisms 
and network aberrations may constrain GABAA receptor function in epilepsy (Cohen et al., 
2003). The rapid kindling of the hippocampus in NSW mice produced an accelerated progression 
of epileptogenesis as well as development of sustained, excitable electrical activity that 
originated within the hippocampus. These results suggest that the hippocampus is more 
susceptible to excitability due to diminished AP. Fully kindled mice undergoing NSW displayed 
enhanced antiseizure sensitivity to the neurosteroid AP (Figure 14A-B), and lack of δ-subunit 
diminished neurosteroid sensitivity (Figure 14C-D).  Therefore, plastic increase in δ-containing 
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GABAA receptors with high affinity for neurosteroids provides the opportunity for novel 
therapeutic targets to dampen excitability in individuals who are susceptible to seizures. 
 
In conclusion, these results provide strong evidence that neurosteroid withdrawal, such as that 
which occurs during perimenstrual period, is associated with striking up-regulation of the 
extrasynaptic δ-containing GABAA receptors that mediate tonic inhibition in the hippocampus. 
This provides a molecular mechanism for enhanced anticonvulsant activity of neurosteroids and 
network inhibition in hyperexcitability conditions of catamenial epilepsy and other menstrual 
conditions linked to neurosteroid withdrawal. These findings provide a mechanistic rationale for 
neurosteroid therapy of catamenial epilepsy. 
 
V.2  Neurosteroid Structure-activity Relationships at δ-subunit Extrasynaptic Receptors  
 
The principal findings of the second specific aim uncover the structural significance of 
neurosteroid interaction with extrasynaptic GABAA receptors that provide tonic inhibition within 
the dentate gyrus. We examined an extensive library of neurosteroid structures and a wide 
concentration range to assess both physiological and clinically relevant potentiation of 
extrasynaptic receptors. The tonic current of DGGCs is highly dependent on δ-containing 
receptors (Stell et al., 2003; Glykys et al., 2008; Carver et al., 2014). We focused on the δ-
subunit-specific tonic inhibition properties of native DGGCs in determination of SAR. Despite 
an inherent heterogeneity of the GABAA receptor population within native neurons, our findings 
support an obligatory role of δ-subunit in neurosteroid modulation of tonic inhibition. Synapse-
localized receptors are less sensitive to neurosteroid modulation (Wohlfarth et al., 2002). Phasic 
and tonically active receptors differ in their GABA affinity (Mortensen et al., 2012), 
desensitization rate, agonist efficacy (Bianchi and Macdonald, 2002; 2003), and neurosteroid 
binding affinity (Brown et al., 2002; Wohlfarth et al., 2002). The differences in subunit 
composition properties are highly relevant to therapeutic use of neurosteroids. They are 
indicative of the complex neurosteroid interactions that occur within the brain that cannot be 
completely determined by heterologous expression systems in which physiological structure and 
receptor heterogeneity may be absent.  
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Previous studies have shown that greater levels of receptor expression in oocytes or HEK293 
cells result in higher frequency of spontaneous GABAA channel opening (Hadley and Amin, 
2007; Jensen et al., 2013). These properties signify artifacts of heterologous expression systems 
that could confound pharmacological activity profiles. Here we examine the spatially and 
functionally significant properties of GABAA receptor tonic current within the slice and 
hippocampal network. Using a model of δ-subunit deletion, we provide evidence of a biphasic 
effect of neurosteroid activity that results in increased inhibitory tone due to alternative receptor 
subtypes. 
 
In the SAR studies, we used a range of concentrations that signify physiological and 
pharmacological levels. Aqueous concentration values of neurosteroid in perfusion reflect levels 
that are circulating within the extracellular fluid; however, the membrane concentration of 
steroid drives the binding interactions with GABAA receptors (Chisari et al., 2009). In 
examination of SAR within the slice, our findings reflect a gradual access of neurosteroid to 
receptors on the order of minutes rather than instantaneous or rapid access. Furthermore, our 
preparation permits possible accumulation of neurosteroid in surrounding tissue at the time of 
receptor modulation, analogous to that of a physiological state. Thus, the concentration-
dependent responses we report here convey the pharmacodynamics activity and specificity of 
neurosteroids via allosteric modulation. 
 
At higher concentrations, neurosteroids (> 1 µM) exhibit direct activation of GABAA receptors 
(Puia et al., 1990). The structural properties of neurosteroids that enable direct binding are not 
well understood. We described AP’s capacity to directly activate extrasynaptic receptors by 
examining tonic current in WT and δKO DGGCs. AP was less efficacious in potentiating tonic 
current via direct receptor activation compared to allosteric binding with GABA. The 
exponential increase in tonic current due to application of 3 μM AP + GABA was greater than 
application of 3 μM AP alone in WT neurons (p = 0.0046). This indicates that the δ-subunit 
highly contributes to direct AP activation of tonic currents, as δ-containing receptors accounted 
for approximately 71% of the tonic current at 3 µM AP (Figure 20C). Previous report of 
cumulative GABAA receptor response indicates that high-efficacy/synaptic receptors are 
sensitive to direct activation by neurosteroid (Kokate et al., 1994). We could not extend such 
findings to tonic current recordings, as direct AP (0.1 - 1 μM) did not potentiate tonic current 
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from δKO DGGCs. Other data suggests that higher concentrations of neurosteroid may block the 
GABAA receptor channel pore, inhibiting chloride conductance (Brown et al., 2002). In contrast, 
we demonstrate extrasynaptic receptors displayed further potentiation at higher neurosteroid 
concentrations as well as direct activation of chloride channel conductance. A delayed response 
to the direct activation of neurosteroid has been previously observed (Kokate et al., 1994). 
However, due to the gradual bath perfusion of neurosteroid in interaction with the slice tissue, 
we were unable to detect any differences in the required time of channel modulation between 
allosteric and directly activating drug.  
 
GABAA receptors have distinct gating properties in low-efficacy and high-efficacy states, and 
neurosteroids are uniquely sensitive to the channel function conferred by δ-subunit that enables 
continuous, inhibitory conductance (Bianchi and Macdonald, 2003). We found that neurosteroid 
activity on tonic currents to be δ-subunit dependent within DGGC. Deletion of δ-subunit 
completely diminished the allosteric potentiation and direct activation effects of AP. Therefore, 
the low-to-high efficacy transduction produced by neurosteroid is δ-subunit mediated under 
physiological conditions. These data support our previous findings of the significance of δ-
subunit plasticity to tonic current function (Carver et al., 2014; Wu et al., 2013). Additionally, 
we discovered a role for other GABAA receptors which may contribute to tonic conductance in 
facilitation of high-efficacy states. Within δKO DGGCs, 10 µM GABA or ≥ 3 µM neurosteroid 
elicited modest hyperpolarizing, tonic responses. Despite δ-deficiency, the high-efficacy 
modulation signifies a biphasic response of the native receptor population in which non-δ 
receptors are being potentiated to influence tonic current. We have shown this potentiating 
response both in conditions of allosteric and direct neurosteroid activity. The subunit 
configuration and location of these high-efficacy receptors remains unclear, but may relate to the 
compensational shift of other subunit expression within the germline δKO mouse strain (Peng et 
al., 2002). Changes to neurosteroid sensitivity are also relevant to the hyperexcitability of 
epileptic granule cells (Kobayashi and Buckmaster, 2003) and the decreased expression of δ-
subunit in epileptic hippocampus (Whissell et al., 2015). Large neurosteroid accumulation could 
overcome the fast desensitization of synaptic or perisynaptic receptors to provide for prolonged 
GABAA channel opening and increased hyperpolarizing tone. A large reduction in tonic 
conductance may lead to lack of shunting inhibition for δ-deficient neurons and likely presents a 
model for hyperexcitability within the hippocampus in which neurosteroids may still modulate 
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current at higher concentrations. A recent concatamer-receptor study reported that α4βδ and 
α1βγ2 GABAA receptors have largely similar structure-activity profiles for neurosteroids (Shu et 
al., 2012). We demonstrate SAR of neurosteroids that is specific to native, δ-containing receptors 
and further reveals a divergent role of tonic inhibition that is specific for the function of granule 
cells in the dentate gyrus. 
 
Sex-dependent differences in GABAA receptor expression and function remain important to 
understanding network excitability and modulation by anticonvulsant drugs like neurosteroids 
(Galanopoulou et al., 2008ab). Our behavioral studies provide supporting evidence for sex-
specific, distinctive receptor expression and plasticity within the adult brain. We used the 6-Hz 
model as diagnostic of a large array of structurally diverse neurosteroids, correlating their 
antiseizure effects with tonic function in the slice. In addition, we provide insight to comparative 
effects of neurosteroids in male and female mice in vivo, indicating differences in GABAA 
receptor substrate and extrasynaptic environment.  
 
A previous report represented the GABAergic EC100 as the two-fold potentiation of GABA 
current by neurosteroid (Kokate et al., 1994). We ascertained the true extrasynaptic contribution 
of δ-subunit by parsing the contributions of δ- and non-δ-containing receptors in modulation of 
tonic current by GABA and neurosteroid. Relative efficacy of tonic current potentiation for our 
library of neurosteroids was compared for a wide range of concentrations (0.1 – 3.0 μM) to 
better assess structure-activity contributions to extrasynaptic, tonic current (Table 5). In 
addition, we developed a table to ascertain the correlation between neurosteroid modulation of 
tonic current inhibition and anticonvuslant profiles in the 6-Hz seizure model in mice (Table 6). 
We determined a strongly correlated relationship between the anticonvulsant potency of 
neurosteroids in protection of 6-Hz seizures and the capacity of neurosteroid to potentiate current 
of δ-containing extrasynaptic receptors. 
 
Our experiments focused on neurosteroid SAR by experimentally isolating the extrasynaptic 
responses in native neurons within slice. This study reflects physiological modulation of 
localized, extrasynaptic receptors rather than measurement of aggregate responses, which are 
inclusive of all GABAA receptors within the neuronal membrane. All allosteric experiments were 
carried out in the presence of 1 μM GABA to compare neurosteroid concentration-dependent 
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current responses. AP was examined as a prototypical modulator of GABAA receptor function in 
comparison of other steroidal structures. The 3β-OH-modified neurosteroid (3β-AP) was unable 
to modulate extrasynaptic receptors, exhibiting a motif of inactivity for 3β-reduced steroids (Puia 
et al., 1990). The 3α-hydroxyl therefore has a critcal role in extrasynaptic receptor modulation. 
The α or β orientation of the C5 position affects the shape of the A ring of the steroid molecule 
(Hosie et al., 2007), and may influence receptor affinity. However, some previous studies using 
post-synaptic preparations report no change in the structure-activity relationship of 5β- compared 
to 5α-pregnane neurosteroids (Simmonds, 1991; Xue et al., 1997). In contrast, we observed 
significantly less tonic current modulation by 5β-AP stereoisomer, as AP maintained nearly 2-
fold greater tonic current response compared to 5β-AP. These findings are consistent with prior 
reports of reduced 5β efficacy (Kokate et al., 1994; Hosie et al., 2006), but we reveal specific 
information for extrasynaptic receptor binding. Another report of neurosteroid modulation on δ-
containing receptors had observed greater sensitivity to THDOC than AP (Brown et al., 2002). 
Interestingly, THDOC displayed significantly lower tonic current modulation compared to AP at 
sub-micromolar concentrations. ALFX exhibited reduced tonic current compared with AP, likely 
due to its ketone at the C11 region, which could interfere with the coordinated binding at the 
hydrophobic pocket in the transmembrane domain of the receptor. Thus, the conserved C3α and 
C17 groups may be influenced by other structural factors in extrasynaptic receptor interaction. 
Weaker tonic modulation by androstane neurosteroids indicates lower allosteric activation of 
tonic current. The androstane 17-β functional groups (see Table 3) suggest a more polar C17 
position, resulting in weaker affinity for the hydrophobic binding pocket (Reddy and Jian, 2010). 
Structural differences in electronegativity stemming from the C17 position may therefore be 
crucial to the binding activity for extrasynaptic receptors. The ORG-20599 compound exhibited 
high extrasynaptic efficacy and affinity greater than AP. The morpholinyl conjugation in the A 
ring could drastically alter the shape of molecule and serve to facilitate the hydrogen bonding of 
the 3α group. However, ORG-20599 possessed very weak potency in 6-Hz antiseizure function 
for reasons possibly related to pharmacokinetics or ability to cross the blood-brain barrier, 
despite report as a potent anesthetic (Hill-Venning et al., 1996).  
 
The site-specific residues determined to be crucial for neurosteroid binding were determined to 
be Q241 and N407/Y410 (Hosie et al., 2007). However, these studies were carried out in α1 
subunit, and the α4 subunit similarities in interaction with the transmembrane binding pocket 
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remain unclear. A recent report incorporated T235W and Q240W mutations into the α4 subunit 
and rendered δ-containing receptors (α4βδ) insensitive to positive allosteric modulation by AP 
(Jensen et al., 2013). Therefore, the higher affinity for the α4 subunit binding interface and δ-
dependent channel transduction greatly contribute to neurosteroid binding.  
 
Based on the structure-activity data and integration of literature concerning extrasynaptic 
receptors, we designed a consensus pharmacophore model (Figure 39). Our proposed 
pharmacophore model suggests coordination of the two hydrogen bond donating groups in 
affinity for the transmembrane allosteric interface, facilitated by the δ-subunit. The proposed 
pharmacophore map is derived based on the correlation between neurosteroid modulation of 
tonic current and anticonvulsant profiles from the 6-Hz seizure model. The salient features of our 
proposed pharmacophore model are: a) The C3 and C17 regions remain critical to the δ efficacy 
of neurosteroids. b) The C5 region indicates a stereo-selectivity for neurosteroid interaction at 
extrasynaptic sites, similar to that of synaptic receptor binding. c) The C20 branch of the 
pregnane neurosteroids likely provides coordination of the hydrophobic pocket affinity that 
yields effects on both potency and efficacy. d) This potency is attenuated in the case of 
androstane neurosteroid binding of extrasynaptic receptors. e) Ketone group attached to the C11 
position such as that in the synthetic neurosteroid alfaxalone proves detrimental to δ-subunit-
containing receptor efficacy. 
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Figure 39. Pharmacophore map of neurosteroid structure-activity at δ-containing extrasynaptic 
GABAA receptors. The key structural components of the neuroactive-steroid chemical structure, based on 
structure-activity studies from Results section IV.2 and Table 5-6. These key structures are derived from 
electrophysiological and behavioral studies of neurosteroid activity on the putative extrasynaptic function 
of δ-containing GABAA receptors. R1: C3-position stereoselectivity of the hydroxyl group. R2: C3-position 
β-conjugation in conjunction with the 3α-hydroxyl group. R3: C5-position stereoselectivity of the 
hydrogen bond upon 5α- or 5β-reductase activity. R4: C11-position conjugation of double-bonded oxygen 
in the case of alfaxolone and alfadalone synthetic neurosteroids. R5: C17-position β-conjugation necessary 
for efficacy, C20-position ketone for pregnane neurosteroids (AP, THDOC), or C17-position for 
androstane neurosteroids (AD, AN, ETIO). Values listed are approximate range of neurosteroid 
potentiation of Itonic as a percentage of the AP prototypical Itonic responses in electrophysiology slice 
recordings.  
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V.3  Role of δ-subunit in Seizure Susceptibility and Epileptogenesis 
 
The principal finding for this study is that mice with a targeted germline deletion of δ-subunit in 
the brain exhibit increased propensity for the development and persistence of kindling 
epileptogenesis, indicating a crucial role for δ-containing receptors in seizure susceptibility. We 
observed a markedly increased rate of kindling epileptogenesis, afterdischarge duration, and 
seizure severity within δKO mice. In addition, we found sex-specific differences in kindling 
epileptogenesis. Male WT and δKO mice exhibited more rapid kindling and persistence of 
seizures than their female genotype counterparts. Previous studies have indicated sex-specific 
distinctions in seizure propensity and epilepsy (Galanopolou, 2008ab; Pack et al., 2011; Reddy, 
2009b; 2011; Reddy and Kulkarni 1999; Wu et al., 2013). These differences span a wide range 
of properties, including expression of GABAA receptors as the substrate for network inhibition, 
as well as neuroendocrine pathophysiology that may promote conditions of seizure 
susceptibility. Our findings suggest that alterations in δ-containing extrasynaptic receptors 
contribute to the balance of excitatory inputs in the hippocampus and may be key mediators of 
epilepsy pathophysiology. Collectively, our functional and behavioral observations indicate that 
epileptogenesis is facilitated in conditions of attenuated tonic current in the dentate gyrus, 
attributed to lack of δ-containing extrasynaptic receptors. 
 
The hippocampus is a key structure in epilepsy pathophysiology. As the modulatory “gate-
keeper” and filter for the hippocampus, the dentate gyrus possesses inhibitory control over 
excitatory inputs from the entorhinal cortex and other brain regions (Coulter and Carlson, 2007; 
Heinemann et al., 1992). The putative function of tonic inhibition in the hippocampal principal 
cells is achieved by shunting of excitatory current, thereby altering the slope of the input-output 
relationship as divisive inhibition (Mitchell and Silver, 2003; Wlodarczyk et al., 2013). Tonic 
chloride conductance also mediates the baseline hyperpolarizing membrane current via 
subtractive inhibition. However, the function of δ-containing extrasynaptic receptor modulation 
at the network and systems level remains poorly understood. Our results from behavioral 
kindling of the hippocampus in δ-deficient mice provide a better understanding of the role of 
extrasynaptic receptors in the epileptogenic pathways. 
 
 131 
 
Several caveats regarding interpretation of the findings are of consequence to these behavioral 
studies, in which the proper context must be considered. First, the results apply only to the 
hippocampus kindling model used in these studies. The kindling model, while sharing many 
similarities with human complex seizures, cannot accurately or reliably account for all idiopathic 
forms of epilepsy. Therefore, better understanding as to the underlying causes of seizure 
progression will help to more closely link the kindling model to human epileptogenesis in 
translational studies. In an effort to recapitualate the genotypic differences brought on by lack of 
δ-subunit, we were unable to show similarly increased seizure susceptibility in δKO mice with 
the PTZ chemoconvulsant model. Secondly, the knockout animals used in these experiments 
possess unique qualities that could represent epiphenomena related to the transgenic 
manipulation that results in compensatory receptor expression and other changes (see section 
I.8). Moreover, we uncovered developmental differences between WT and null mutants, 
indicating the possibility of brain development alterations leading to divergent phenotypes in 
addition to loss of δ-subunit function. Nevertheless, we provide strong evidence for the 
contribution of δ-subunit to seizure modulation of the kindling model. Conditional transgenic 
and translational models will be useful in future directions to study network control of 
excitability and epileptogenesis. 
 
In the kindling model, there was no observable change in the baseline behavioral seizure activity 
during the early stimulations, and the electrographic afterdischarge threshold was simliar 
between genotypes. Focal electrographic afterdischarge is required for the induction of 
epileptogenesis in the kindling model (Goddard et al., 1969). The accelerated kindling 
development in δKO mice could be attributed in part to the differences in focal electrographic 
seizures, as the duration of evoked afterdischarge duration displayed disparity among WT and 
δKO during the early stimulation sessions. There was a reliable correlation of kindling 
rate/progression of seizures and afterdischarge duration. However, as kindling progressed to later 
stages of seizure activity, afterdischarge duration tended to normalize among genotypes. 
Hyperexcitability was reinforced with recurrent electrical stimulation, resulting in a steeper slope 
of progression for δKO mice compared to WT. These results indicate that the structural and 
functional connections required to exhibit behavioral and electrographic seizures may be altered 
in δKO mice. Seizure propogation originated in the hippocampus, and we conclude from our 
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functional studies that this region has significant alterations in network excitability due to 
germline knockout. 
 
The mechanisms underlying epileptogenesis involve an interaction of acute and delayed 
anatomic, molecular, and physiological events that are complex and multifaceted (Walker et al., 
2002). Neuronal injury activates diverse signaling events, such as inflammation, oxidation, 
apoptosis, neurogenesis, and synaptic plasticity, which eventually lead to structural and 
functional changes in neurons (Löscher, 2002; Pitkӓnen et al., 2009). In addition, information is 
emerging concerning extrasynaptic inhibition alterations due to seizures, injury, and 
excitotoxicity (Cohen et al., 2003; Dibbens et al., 2004; Pandit et al., 2013; Pavlov et al., 2011). 
These changes are eventually manifested as abnormal hyperexcitability and spontaneous 
seizures. Reduction to GABAergic tonic inhibition that typically facilitates shunting of 
excitatory current could be a reasonable mechanism for the promotion of epileptogenesis in δKO 
mice, along with other precipitating conditions.  
 
To assess specific modulation of tonic inhibition we administered low pharmacological dose of 
AP neurosteroid to mice that did not result in any sedative, anesthetic, or motor toxicity effects. 
This dose was studied in prolonging the progression of seizures, but it was not effective in 
preventing the full kindling of maximum seizure severity. Overall, neurosteroid treatment 
retarded epileptogenesis compared to vehicle-injected controls in both WT and δKO mice. 
However, the disease-modifying effects of neurosteroid were diminished in δKO animals in later 
stages of kindling development. The delay in anticonvulsant effect over late-stage kindling of 
δKO is significant in the therapeutic control of seizures in which individuals with greater 
susceptibility to seizures and hyperexcitability due to brain insult are resistant to conventional 
antiepileptic drugs. We show that δKO exacerbation of repeated electrical stimulation is less 
sensitive to the antiepileptogenic effect of the neurosteroid AP.  This may provide a framework 
for understanding neurosteroid anticonvulsant retardation of epileptogenesis in epilepsy models. 
 
In this study, we demonstrate that δ-containing receptors play an important role in the 
development and persistence of limbic epileptogensis. These findings suggest extrasynaptic 
GABAA receptors may serve as a novel target for therapeutic modulation of inhibition and may 
provide unique approaches to prevent epileptogenesis. Additional understanding of the 
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molecular mechanisms underlying expression of δ-containing receptors may provide better 
insights on how dentate gyrus tonic inhibition influences neuronal excitability in the context of a 
variety of pathophysiological conditions. We have also provided a behavioral framework for 
understanding the developmental and cognitive differences of the germline δ knockout in the 
support of seeking better conditional transgenic models for understanding the role of δ-subunit in 
the hippocampus.  
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CHAPTER VI 
CONCLUSIONS 
 
This work defines a clear role for δ-subunit-containing extrasynaptic receptors in mediation of 
tonic inhibition and seizure susceptibility. The extrasynaptic receptor class within the dentate 
gyrus represents an important target for novel therapeutic drugs that could control brain 
excitability. We have identified a molecular mechanism of catamenial epilepsy by exploring 
increases to extrasynaptic receptor expression and function using an animal model of 
perimenstrual-like neurosteroid withdrawal. This withdrawal model provides a rationale 
underlying neurosteroid therapy in treatment of catamenial epilepsy conditions, whereby tonic 
inhibition is the functional target by neurosteroid modulation of δ-subunit GABAA receptors.  As 
investigation of neurosteroid pharmacology continues, new agents that are more specific in 
binding to extrasynaptic GABAA receptors could help to further identify the allosteric and direct 
binding of neurosteroids. The lipophilic nature of neurosteroids denotes more complex lateral 
binding on the receptor structure. In our approach, we have outlined the structure-activity 
relationship of neurosteroids at δ-containing extrasynaptic receptors in native neurons within the 
hippocampus. We have identified key structural features that provide strong efficacy for 
neurosteroid potentiation of tonic current inhibition. This research also determines a role for δ-
subunit in network excitability by hippocampus epileptogenesis with in vivo mouse models. We 
have provided a framework that confirms δ-subunit-containing GABAA receptors as a 
functionally significant target of neurosteroids in the promotion of network inhibition using the 
germline δKO mouse model. Due to the compensational alterations to GABAA receptor 
expression in the germline δKO mouse, it remains possible that the behavioral and physiological 
profiles of the model are indirectly altered (Stell et al., 2003). Regional and temporal control of 
δ-subunit expression in mice would aid in clarifying the role of extrasynaptic receptors in the 
brain. Future directions include seeking to further resolve the functional significance and 
plasticity of δ-containing, extrasynaptic receptors in epilepsy, stress, and other 
pathophysiological states in which neurosteroid interaction could play a significant role. 
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